Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",A1BG,Alpha-1B-glycoprotein,21172,1227,1.24 [0.90-1.71],0.1896048079164831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AAMDC,Mth938 domain-containing protein,20595,1191,1.05 [0.94-1.16],0.3944708209097767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,24101,1383,1.06 [0.97-1.15],0.193798608754013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,20461,1174,1.23 [1.06-1.42],0.006120158764198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABHD14B,Protein ABHD14B,23951,1370,1.03 [0.95-1.12],0.5216319749584566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,24101,1383,1.10 [1.03-1.18],0.0041912991639404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABO,Histo-blood group ABO system transferase,21143,1218,0.98 [0.95-1.02],0.3343671634394641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,20461,1174,1.03 [0.95-1.12],0.4821774097347511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",23618,1368,1.16 [1.10-1.23],2.500695973873907e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",20717,1204,0.95 [0.88-1.03],0.1995093835166964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",21125,1219,0.98 [0.92-1.04],0.5245850545850157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAN,Aggrecan core protein,23987,1381,0.76 [0.64-0.90],0.0014093317743916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,21143,1218,1.05 [0.86-1.29],0.6382671935939659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,23739,1376,1.55 [1.41-1.69],2.754263170267733e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACHE,Acetylcholinesterase,20675,1203,0.91 [0.76-1.09],0.2914591805961595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,21010,1209,1.01 [0.96-1.06],0.6793008174212474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,24200,1394,1.07 [0.97-1.17],0.1747168435258105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,20528,1188,0.85 [0.75-0.97],0.0127651785839425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,24299,1407,1.25 [1.09-1.45],0.001755964362649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,24361,1398,1.11 [1.03-1.19],0.0061857930664003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRBP,Acrosin-binding protein,21007,1211,1.12 [0.96-1.31],0.1345993434193038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRV1,Acrosomal protein SP-10,20528,1188,0.90 [0.77-1.07],0.2344756993718954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,20461,1174,1.12 [0.98-1.28],0.1031287667952182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",23739,1376,1.12 [1.01-1.23],0.0269305564762047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN2,Alpha-actinin-2,20461,1174,1.11 [1.01-1.23],0.0332904350841387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN4,Alpha-actinin-4,23703,1359,0.95 [0.80-1.12],0.5287489894669527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,23992,1371,2.32 [1.95-2.75],4.721552868171149e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,24200,1394,1.28 [1.19-1.38],1.0388636380301344e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,20461,1174,1.17 [1.06-1.29],0.001339109748012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACYP1,Acylphosphatase-1,20593,1199,1.06 [0.98-1.15],0.1708911606784847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,24435,1413,1.26 [1.11-1.43],0.0004194035683902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,24024,1387,1.10 [0.98-1.24],0.1056360164415421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,20528,1188,1.34 [1.22-1.48],4.2912760265561055e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,23739,1376,1.05 [0.90-1.22],0.539423374982295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,24033,1375,0.85 [0.74-0.98],0.0237407119271537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,24435,1413,1.06 [0.93-1.21],0.3881145479618592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,24369,1401,1.17 [0.99-1.39],0.0594496530137999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,21010,1209,1.41 [1.18-1.69],0.0001436143135969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,20528,1188,1.23 [1.05-1.44],0.0099662697831874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,24485,1416,0.69 [0.56-0.85],0.0004368152894436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,24101,1383,1.20 [1.07-1.34],0.0023429036667306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,23739,1376,1.19 [1.06-1.34],0.0025955043034443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,20528,1188,1.34 [1.15-1.56],0.000160420864275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,24272,1406,0.89 [0.80-0.99],0.0345493273484681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,21122,1217,1.87 [1.58-2.21],1.3930563690189174e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,20595,1191,1.39 [1.11-1.75],0.0041908867591603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,21125,1219,1.01 [0.88-1.16],0.8526258637776035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,23618,1368,0.97 [0.85-1.11],0.6435922337542986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADD1,Alpha-adducin,20675,1203,1.00 [0.93-1.09],0.9404098394242862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,23992,1371,0.91 [0.79-1.05],0.2116417462319783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,20675,1203,1.38 [1.19-1.60],1.7205903034528125e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,21010,1209,0.99 [0.89-1.09],0.7865979433747013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,24314,1410,0.74 [0.63-0.88],0.0004974118788513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,24364,1410,0.74 [0.63-0.87],0.0002617379877262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,21125,1219,1.30 [1.09-1.55],0.0030815598181021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,24101,1383,1.19 [1.10-1.28],1.6149712222120504e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,24200,1394,0.68 [0.57-0.81],1.2060168200268324e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,20435,1186,1.01 [0.93-1.09],0.8297727471342726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,20675,1203,1.13 [1.05-1.22],0.000789128464116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,23739,1376,1.12 [1.06-1.18],7.93107732199571e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADIPOQ,Adiponectin,21172,1227,0.96 [0.88-1.04],0.3169445635373827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,24400,1401,2.15 [1.80-2.58],7.560908821951642e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,20461,1174,0.93 [0.85-1.01],0.0736987573993357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFAP1,Actin filament-associated protein 1,20675,1203,0.99 [0.93-1.06],0.771175586835702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFM,Afamin,21172,1227,1.05 [0.78-1.43],0.7327525621108387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFP,Alpha-fetoprotein,23954,1366,1.01 [0.94-1.09],0.7526479963662642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,20435,1186,0.99 [0.93-1.05],0.6610232508204026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,24157,1400,0.88 [0.78-0.98],0.0239344298269411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,23416,1343,1.16 [1.11-1.22],2.3522813769201354e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR3,Anterior gradient protein 3,23576,1366,1.23 [1.14-1.33],3.1439393312123146e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,24314,1410,1.62 [1.43-1.84],4.6553014646523477e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRP,Agouti-related protein,24435,1413,1.21 [1.11-1.33],2.0175192971091505e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGT,Angiotensinogen,21143,1218,1.20 [0.94-1.53],0.1432779161980171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,24200,1394,1.13 [1.06-1.20],7.576996440818341e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHCY,Adenosylhomocysteinase,24200,1394,1.06 [0.99-1.13],0.0919625234870593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,20595,1191,1.23 [1.04-1.45],0.0156993236724326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK2,Protein AHNAK2,20595,1191,1.11 [0.91-1.34],0.3128317237908316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,21007,1211,1.00 [0.92-1.09],0.9778405906332314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,21143,1218,1.01 [0.84-1.23],0.8814131422045952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,24158,1397,0.98 [0.93-1.04],0.5223239032362244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",20531,1187,0.96 [0.89-1.02],0.1811821158953127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1,Allograft inflammatory factor 1,23618,1368,1.08 [0.99-1.19],0.0966456508444117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,20595,1191,1.01 [0.92-1.10],0.9088310977263392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",24055,1380,1.07 [1.03-1.12],0.0022150882885003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK1,Adenylate kinase isoenzyme 1,24200,1394,1.00 [0.92-1.07],0.8958388888986797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",21076,1210,1.02 [0.97-1.07],0.5273025165597778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKAP12,A-kinase anchor protein 12,20675,1203,0.94 [0.72-1.22],0.6531732387988445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,23618,1368,1.07 [1.00-1.14],0.0381985454569691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,20531,1187,1.08 [0.99-1.18],0.0983445185804379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,23739,1376,1.09 [1.01-1.17],0.0243169574187064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,20528,1188,1.07 [0.99-1.15],0.087455367316867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,23615,1355,1.04 [0.97-1.12],0.2652072154042914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,21095,1216,1.01 [0.97-1.05],0.7043240788913103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,23506,1364,1.02 [0.94-1.11],0.6146724897654195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALCAM,CD166 antigen,24485,1416,1.00 [0.79-1.27],0.9902025170592454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,24192,1398,1.01 [0.93-1.11],0.7491349726258769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",21007,1211,1.06 [0.96-1.18],0.2618814744959417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",24108,1395,1.30 [1.23-1.37],1.5285394225647432e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",21095,1216,1.11 [0.98-1.25],0.0873302572524307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALMS1,Alstrom syndrome protein 1,20717,1204,1.09 [0.98-1.22],0.1022255159641273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,20528,1188,1.02 [0.97-1.07],0.4035467377743102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",24101,1383,1.40 [1.34-1.46],2.792822708155567e-56
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBN,Ameloblastin,23703,1359,0.82 [0.69-0.98],0.0301011377242156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,24365,1399,1.87 [1.48-2.37],2.221051201167483e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,21122,1217,0.97 [0.78-1.20],0.7749942348445253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,23615,1355,1.05 [0.98-1.13],0.1717506871907215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO1,Amphoterin-induced protein 1,20531,1187,0.93 [0.82-1.04],0.1979519096410199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO2,Amphoterin-induced protein 2,24101,1383,1.07 [0.87-1.31],0.5140925872998291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMN,Protein amnionless,23703,1359,1.13 [1.03-1.24],0.0122688069983143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOT,Angiomotin,20675,1203,0.88 [0.77-1.01],0.0698849816982509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOTL2,Angiomotin-like protein 2,20943,1209,1.05 [0.93-1.18],0.4267003092982703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMPD3,AMP deaminase 3,21076,1210,0.98 [0.91-1.06],0.6215136824264946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,19794,1153,0.83 [0.74-0.94],0.0027198971028293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2A,Pancreatic alpha-amylase,23216,1356,0.86 [0.78-0.95],0.0032827012791696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2B,Alpha-amylase 2B,22520,1308,0.87 [0.79-0.96],0.0060799594344365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,24105,1392,1.23 [1.08-1.40],0.0019221735921043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT1,Angiopoietin-1,24111,1392,1.06 [1.00-1.12],0.0422707000129365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,24400,1401,1.48 [1.32-1.67],5.885608681517681e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,23875,1378,1.31 [1.11-1.54],0.0012344164968664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,24246,1407,1.00 [0.89-1.12],0.9521556573999346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,24182,1397,1.10 [0.97-1.24],0.144822374844246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,24271,1407,1.23 [1.10-1.36],0.0001218712424977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,24400,1401,1.24 [1.10-1.40],0.0005390339665319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANK2,Ankyrin-2,20461,1174,0.97 [0.90-1.05],0.5181253195899214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,20528,1188,1.02 [0.95-1.09],0.5646230389342063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,20372,1173,0.98 [0.88-1.08],0.6241476474937709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,23618,1368,1.04 [0.96-1.13],0.2973721707867103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,20595,1191,1.02 [0.88-1.17],0.8262881636464114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,24221,1402,1.12 [0.94-1.32],0.1951745350098955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA1,Annexin A1,20551,1201,1.08 [0.97-1.21],0.1782434046949708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,23615,1355,1.18 [1.12-1.25],9.179812226822255e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA11,Annexin A11,24113,1394,1.01 [0.94-1.09],0.7230893242884566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,20274,1176,1.11 [1.03-1.19],0.0047302142831323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA3,Annexin A3,24369,1401,1.04 [0.97-1.11],0.3155622358555126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA4,Annexin A4,24075,1387,1.04 [0.97-1.10],0.2941166763101783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA5,Annexin A5,23545,1353,1.23 [1.05-1.45],0.0101804801588303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],23703,1359,0.97 [0.89-1.06],0.5126130905242332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,24267,1406,1.03 [0.88-1.21],0.6873532197889934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,21007,1211,1.07 [1.01-1.15],0.0348598871565442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP2B1,AP-2 complex subunit beta,20531,1187,1.00 [0.89-1.12],0.982848706700197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3B1,AP-3 complex subunit beta-1,21010,1209,1.05 [0.98-1.13],0.1838965251427456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,21076,1210,1.09 [0.97-1.22],0.1288457901841114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,24101,1383,1.11 [1.01-1.23],0.0382638682737543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APCS,Serum amyloid P-component,20972,1213,1.36 [1.17-1.60],0.0001065811593465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,24318,1397,1.07 [0.99-1.16],0.0913737471002465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,24200,1394,0.76 [0.69-0.83],3.649175153600969e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA1,Apolipoprotein A-I,21172,1227,0.88 [0.71-1.09],0.244004922888904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,21143,1218,1.12 [1.01-1.25],0.0379089857454554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA4,Apolipoprotein A-IV,21172,1227,1.05 [0.90-1.22],0.5283020517957585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOB,Apolipoprotein B-100,21143,1218,0.99 [0.79-1.25],0.9427029448692392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOBR,Apolipoprotein B receptor,20595,1191,1.04 [0.91-1.18],0.5656364704458142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOC1,Apolipoprotein C-I,21123,1225,0.97 [0.83-1.13],0.6846425895540487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOD,Apolipoprotein D,20178,1177,0.93 [0.80-1.08],0.3445421509667051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOE,Apolipoprotein E,21172,1227,0.98 [0.91-1.06],0.6014777140531642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOF,Apolipoprotein F,21143,1218,0.68 [0.55-0.84],0.0002879001699415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOH,Beta-2-glycoprotein 1,24192,1398,1.09 [0.95-1.26],0.1999253108298807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOL1,Apolipoprotein L1,21143,1218,0.97 [0.88-1.06],0.4971930582830828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOM,Apolipoprotein M,24226,1403,0.95 [0.80-1.13],0.5835627983872932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APP,Amyloid-beta precursor protein,24157,1393,1.10 [1.03-1.18],0.0060944049769701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APPL2,DCC-interacting protein 13-beta,20675,1203,1.02 [0.97-1.08],0.3463069472375293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APRT,Adenine phosphoribosyltransferase,23999,1374,0.95 [0.86-1.05],0.3304065020904445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,20717,1204,1.06 [0.98-1.15],0.1528205669261267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,24101,1383,1.40 [1.28-1.53],1.2831427402161336e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARF6,ADP-ribosylation factor 6,21010,1209,1.00 [0.95-1.05],0.85441641734628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARFIP1,Arfaptin-1,21095,1216,1.01 [0.93-1.10],0.7509750605805692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG1,Arginase-1,24061,1379,0.96 [0.88-1.05],0.3312568822146241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG2,"Arginase-2, mitochondrial",21007,1211,1.05 [0.92-1.19],0.4842716646165069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,23618,1368,0.94 [0.85-1.04],0.2536399848037592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,23618,1368,1.03 [0.95-1.12],0.4446167616666896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,20717,1204,1.04 [0.89-1.22],0.6253047607331232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,20675,1203,1.03 [0.97-1.10],0.3497072672642863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,20372,1173,1.07 [1.00-1.15],0.0548088721912142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,21076,1210,1.05 [0.99-1.11],0.1401985919519187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,21095,1216,1.05 [0.99-1.11],0.1039426328169907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,24143,1396,1.06 [1.02-1.11],0.0090720243604945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,20435,1186,1.01 [0.94-1.09],0.7280964409948647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,20435,1186,1.06 [0.92-1.21],0.4481893293475574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,23615,1355,1.03 [0.92-1.14],0.6428331394617306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,20461,1174,1.07 [0.99-1.15],0.0936800841000895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,20461,1174,1.04 [0.91-1.20],0.5579076714955351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,20435,1186,1.01 [0.93-1.10],0.8622030679667658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,23703,1359,0.97 [0.83-1.13],0.7083917757416622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,20461,1174,0.90 [0.81-1.00],0.0563406230013506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSA,Arylsulfatase A,24192,1398,1.11 [1.00-1.23],0.0414032822894378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSB,Arylsulfatase B,24101,1383,1.13 [1.03-1.22],0.0060369768552783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,24267,1406,0.92 [0.80-1.06],0.2327758309016068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,20435,1186,1.04 [0.96-1.14],0.3282215614895541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARTN,Artemin,23703,1359,1.12 [1.05-1.21],0.0013714825106706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,20916,1205,1.14 [1.01-1.28],0.0331585326677165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH2,Neutral ceramidase,24033,1375,0.94 [0.86-1.03],0.2089716439021344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,24033,1375,2.19 [1.89-2.55],5.38708291624386e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,21143,1218,1.68 [1.38-2.03],1.504239626220823e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPN,Asporin,21125,1219,0.92 [0.76-1.11],0.3741624087917148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,21095,1216,1.00 [0.93-1.09],0.955380435211314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,20595,1191,1.03 [0.98-1.09],0.2769269814703149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASS1,Argininosuccinate synthase,20461,1174,1.07 [1.00-1.14],0.0675063690174933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,23615,1355,0.96 [0.90-1.04],0.3217903975868171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,20372,1173,0.90 [0.76-1.06],0.2079194049153631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG16L1,Autophagy-related protein 16-1,21010,1209,1.05 [0.99-1.13],0.1111487670231892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG4A,Cysteine protease ATG4A,23618,1368,1.02 [0.95-1.11],0.5556292725216507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATOX1,Copper transport protein ATOX1,24272,1406,1.10 [1.03-1.18],0.0053938519754676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,20461,1174,0.96 [0.85-1.09],0.5328111467828218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,20461,1174,1.00 [0.84-1.19],0.9716895018017122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,20461,1174,1.04 [0.90-1.19],0.6265340407675724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B4,Protein ATP1B4,20372,1173,1.07 [0.94-1.21],0.3043220437824041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,20461,1174,0.93 [0.85-1.03],0.1679277535413432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",20461,1174,0.94 [0.85-1.05],0.2672009673621481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",24314,1410,1.01 [0.97-1.05],0.7353924958931088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",23615,1355,1.04 [0.92-1.16],0.5319694191562514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6AP2,Renin receptor,23618,1368,1.15 [1.04-1.27],0.0070948675852256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,24101,1383,0.99 [0.82-1.20],0.9173866654483226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,23566,1353,1.03 [0.96-1.11],0.4561993070561114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,20595,1191,1.08 [1.00-1.16],0.0562963061030586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,20461,1174,1.04 [0.98-1.10],0.2180139802236709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,21010,1209,1.25 [1.05-1.48],0.0119792325764589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRN,"Attractin, Isoform 2",21172,1227,1.08 [0.77-1.51],0.6573627501074153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN10,Ataxin-10,23615,1355,1.05 [0.98-1.12],0.1875106410714746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2,Ataxin-2,20435,1186,0.99 [0.94-1.04],0.680266182244148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2L,Ataxin-2-like protein,21095,1216,1.01 [0.90-1.13],0.9241748242969408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN3,Ataxin-3,21076,1210,1.00 [0.92-1.09],0.9808072063531008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXIN1,Axin-1,24143,1396,1.07 [1.01-1.12],0.0124561154981585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,24267,1406,0.88 [0.74-1.04],0.1455361316133717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZI2,5-azacytidine-induced protein 2,21095,1216,1.07 [0.97-1.18],0.1546844325514079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZU1,Azurocidin,23413,1359,1.05 [0.99-1.11],0.0974150005433006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,21172,1227,1.30 [1.10-1.53],0.0022031450711827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,20461,1174,0.92 [0.69-1.23],0.5798495489144121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",20595,1191,1.37 [1.18-1.60],4.999158315068169e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",24314,1410,1.43 [1.21-1.70],2.941755873259045e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",24192,1398,0.81 [0.67-0.98],0.0337773682949254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,20528,1188,1.00 [0.82-1.22],0.9831528165977008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BACH1,Transcription regulator protein BACH1,24143,1396,1.12 [1.05-1.20],0.000483244075141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,23992,1371,1.03 [0.91-1.17],0.6009430788240718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,20528,1188,1.12 [1.00-1.25],0.0435039587393962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG6,Large proline-rich protein BAG6,23739,1376,1.03 [0.90-1.17],0.6933474731693392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,23618,1368,1.26 [1.17-1.35],8.38086036939785e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,23618,1368,1.10 [0.94-1.29],0.2294511661497762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,24143,1396,1.05 [1.01-1.10],0.0281716508617062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAP18,Chromatin complexes subunit BAP18,21076,1210,1.06 [0.98-1.15],0.1290408597879103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,20531,1187,1.03 [0.97-1.10],0.341477570586719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAX,Apoptosis regulator BAX,23578,1353,1.08 [1.02-1.14],0.008219325343774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,24192,1398,0.87 [0.71-1.06],0.1725389934820407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,24033,1375,0.59 [0.51-0.68],1.1792853486216962e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",21125,1219,1.23 [1.03-1.47],0.0205170339455216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",20435,1186,0.95 [0.86-1.06],0.3621435241076711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCHE,Cholinesterase,20751,1196,0.99 [0.81-1.20],0.8797408030939899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2,Apoptosis regulator Bcl-2,21010,1209,1.12 [1.01-1.23],0.0253944351883343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L1,Bcl-2-like protein 1,21076,1210,1.00 [0.95-1.06],0.9129065489386532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",24143,1396,1.23 [1.10-1.37],0.000178068691097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L15,Bcl-2-like protein 15,20528,1188,1.06 [0.97-1.16],0.2314577995376921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,20372,1173,1.02 [0.93-1.11],0.6909193604592625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,21007,1211,0.96 [0.83-1.12],0.6280133433591228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCR,Breakpoint cluster region protein,24143,1396,1.07 [1.02-1.13],0.006867973677512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BDNF,Brain-derived neurotrophic factor,21122,1217,1.08 [1.01-1.16],0.0225389395801446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BECN1,Beclin-1,20595,1191,1.13 [1.03-1.23],0.0086326676093279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BEX3,Protein BEX3,20372,1173,1.07 [0.95-1.19],0.2683429296536868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGLAP,Osteocalcin,21122,1217,0.91 [0.86-0.97],0.0024173424987733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGN,Biglycan,23574,1365,0.97 [0.93-1.01],0.0971809313668658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,20435,1186,0.97 [0.89-1.05],0.414291716956786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,20461,1174,0.91 [0.73-1.13],0.408459780410523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BID,BH3-interacting domain death agonist,24143,1396,1.07 [1.00-1.14],0.0690002772121355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIN2,Bridging integrator 2,24192,1398,1.03 [0.98-1.09],0.2551368449238347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,23618,1368,1.05 [0.97-1.13],0.2072436418797686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLMH,Bleomycin hydrolase,24485,1416,0.97 [0.84-1.12],0.6853033593483722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLNK,B-cell linker protein,20528,1188,1.14 [1.00-1.31],0.0511238828589781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,20435,1186,0.97 [0.90-1.05],0.431036740550766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,21076,1210,1.13 [0.99-1.28],0.0764921666987668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLVRB,Flavin reductase,24192,1398,0.95 [0.88-1.02],0.1775492182118939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP10,Bone morphogenetic protein 10,20675,1203,0.82 [0.68-1.00],0.0556476101344747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP4,Bone morphogenetic protein 4,23992,1371,1.03 [0.92-1.14],0.6425759000898005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP6,Bone morphogenetic protein 6,23700,1375,1.02 [0.91-1.14],0.7553000606439271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,20675,1203,1.93 [1.66-2.25],2.1176183298501186e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,21125,1219,1.03 [0.87-1.22],0.7144219686804751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,20528,1188,1.15 [1.02-1.29],0.0230083928812669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOC,Brother of CDO,23739,1376,0.82 [0.67-1.01],0.0592603650988311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA1,BolA-like protein 1,20435,1186,1.18 [1.08-1.29],0.000285709285698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,20595,1191,1.04 [0.94-1.16],0.4289877728522733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFA2,BPI fold-containing family A member 2,19834,1144,0.90 [0.85-0.95],0.0003281511634342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,24126,1399,1.19 [1.10-1.29],2.1309668080289497e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB2,BPI fold-containing family B member 2,21082,1218,1.02 [0.95-1.10],0.5942134781921393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRAP,BRCA1-associated protein,20822,1197,1.02 [0.97-1.08],0.357340948684925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD1,Bromodomain-containing protein 1,20717,1204,0.90 [0.75-1.09],0.2903921823502641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD2,Bromodomain-containing protein 2,20435,1186,1.02 [0.86-1.21],0.8278468923346329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD3,Bromodomain-containing protein 3,20461,1174,1.02 [0.91-1.14],0.7158032186620836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRDT,Bromodomain testis-specific protein,20461,1174,1.06 [0.91-1.24],0.4286115407782834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRK1,Protein BRICK1,23615,1355,1.13 [1.02-1.26],0.0206394599698533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,20435,1186,1.06 [0.93-1.21],0.3615530758246296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,21095,1216,0.89 [0.76-1.03],0.1265833840204822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,24392,1408,1.85 [1.46-2.33],2.498260206394095e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSND,Barttin,20372,1173,0.93 [0.78-1.10],0.3982844772508623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,24408,1403,1.02 [0.91-1.14],0.7468408721275909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,24408,1403,1.25 [1.16-1.34],6.5948136343341875e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTC,Probetacellulin,23618,1368,1.06 [1.00-1.13],0.0577910337313816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTD,Biotinidase,21172,1227,0.92 [0.71-1.20],0.549053565421752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTLA,B- and T-lymphocyte attenuator,20372,1173,1.07 [1.02-1.13],0.0105430391291211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,20966,1208,1.07 [0.95-1.22],0.278457493440548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,24314,1410,1.45 [1.22-1.74],3.336831918148206e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,24143,1396,1.32 [1.17-1.48],2.413786844467597e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTNL10,Butyrophilin-like protein 10,20372,1173,1.00 [0.87-1.15],0.9958458708338616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,23615,1355,1.08 [1.00-1.16],0.0368419890526615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,20461,1174,1.00 [0.83-1.19],0.9569942093310856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QA,Complement C1q subcomponent subunit A,24307,1401,1.05 [0.86-1.30],0.6197130977278948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",21095,1216,1.04 [0.97-1.11],0.239958911455453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QL2,Complement C1q-like protein 2,20528,1188,0.86 [0.75-0.98],0.0275029030726305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,24267,1406,1.05 [0.95-1.17],0.3300955079813489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,20675,1203,1.05 [0.91-1.21],0.511025776237062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,21095,1216,1.07 [0.92-1.26],0.3813072631818497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,20632,1201,0.85 [0.76-0.95],0.0037118322698286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1R,Complement C1r subcomponent,21172,1227,0.97 [0.72-1.31],0.8380428331376466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1RL,Complement C1r subcomponent-like protein,21141,1226,1.25 [0.94-1.66],0.1180843140602268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1S,Complement C1s subcomponent,21172,1227,0.99 [0.76-1.29],0.9395833436900792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2,Complement C2,24226,1403,1.02 [0.84-1.24],0.8460255108855657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,23566,1353,1.03 [0.93-1.15],0.5740632688932887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2orf69,UPF0565 protein C2orf69,20531,1187,1.07 [0.98-1.17],0.1500823193605063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C3,Complement C3,20078,1159,1.07 [0.93-1.22],0.3285461484505712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C4BPB,C4b-binding protein beta chain,24272,1406,1.00 [0.89-1.11],0.9362320485179148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C5,Complement C5,21172,1227,1.59 [1.11-2.27],0.0113345885524022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,20658,1198,1.21 [1.01-1.44],0.0398503518217138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7orf50,Uncharacterized protein C7orf50,21076,1210,1.15 [0.93-1.43],0.2005749871241813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C8B,Complement component C8 beta chain,21172,1227,1.06 [0.89-1.27],0.5153248344619596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9,Complement component C9,21143,1218,0.99 [0.89-1.10],0.8148660990083549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9orf40,Uncharacterized protein C9orf40,21010,1209,0.98 [0.92-1.05],0.5847709063414421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA1,Carbonic anhydrase 1,23617,1369,0.96 [0.90-1.04],0.3489235101060837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA11,Carbonic anhydrase-related protein 11,23618,1368,1.03 [0.89-1.19],0.6891867159134711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,24101,1383,1.09 [0.94-1.27],0.2437073370798384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA13,Carbonic anhydrase 13,23946,1382,1.01 [0.97-1.06],0.5799784696996819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,24400,1401,0.71 [0.62-0.82],1.1567059722535648e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA2,Carbonic anhydrase 2,24116,1396,1.01 [0.94-1.08],0.8497174195333026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA3,Carbonic anhydrase 3,24442,1414,0.98 [0.90-1.06],0.5538593396461065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,24485,1416,1.56 [1.29-1.89],6.330828216021847e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",23739,1376,1.13 [1.07-1.19],3.1600446563310137e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,24117,1394,0.82 [0.77-0.89],4.036438829727982e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA7,Carbonic anhydrase 7,20717,1204,1.02 [0.87-1.19],0.8019554218869762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA8,Carbonic anhydrase-related protein,20528,1188,1.05 [0.86-1.28],0.642186822528227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,24400,1401,1.05 [0.95-1.17],0.3330496768709426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CABP2,Calcium-binding protein 2,20531,1187,0.95 [0.87-1.03],0.2326549497295073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,20435,1186,0.94 [0.79-1.12],0.5091785953005736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,20461,1174,0.92 [0.83-1.02],0.1287603340177713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,20435,1186,1.00 [0.92-1.10],0.9141545856134788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,21095,1216,1.06 [0.99-1.13],0.0826545282821172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACYBP,Calcyclin-binding protein,20634,1200,1.04 [0.98-1.10],0.173233719543168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CADPS,Calcium-dependent secretion activator 1,20531,1187,0.98 [0.86-1.11],0.7649256324688213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB1,Calbindin,24101,1383,0.96 [0.86-1.07],0.4916186071737657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB2,Calretinin,23615,1355,1.06 [0.91-1.25],0.4523024720366261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,23984,1373,1.17 [1.08-1.26],5.57382538128882e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCB,Calcitonin gene-related peptide 2,21076,1210,1.09 [0.96-1.25],0.1911189551955502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,24323,1396,1.03 [0.99-1.08],0.1500223974090664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,20595,1191,1.06 [0.99-1.14],0.099557890880643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,20461,1174,1.10 [0.95-1.27],0.2261680868180116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,23618,1368,1.13 [1.01-1.25],0.0306274587288625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,20531,1187,0.96 [0.87-1.07],0.4859087264927187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,21095,1216,1.03 [0.98-1.08],0.316692543059069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,24137,1388,1.69 [1.34-2.13],8.600285942114629e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,23999,1383,1.16 [1.07-1.26],0.0002190470734144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPN3,Calpain-3,21007,1211,1.06 [0.91-1.24],0.4502137394577736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPS,Calcyphosin,21076,1210,1.06 [1.00-1.12],0.0465256043663593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,23615,1355,1.00 [0.91-1.09],0.9345803874513644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASC3,Protein CASC3,20531,1187,1.19 [1.04-1.35],0.0096170982312218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP1,Caspase-1,23615,1355,1.09 [1.02-1.16],0.0111594358064585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP10,Caspase-10,23615,1355,1.09 [1.01-1.16],0.018675150142265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP2,Caspase-2,24143,1396,1.08 [1.01-1.16],0.0285297517265153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP3,Caspase-3,24485,1416,1.03 [0.98-1.09],0.2106668854672038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP4,Caspase-4,20717,1204,1.02 [0.99-1.06],0.1459929099031959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP7,Caspase-7,21076,1210,1.05 [0.98-1.12],0.1562431870873883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP8,Caspase-8,24326,1396,1.02 [0.95-1.10],0.6004870045548083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP9,Caspase-9,20528,1188,1.08 [0.99-1.17],0.0958529856080088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASQ2,Calsequestrin-2,20461,1174,1.02 [0.92-1.15],0.6799548142170292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAT,Catalase,20827,1203,0.97 [0.88-1.07],0.5473173737972696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,24160,1391,1.04 [0.97-1.11],0.2552788961147945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN1,Cerebellin-1,20435,1186,0.99 [0.93-1.05],0.6478430042139824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,24400,1401,0.62 [0.53-0.72],1.6612718790161566e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,20595,1191,1.21 [1.08-1.35],0.0006980996926219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBX2,Chromobox protein homolog 2,20461,1174,1.02 [0.90-1.17],0.7204197451191183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,24033,1375,1.08 [1.02-1.15],0.0153742512187074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,21076,1210,1.00 [0.91-1.10],0.9374153721713469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,21007,1211,1.03 [0.93-1.15],0.5371797877336826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,20531,1187,0.94 [0.78-1.14],0.5135811234185406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,21095,1216,1.02 [0.95-1.10],0.5793124015008728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,24200,1394,1.39 [1.21-1.59],2.317726889972037e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,20595,1191,1.05 [0.96-1.14],0.3122464102426262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,24435,1413,1.24 [1.10-1.41],0.0005363516775015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL13,C-C motif chemokine 13,24389,1412,1.04 [0.97-1.11],0.2966767702559237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,24105,1392,1.20 [1.07-1.34],0.0012857924730051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,24485,1416,1.29 [1.17-1.42],6.61533828338097e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,24485,1416,1.26 [1.15-1.39],1.015217264153002e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,24166,1400,1.18 [1.12-1.24],1.7172462307357308e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,23825,1381,1.07 [1.01-1.14],0.0250419616322689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,24408,1403,1.04 [1.00-1.07],0.0352494809157837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL2,C-C motif chemokine 2,23992,1371,1.07 [0.98-1.17],0.149987386927746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,24435,1413,1.16 [1.10-1.21],4.257999470410115e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,24314,1410,1.22 [1.10-1.34],7.046724863284478e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,23981,1394,1.29 [1.18-1.40],7.902110544114269e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,24314,1410,1.29 [1.15-1.44],9.6988442897284e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL24,C-C motif chemokine 24,24271,1407,1.02 [0.97-1.08],0.4057819169939003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,24435,1413,1.23 [1.12-1.35],2.2243991029568387e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL26,C-C motif chemokine 26,24143,1396,1.07 [1.02-1.12],0.0076426418153068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,24200,1394,1.19 [1.10-1.29],2.6718871635436487e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,24072,1392,1.19 [1.10-1.28],5.09420956922602e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,24143,1396,1.20 [1.13-1.28],6.232231260876317e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL4,C-C motif chemokine 4,24237,1405,1.10 [1.03-1.17],0.0024613307419086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,24267,1406,1.10 [1.05-1.15],5.0588756713643024e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,24143,1396,1.32 [1.24-1.41],5.3862212502760666e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL8,C-C motif chemokine 8,24365,1399,1.03 [0.95-1.12],0.4224332099459312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,24056,1380,1.16 [1.09-1.23],1.960581298961151e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN2,CCN family member 2,24194,1402,1.11 [1.02-1.20],0.0129655898202302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,24451,1416,1.40 [1.22-1.61],1.7917171719000338e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,24400,1401,1.20 [1.08-1.34],0.00106270522093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN5,CCN family member 5,24192,1398,1.11 [0.98-1.25],0.0868246952379556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCND2,G1/S-specific cyclin-D2,20717,1204,0.93 [0.80-1.08],0.3638116556766851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCNE1,G1/S-specific cyclin-E1,20528,1188,0.99 [0.93-1.06],0.8043378662741525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCS,Copper chaperone for superoxide dismutase,24033,1375,0.95 [0.86-1.05],0.3288245291313613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,23618,1368,1.09 [0.98-1.20],0.1069496265104832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,21010,1209,1.22 [1.06-1.41],0.0056585707540213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD109,CD109 antigen,24192,1398,0.96 [0.83-1.11],0.5717561704375582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,23655,1370,1.40 [1.25-1.57],2.892488617281125e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD160,CD160 antigen,24435,1413,0.98 [0.89-1.09],0.7357852192603478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,24267,1406,1.06 [0.95-1.19],0.2859404264552346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164,Sialomucin core protein 24,24192,1398,0.95 [0.79-1.13],0.543999281367717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,20531,1187,0.96 [0.82-1.12],0.5968550179023657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD177,CD177 antigen,24154,1397,0.99 [0.96-1.03],0.6048671480552068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,24272,1406,0.89 [0.74-1.09],0.2597023970504914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2,T-cell surface antigen CD2,20461,1174,1.02 [0.89-1.16],0.8226053001101521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200,OX-2 membrane glycoprotein,24143,1396,0.85 [0.71-1.03],0.0926543044774601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,24069,1393,0.98 [0.86-1.13],0.7847514787769956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,23711,1357,1.26 [1.11-1.42],0.0002759981934381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD209,CD209 antigen,24252,1407,0.83 [0.74-0.93],0.0015261415033114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD22,B-cell receptor CD22,24435,1413,1.03 [0.92-1.16],0.5648557554206884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD226,CD226 antigen,20528,1188,1.03 [0.90-1.17],0.6943403196712278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD244,Natural killer cell receptor 2B4,24435,1413,0.97 [0.82-1.16],0.7502251398481307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,21122,1217,0.75 [0.66-0.86],3.840474900892241e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,24272,1406,1.35 [1.20-1.51],2.258440289479073e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,24033,1375,1.45 [1.28-1.66],1.6547858944265783e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,24201,1404,1.21 [1.06-1.38],0.0059815252305862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,23618,1368,1.05 [0.92-1.20],0.4908218074408663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2AP,CD2-associated protein,24200,1394,1.10 [1.03-1.19],0.0072356554810016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,20675,1203,1.25 [1.03-1.50],0.0215212337546728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,24408,1403,1.29 [1.13-1.48],0.0001828209556518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,24314,1395,1.42 [1.27-1.59],1.1466212950202095e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,24400,1401,1.12 [1.04-1.22],0.0054109179718851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LG,CMRF35-like molecule 9,24192,1398,0.90 [0.79-1.02],0.0894012982876975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,24101,1383,1.75 [1.51-2.03],1.1113875480192831e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD33,Myeloid cell surface antigen CD33,24272,1406,1.04 [0.98-1.10],0.2007172247164664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,24323,1401,0.68 [0.56-0.82],8.557166398141473e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD36,Platelet glycoprotein 4,20528,1188,1.13 [1.00-1.28],0.0505851675821101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,24101,1383,1.09 [0.93-1.28],0.2630260657205088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,20435,1186,0.91 [0.77-1.07],0.260392979585209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,20717,1204,1.03 [0.89-1.19],0.6500518641899566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,20528,1188,0.99 [0.93-1.06],0.857648656590076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,24107,1393,1.55 [1.41-1.71],2.8038914623531614e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,24194,1402,1.15 [1.05-1.26],0.0029832855290321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40LG,CD40 ligand,24435,1413,1.06 [1.00-1.12],0.0616962038951377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,24018,1387,1.41 [1.22-1.64],3.631260394479967e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,24271,1407,1.13 [0.96-1.33],0.1455810063818113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,24365,1399,1.54 [1.35-1.75],4.395046285490122e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,23326,1347,1.26 [1.07-1.48],0.0050313497785237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD58,Lymphocyte function-associated antigen 3,24165,1404,0.82 [0.63-1.06],0.1319966498394234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,23272,1327,1.60 [1.31-1.96],5.974994481312544e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,21041,1221,0.99 [0.88-1.11],0.8216464724854676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD6,T-cell differentiation antigen CD6,24392,1408,1.14 [1.04-1.24],0.0031345647818149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD63,CD63 antigen,23992,1371,1.04 [0.95-1.15],0.3596253792715489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD69,Early activation antigen CD69,24085,1388,1.05 [1.00-1.11],0.0681904641973978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,20484,1187,1.13 [0.99-1.28],0.0629785214797642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,24143,1396,1.04 [0.93-1.16],0.5034993306091906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD72,B-cell differentiation antigen CD72,20675,1203,1.05 [0.92-1.20],0.4481165437790575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,24408,1403,1.32 [1.16-1.51],4.162570801046334e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,24435,1413,1.12 [1.01-1.25],0.0329580749442708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,21125,1219,1.33 [1.13-1.56],0.0006122942091876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD82,CD82 antigen,20717,1204,1.01 [0.88-1.15],0.9189629639285332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,24143,1396,1.78 [1.57-2.02],2.974378128716016e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD84,SLAM family member 5,24143,1396,1.11 [0.95-1.29],0.1961000686980402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD86,T-lymphocyte activation antigen CD86,21010,1209,0.82 [0.68-0.98],0.0315763678667946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,24408,1403,1.02 [0.92-1.12],0.7343853232094266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,23254,1343,1.19 [1.02-1.38],0.0243607227585306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99,CD99 antigen,24192,1398,1.03 [0.81-1.32],0.7897670386405905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,24192,1398,1.59 [1.31-1.92],1.8977666726872267e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDA,Cytidine deaminase,21083,1218,0.97 [0.86-1.09],0.5848839978741394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDAN1,Codanin-1,21076,1210,1.08 [0.87-1.33],0.495634427731719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC123,Cell division cycle protein 123 homolog,20372,1173,0.99 [0.90-1.08],0.7457421078097008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC25A,M-phase inducer phosphatase 1,20372,1173,1.04 [0.91-1.19],0.5427967015694357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,20974,1209,1.01 [0.93-1.09],0.8207882155799204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC27,Cell division cycle protein 27 homolog,23618,1368,1.13 [1.04-1.22],0.002105379021058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,24272,1406,1.03 [0.97-1.09],0.3332224348200455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,21010,1209,1.03 [0.97-1.08],0.3224448498689474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,24033,1375,1.66 [1.52-1.81],1.790949267349952e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH1,Cadherin-1,23370,1348,1.17 [1.05-1.30],0.0041815381145382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH15,Cadherin-15,24359,1401,0.95 [0.85-1.05],0.3111518618147765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH17,Cadherin-17,24200,1394,1.03 [0.96-1.11],0.415870932359619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,24200,1394,1.22 [1.06-1.40],0.004229880069712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH22,Cadherin-22,20717,1204,1.03 [0.85-1.23],0.7853341415319219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH23,Cadherin-23,21076,1210,0.78 [0.63-0.96],0.0210322622982581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH3,Cadherin-3,24408,1403,0.95 [0.84-1.09],0.4733653966275106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH4,Cadherin-4,20435,1186,1.09 [0.98-1.21],0.1156236143411173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH5,Cadherin-5,24485,1416,0.79 [0.67-0.93],0.0034839463056342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH6,Cadherin-6,24200,1394,0.91 [0.80-1.02],0.1141615397018786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR1,Cadherin-related family member 1,23615,1355,0.88 [0.78-0.99],0.0361631180671159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,24101,1383,1.13 [1.06-1.20],0.0002497443547997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,24200,1394,0.88 [0.78-1.00],0.0436919874220887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK1,Cyclin-dependent kinase 1,20372,1173,1.07 [0.92-1.24],0.4072116391651078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,21095,1216,1.01 [0.92-1.11],0.7920718140974303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,20435,1186,0.95 [0.85-1.06],0.3226582523300674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,24101,1383,1.05 [1.01-1.10],0.0202044443558865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,24101,1383,1.01 [0.96-1.06],0.77751483723363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,24101,1383,1.10 [0.95-1.27],0.212126086975803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,24243,1405,0.93 [0.78-1.11],0.4036012896893048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDSN,Corneodesmosin,24358,1409,1.08 [0.97-1.20],0.1808375666738906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,24233,1403,1.23 [0.99-1.53],0.0625147038738871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,21010,1209,0.84 [0.79-0.90],1.1136341898435158e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,20717,1204,0.98 [0.90-1.06],0.5581358819974263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,21010,1209,0.98 [0.86-1.12],0.7775371490835506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,20717,1204,1.15 [1.04-1.28],0.008780880320135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,24143,1396,1.04 [0.98-1.10],0.1732866815612841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,23618,1368,1.07 [0.97-1.19],0.1639162911453591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,23317,1345,1.44 [1.36-1.53],1.5722968226456983e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,21122,1217,1.99 [1.72-2.29],2.0439461253022565e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,23739,1376,1.20 [1.10-1.31],6.181732008366115e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,20528,1188,1.08 [0.94-1.23],0.285787648670864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,23739,1376,0.97 [0.85-1.09],0.5848512811023632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,21122,1217,0.92 [0.84-1.00],0.0573797972997053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,24440,1415,0.92 [0.85-1.00],0.0493636854848839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,20675,1203,0.95 [0.78-1.15],0.5827720206767577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEMIP2,Cell surface hyaluronidase,20528,1188,1.09 [0.94-1.26],0.2663612889090847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,20435,1186,1.07 [0.97-1.17],0.1691901901007226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPF,Centromere protein F,20717,1204,0.98 [0.89-1.08],0.7233061667505449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPJ,Centromere protein J,20717,1204,0.99 [0.92-1.07],0.7848870401750453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP112,Centrosomal protein of 112 kDa,20461,1174,1.01 [0.89-1.15],0.8622365445530528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP152,Centrosomal protein of 152 kDa,20372,1173,0.97 [0.84-1.10],0.604041019103516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP164,Centrosomal protein of 164 kDa,23703,1359,0.99 [0.92-1.07],0.852035323439688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP170,Centrosomal protein of 170 kDa,20595,1191,1.04 [0.97-1.12],0.2499068977350543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP20,Centrosomal protein 20,23618,1368,1.06 [1.00-1.14],0.0615261785975373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP290,Centrosomal protein of 290 kDa,20717,1204,1.08 [0.98-1.20],0.1381431967008766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP350,Centrosome-associated protein 350,20372,1173,0.97 [0.84-1.12],0.6813950399828613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP43,Centrosomal protein 43,23546,1363,1.10 [1.03-1.18],0.0075257989617747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP85,Centrosomal protein of 85 kDa,23618,1368,1.09 [1.01-1.18],0.0260022182292073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CERT,Ceramide transfer protein,23615,1355,1.03 [0.95-1.11],0.4514972636640878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,24242,1407,1.11 [1.05-1.18],0.000475026086937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,24101,1383,1.19 [1.10-1.28],2.657122817372548e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES3,Carboxylesterase 3,24101,1383,1.01 [0.94-1.09],0.7379866892950093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN2,Centrin-2,23615,1355,1.08 [1.01-1.16],0.0293400467960014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN3,Centrin-3,21010,1209,1.03 [0.97-1.11],0.3328724033843707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,20768,1201,1.27 [1.07-1.50],0.0067610744250474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFC1,Cryptic protein,23618,1368,1.09 [0.98-1.22],0.1133178235630641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,21172,1227,1.35 [1.01-1.79],0.039526508723849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,19927,1158,1.32 [1.04-1.68],0.023729064927193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR2,Complement factor H-related protein 2,21002,1222,1.05 [0.95-1.16],0.3070517607630213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR4,Complement factor H-related protein 4,21134,1223,1.01 [0.94-1.09],0.7613847111188863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR5,Complement factor H-related protein 5,20870,1204,1.17 [1.02-1.34],0.0221573188971544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,21172,1227,2.01 [1.54-2.64],3.752460654939589e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFP,Properdin,21172,1227,0.85 [0.65-1.10],0.2173253469434711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,24192,1398,1.01 [0.96-1.06],0.7609448513736924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,21143,1218,1.00 [0.87-1.15],0.971062711629966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGN,Cingulin,20531,1187,1.04 [0.92-1.19],0.5090686995331362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,24200,1394,1.36 [1.22-1.52],3.024697936790205e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,23618,1368,1.05 [0.98-1.13],0.1839352008452534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAD,Chondroadherin,20675,1203,0.83 [0.75-0.91],0.0002167270136944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",21076,1210,1.76 [1.57-1.98],8.331650575803886e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,21007,1211,1.60 [1.37-1.86],2.3620697808949004e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,23739,1376,1.03 [0.89-1.19],0.669650859348243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,21122,1217,1.24 [1.18-1.31],5.364141138824703e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGB,Secretogranin-1,24311,1401,0.99 [0.88-1.12],0.8886781267301398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,23625,1365,1.40 [1.33-1.48],8.452048857488942e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHIT1,Chitotriosidase-1,24279,1401,1.03 [0.99-1.06],0.1495269474093845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,24235,1404,0.79 [0.68-0.92],0.0024557629728129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,20531,1187,0.96 [0.88-1.05],0.3927908176707589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,24033,1375,1.01 [0.95-1.07],0.8652787647649645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP6,Charged multivesicular body protein 6,21125,1219,1.06 [0.96-1.17],0.2688077587612104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHP1,Calcineurin B homologous protein 1,20435,1186,0.98 [0.91-1.06],0.6489098909589925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,24271,1407,1.33 [1.14-1.55],0.0002212184360425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL2,Chordin-like protein 2,24200,1394,0.97 [0.89-1.06],0.4947645940927665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,20531,1187,0.95 [0.81-1.11],0.5166643362405716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIAPIN1,Anamorsin,24272,1406,1.05 [0.98-1.13],0.186147840991461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,21122,1217,1.26 [1.14-1.39],6.65794386993456e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,20717,1204,0.99 [0.88-1.12],0.919753539797846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,21010,1209,1.02 [0.96-1.08],0.5791892270151839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIT,Citron Rho-interacting kinase,20531,1187,1.09 [0.97-1.23],0.1288867985454622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,24316,1403,1.94 [1.67-2.26],2.189594641469514e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,21122,1217,1.13 [1.03-1.23],0.0086103586746278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",24116,1401,1.06 [0.99-1.14],0.1004793496085947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLASP1,CLIP-associating protein 1,20372,1173,1.05 [0.97-1.13],0.2198254686786009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLC,Galectin-10,24166,1390,1.04 [0.97-1.12],0.2746653281544212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,24033,1375,1.32 [1.16-1.52],4.3767699982539776e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,24143,1396,1.02 [0.92-1.13],0.6871546818178746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,20528,1188,1.15 [0.88-1.50],0.3006633043274909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,24192,1398,1.30 [1.12-1.50],0.0004414509359384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,23739,1376,1.13 [0.98-1.30],0.0878546081963391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,24408,1403,1.06 [1.01-1.12],0.01330440111267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,20531,1187,0.89 [0.79-1.00],0.0408986727656601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,20660,1195,0.52 [0.40-0.68],1.210696376822784e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,24143,1396,0.71 [0.62-0.81],2.728117478812995e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,24143,1396,0.88 [0.79-0.97],0.0139712631711803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,24143,1396,1.33 [1.24-1.43],5.729328843551927e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,24143,1396,1.03 [0.89-1.19],0.6623662625988207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,21080,1217,0.82 [0.73-0.91],0.0003937114244056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,24124,1390,1.59 [1.36-1.86],3.600795943030534e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,23618,1368,1.23 [1.12-1.36],4.081825437304243e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,24435,1413,1.18 [1.08-1.30],0.0003458297651657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,20531,1187,1.22 [1.08-1.37],0.0012358817164106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIC5,Chloride intracellular channel protein 5,20531,1187,1.20 [1.01-1.42],0.0395566952911365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLINT1,Clathrin interactor 1,20372,1173,1.01 [0.90-1.15],0.8240429438246555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,24143,1396,1.02 [0.98-1.06],0.4064167752518448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,24400,1401,1.63 [1.29-2.06],4.752087497553779e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLNS1A,Methylosome subunit pICln,20531,1187,0.92 [0.78-1.09],0.3217145818788398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",23984,1373,1.01 [0.96-1.07],0.5983856732630812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPS,Colipase,24158,1397,0.93 [0.87-0.99],0.0263773321777914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSPN,Claspin,23566,1353,1.01 [0.88-1.16],0.8916276690770825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN1,Calsyntenin-1,23615,1355,0.98 [0.89-1.07],0.6694907184825102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,24435,1413,1.07 [0.95-1.20],0.2510030727114977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN3,Calsyntenin-3,21076,1210,1.04 [0.87-1.25],0.6381581785287961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLTA,Clathrin light chain A,23739,1376,1.03 [0.94-1.14],0.5025988323438124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLU,Clusterin,21172,1227,0.90 [0.75-1.09],0.2882921200826374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLUL1,Clusterin-like protein 1,24164,1393,0.79 [0.71-0.87],7.011022770828655e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,21125,1219,1.02 [0.96-1.08],0.5886879241362585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMIP,C-Maf-inducing protein,21007,1211,1.06 [0.99-1.13],0.0892946729445802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,24267,1406,0.95 [0.86-1.05],0.3100952524846038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,20435,1186,0.98 [0.88-1.08],0.643775197326917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",20554,1188,1.07 [1.00-1.15],0.0580263308305354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY2,Protein canopy homolog 2,23739,1376,0.98 [0.91-1.06],0.5808124625557494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY4,Protein canopy homolog 4,24101,1383,1.04 [0.97-1.10],0.2525639288897513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNST,Consortin,24200,1394,1.04 [0.99-1.09],0.088569992243806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTF,Ciliary neurotrophic factor,20435,1186,1.10 [0.95-1.29],0.2117250161903366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,24485,1416,0.59 [0.50-0.71],9.0076854349356e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN2,Contactin-2,24400,1401,0.98 [0.88-1.09],0.7620412868832732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN3,Contactin-3,24192,1398,0.86 [0.75-0.98],0.0283231324573909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN4,Contactin-4,24192,1398,0.70 [0.57-0.85],0.0004112149440569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,24246,1393,0.77 [0.67-0.87],5.178326859638521e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,24143,1396,0.99 [0.88-1.12],0.9313668854337428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,20531,1187,0.97 [0.92-1.02],0.2734400355151457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,21125,1219,1.17 [1.05-1.31],0.0051668970818451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,21122,1217,1.16 [0.95-1.42],0.1416227730134745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,24286,1408,1.97 [1.61-2.41],5.7427150886385185e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL1A1,Collagen alpha-1(I) chain,24485,1416,0.74 [0.62-0.89],0.0014255403790967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,21010,1209,1.06 [0.96-1.17],0.2697933497364368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,20531,1187,0.91 [0.84-0.98],0.0155311287113038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL2A1,Collagen alpha-1(II) chain,20595,1191,1.02 [0.95-1.09],0.5560970499036537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL3A1,Collagen alpha-1(III) chain,21122,1217,1.10 [0.87-1.40],0.4370496164632279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,24200,1394,1.07 [0.95-1.20],0.2911074004892651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,20683,1200,1.01 [0.91-1.13],0.8162716749419492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,20675,1203,1.15 [1.00-1.31],0.0505565911874548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,24485,1416,1.66 [1.46-1.88],1.5776085910213014e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,24143,1396,1.12 [1.02-1.24],0.0191571986017365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,20717,1204,1.02 [0.91-1.14],0.762870387724139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,24201,1404,1.79 [1.50-2.14],2.0601603930222072e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD1,COMM domain-containing protein 1,20595,1191,1.10 [1.01-1.21],0.0302584906780255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD9,COMM domain-containing protein 9,21007,1211,0.97 [0.85-1.11],0.671600190314501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMP,Cartilage oligomeric matrix protein,23913,1384,0.96 [0.83-1.09],0.5047143656060673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMT,Catechol O-methyltransferase,23495,1360,1.07 [1.01-1.13],0.0247893520804808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPB2,Coatomer subunit beta',20461,1174,1.09 [0.95-1.24],0.2141898490008408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPE,Coatomer subunit epsilon,23615,1355,1.03 [0.93-1.14],0.5730331222513685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",20595,1191,1.15 [1.02-1.30],0.0207211369412968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO1A,Coronin-1A,23680,1375,1.07 [1.01-1.12],0.0120870992312596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO6,Coronin-6,20435,1186,1.12 [0.97-1.29],0.1258296781457014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",24101,1383,1.06 [0.99-1.14],0.0779758629451061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,21125,1219,0.98 [0.83-1.17],0.8422046483305288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA1,Carboxypeptidase A1,24485,1416,1.07 [0.99-1.15],0.0875013843196611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA2,Carboxypeptidase A2,24319,1399,1.04 [0.97-1.11],0.3176273026661803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA4,Carboxypeptidase A4,20261,1181,0.92 [0.81-1.05],0.2091476110856361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB1,Carboxypeptidase B,24485,1416,1.02 [0.94-1.10],0.6872543869173211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB2,Carboxypeptidase B2,21123,1225,1.08 [0.85-1.38],0.5422440188566979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPE,Carboxypeptidase E,24220,1388,1.09 [0.96-1.24],0.1715782370374143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPLX2,Complexin-2,20372,1173,1.02 [0.85-1.23],0.7931648900122481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,24295,1398,1.42 [1.24-1.63],4.605418733719873e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",20528,1188,1.29 [1.08-1.55],0.0053575923149848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,24408,1403,1.08 [1.01-1.16],0.0274327677127502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPQ,Carboxypeptidase Q,21080,1217,1.12 [0.97-1.31],0.1309823519300102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,20461,1174,0.99 [0.87-1.14],0.9413396984326508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,24365,1400,1.10 [0.98-1.24],0.1106461421571457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM1,Probable carboxypeptidase X1,24272,1406,1.12 [1.05-1.20],0.0006609371809673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,21125,1219,1.25 [1.00-1.56],0.0483759420494063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR1,Complement receptor type 1,21061,1217,0.92 [0.79-1.08],0.3163711148404865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,24267,1406,0.85 [0.77-0.94],0.0018327012644515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,23618,1368,1.05 [1.00-1.11],0.0657094558380115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRADD,Death domain-containing protein CRADD,23984,1373,1.03 [0.96-1.09],0.4031581959055744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,20372,1173,0.99 [0.89-1.09],0.7873346086888254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,20372,1173,0.89 [0.71-1.10],0.2728199086857537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,23871,1390,1.23 [1.09-1.38],0.0008163171737923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,20675,1203,1.45 [1.25-1.68],6.201044468176746e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,24271,1407,1.15 [1.05-1.26],0.0022067214209413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,23579,1367,0.94 [0.89-1.00],0.0452043555774729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,24201,1404,1.29 [1.09-1.52],0.003256516266761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,23739,1376,0.94 [0.86-1.01],0.0978681245803753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,24314,1410,1.15 [0.91-1.46],0.2299650629936649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,24033,1375,1.32 [1.17-1.49],9.235398216843666e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,24400,1401,0.82 [0.76-0.88],4.9401050494317333e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,20948,1201,0.75 [0.61-0.92],0.004668355593637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRKL,Crk-like protein,24235,1407,1.03 [0.99-1.08],0.1639043453756185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRLF1,Cytokine receptor-like factor 1,24314,1410,1.17 [0.98-1.40],0.0868804237557552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRNN,Cornulin,23477,1361,0.97 [0.91-1.04],0.4652357505138089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAC1,Cartilage acidic protein 1,24485,1416,0.89 [0.76-1.04],0.1379445901551747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,24033,1375,0.99 [0.90-1.09],0.7979087027742586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAP,Cartilage-associated protein,20531,1187,0.91 [0.81-1.03],0.1290473468495921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRX,Cone-rod homeobox protein,23739,1376,0.99 [0.95-1.04],0.8145491356508348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB1,Beta-crystallin B1,21125,1219,1.07 [0.98-1.16],0.1262686635911198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB2,Beta-crystallin B2,21076,1210,1.06 [0.98-1.13],0.1294973773282948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYGD,Gamma-crystallin D,21076,1210,1.03 [0.98-1.09],0.2679657560855477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYM,Ketimine reductase mu-crystallin,20435,1186,1.04 [0.97-1.12],0.2425350875209632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,20595,1191,1.04 [0.98-1.10],0.221686365949057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSDE1,Cold shock domain-containing protein E1,20461,1174,1.00 [0.95-1.05],0.8657659941451014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,24314,1410,1.53 [1.30-1.80],3.9532093995880666e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,21143,1218,0.92 [0.80-1.05],0.2181554338535005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,20461,1174,1.15 [0.99-1.34],0.0710210875293444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,24033,1375,1.08 [1.00-1.17],0.0474306000725054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,20528,1188,0.95 [0.83-1.07],0.3897453531542973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3,Granulocyte colony-stimulating factor,23703,1359,1.12 [1.01-1.23],0.027191324303426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,20528,1188,1.05 [0.88-1.26],0.5698088074412873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,21143,1218,1.01 [0.83-1.23],0.9094370238480184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK1D,Casein kinase I isoform delta,20528,1188,0.98 [0.89-1.07],0.6465397201452233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,21095,1216,0.98 [0.87-1.11],0.7386825881871889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,21122,1217,0.76 [0.65-0.89],0.0008648243378789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,20435,1186,0.89 [0.79-1.00],0.0555740196076381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,20461,1174,1.04 [0.98-1.10],0.1759548052400298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST1,Cystatin-SN,18322,1079,0.95 [0.90-1.01],0.1330975464621979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,24233,1405,1.85 [1.59-2.15],1.0394909566099118e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST5,Cystatin-D,23784,1360,1.01 [0.93-1.10],0.8004205647036017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST6,Cystatin-M,23551,1344,0.89 [0.80-0.99],0.0291655016989305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,24237,1405,1.09 [1.04-1.14],0.0002114565663108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,23836,1382,1.42 [1.27-1.59],3.90413499154342e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,20671,1201,0.99 [0.89-1.11],0.9110985909315164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTBS,Di-N-acetylchitobiase,20843,1200,1.30 [1.06-1.61],0.0123697806107389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTF1,Cardiotrophin-1,23739,1376,1.03 [0.97-1.09],0.3570106480896126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,21122,1217,1.42 [1.17-1.72],0.0003365293407909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,21122,1217,0.94 [0.78-1.12],0.4795279556965774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTNNA1,Catenin alpha-1,20435,1186,1.03 [0.88-1.20],0.7219330677254786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRB1,Chymotrypsinogen B,24192,1398,0.97 [0.89-1.06],0.5091784652095876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,24202,1403,0.87 [0.81-0.94],0.0002622039108661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,21076,1210,0.84 [0.77-0.91],2.7269660237671985e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSB,Cathepsin B,24201,1399,1.03 [0.95-1.13],0.4754584684995724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,24162,1403,1.17 [1.05-1.30],0.004101007565494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,22576,1303,1.79 [1.64-1.95],1.5445406934010866e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSE,Cathepsin E,20675,1203,1.04 [0.94-1.15],0.4797635819888206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,24272,1406,1.23 [1.09-1.37],0.0004221073751985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSH,Pro-cathepsin H,23667,1375,1.07 [1.00-1.14],0.0484643078649588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,24200,1394,1.85 [1.55-2.21],2.1309767215688446e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,24435,1413,1.28 [1.11-1.49],0.0009935145025576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,18998,1112,1.36 [1.07-1.73],0.0122588056043677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSV,Cathepsin L2,24329,1397,0.93 [0.83-1.03],0.1709880182430591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,24179,1400,1.46 [1.26-1.69],3.236203868143597e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,20531,1187,0.93 [0.80-1.09],0.355747087939936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,20887,1199,1.03 [0.93-1.14],0.5820715927615939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CX3CL1,Fractalkine,24033,1375,0.96 [0.83-1.11],0.5725919139908777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,24143,1396,1.28 [1.18-1.38],6.247834919111619e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL1,Growth-regulated alpha protein,24159,1404,0.99 [0.94-1.04],0.7843777639127385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL10,C-X-C motif chemokine 10,24314,1410,1.05 [0.98-1.12],0.1836253669791849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,24408,1403,1.04 [0.98-1.09],0.2219028277425539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,23703,1359,1.05 [0.93-1.18],0.4367190233195849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,24408,1403,1.10 [1.03-1.18],0.0043145666783513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL14,C-X-C motif chemokine 14,23703,1359,1.06 [0.98-1.15],0.1338269032889169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,24443,1415,1.91 [1.56-2.33],2.0303111520696806e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,24435,1413,2.78 [2.55-3.03],6.540870306358869e-123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL3,C-X-C motif chemokine 3,24194,1402,1.00 [0.95-1.05],0.9604921564273956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL5,C-X-C motif chemokine 5,24124,1389,1.05 [1.01-1.09],0.0246458346704735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL6,C-X-C motif chemokine 6,24435,1413,1.03 [0.97-1.10],0.2853477975569232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,23995,1387,1.15 [1.08-1.23],1.3680952052875571e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,24314,1410,1.17 [1.10-1.26],2.163947014663175e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5A,Cytochrome b5,20372,1173,1.00 [0.93-1.08],0.9187774586977624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,20757,1196,1.12 [1.02-1.23],0.0143944446101209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",20461,1174,0.95 [0.89-1.02],0.1736174826541792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTH3,Cytohesin-3,20372,1173,1.05 [0.98-1.13],0.1598627416714071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTL1,Cytokine-like protein 1,21122,1217,1.30 [1.04-1.62],0.0191280664718968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,20675,1203,1.04 [0.98-1.11],0.2202439787944528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAB2,Disabled homolog 2,24400,1401,1.02 [0.98-1.07],0.2968373246116172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAG1,Dystroglycan,24314,1410,1.10 [1.00-1.21],0.0620372064266686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAND5,DAN domain family member 5,20528,1188,1.08 [0.97-1.21],0.135856121018467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPK2,Death-associated protein kinase 2,20528,1188,1.12 [1.02-1.23],0.0198162771584384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,24143,1396,1.00 [0.96-1.04],0.8153971545358644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",23984,1373,1.00 [0.94-1.06],0.9631615435833382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBH,Dopamine beta-hydroxylase,21101,1217,0.96 [0.91-1.01],0.1086836079459088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBI,Acyl-CoA-binding protein,24075,1394,1.08 [1.02-1.15],0.0099700716008479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBN1,Drebrin,20528,1188,1.04 [0.93-1.16],0.4961254863288115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBNL,Drebrin-like protein,24314,1410,1.04 [0.99-1.09],0.1331734786458006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",24272,1406,1.13 [0.99-1.29],0.0772394802279674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCC,Netrin receptor DCC,20531,1187,0.70 [0.53-0.92],0.010151356128766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,20372,1173,0.97 [0.89-1.06],0.5465962086089455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCLRE1C,Protein artemis,20372,1173,0.91 [0.76-1.09],0.3034644412381267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCN,Decorin,23739,1376,0.90 [0.72-1.11],0.3301927429207768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTD,Deoxycytidylate deaminase,20675,1203,1.03 [0.97-1.09],0.3320389159331807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN1,Dynactin subunit 1,24400,1401,1.05 [0.98-1.13],0.1820248467900531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN2,Dynactin subunit 2,24101,1383,1.03 [0.97-1.08],0.3225714119360354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN6,Dynactin subunit 6,23615,1355,1.05 [0.98-1.13],0.1312058356232233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,24200,1394,1.08 [0.93-1.26],0.3056863785886787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D1,DCN1-like protein 1,20435,1186,0.98 [0.90-1.06],0.5856515418765476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D2,DCN1-like protein 2,20372,1173,1.02 [0.96-1.09],0.5352069437254748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCXR,L-xylulose reductase,24272,1406,1.10 [1.01-1.20],0.0282421100321435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,20461,1174,1.06 [0.93-1.21],0.4050957650881586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",24101,1383,1.31 [1.19-1.45],6.062688820949484e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,24160,1391,0.99 [0.90-1.08],0.7915799548549496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDHD2,Phospholipase DDHD2,21095,1216,1.05 [0.97-1.15],0.2113418929222457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDI2,Protein DDI1 homolog 2,20675,1203,1.01 [0.94-1.08],0.8086911403673847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,24408,1403,1.30 [1.07-1.58],0.008707278593438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDT,D-dopachrome decarboxylase,21122,1217,1.13 [0.99-1.28],0.066018449203533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,21010,1209,0.97 [0.87-1.08],0.6091789667183647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,20531,1187,0.99 [0.86-1.15],0.9345094956928904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,20528,1188,1.09 [0.86-1.39],0.4560175186676642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,20528,1188,0.97 [0.87-1.08],0.5922185792036304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,20531,1187,0.94 [0.80-1.10],0.4289098340432913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,23618,1368,1.00 [0.92-1.08],0.9584001596889462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",24143,1396,1.05 [1.00-1.11],0.0429040062789259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,23678,1375,1.10 [1.01-1.19],0.0370118305250604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,20374,1183,1.01 [0.88-1.16],0.8629360969621349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,20435,1186,1.04 [0.95-1.14],0.4363823333008965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB116,Beta-defensin 116,20435,1186,0.96 [0.89-1.03],0.2636995456396471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB118,Beta-defensin 118,20435,1186,0.96 [0.87-1.06],0.4067196027882404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,23882,1373,1.08 [1.05-1.12],2.600164141592518e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENND2B,DENN domain-containing protein 2B,20461,1174,1.04 [0.94-1.16],0.452609615633059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENR,Density-regulated protein,20528,1188,1.08 [0.99-1.19],0.0886193470799922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,24435,1413,1.10 [1.03-1.18],0.0068970066854086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGCR6,Protein DGCR6,20435,1186,0.95 [0.83-1.08],0.4180669267411374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKA,Diacylglycerol kinase alpha,20528,1188,1.08 [0.98-1.20],0.1125492089428845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKZ,Diacylglycerol kinase zeta,23703,1359,1.01 [0.88-1.17],0.8403860007244965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHODH,Dihydroorotate dehydrogenase,20461,1174,0.93 [0.82-1.05],0.2484869140778763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHPS,Deoxyhypusine synthase,21007,1211,1.04 [0.89-1.20],0.6316183675227653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,21076,1210,1.01 [0.90-1.13],0.8801265155035509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",24124,1390,1.01 [0.97-1.06],0.6107338026794642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,20531,1187,1.03 [0.90-1.16],0.6829225716668406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,20675,1203,1.01 [0.82-1.24],0.9548676176568748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK1,Dickkopf-related protein 1,24408,1403,1.07 [0.99-1.15],0.0958696562935259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK3,Dickkopf-related protein 3,24485,1416,1.01 [0.86-1.19],0.9278498532959912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK4,Dickkopf-related protein 4,23996,1375,1.01 [0.91-1.12],0.8684048299175715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKKL1,Dickkopf-like protein 1,24101,1383,0.94 [0.89-1.00],0.0435522843024459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLG4,Disks large homolog 4,21076,1210,1.00 [0.93-1.08],0.9467338055913744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLGAP5,Disks large-associated protein 5,21095,1216,1.03 [0.94-1.12],0.5856903763345102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,24485,1416,0.97 [0.89-1.06],0.5540761791002073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,24272,1406,1.34 [1.15-1.57],0.0002297451833764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL4,Delta-like protein 4,20595,1191,1.02 [0.96-1.09],0.4506523577854531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMD,Dystrophin,20595,1191,1.10 [0.99-1.22],0.0677495779288858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,20595,1191,0.83 [0.76-0.90],1.4635855968678817e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,20372,1173,0.96 [0.85-1.09],0.5355925991278785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,24359,1408,1.03 [0.98-1.10],0.2401625884551382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,21076,1210,1.02 [0.94-1.09],0.685988804702697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,24101,1383,1.05 [1.00-1.11],0.0644275247035029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,21010,1209,1.09 [1.00-1.18],0.0452843379899346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,20675,1203,1.04 [0.94-1.15],0.4339729686437181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,20482,1190,1.04 [0.98-1.11],0.2006401727686095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,23739,1376,1.04 [0.96-1.12],0.3408786281056775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,21076,1210,1.03 [0.90-1.18],0.6607415691556863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,20595,1191,1.07 [1.00-1.14],0.0588469729589324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,21010,1209,1.04 [0.97-1.12],0.2350447883545416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,24160,1401,0.69 [0.57-0.84],0.0001601770314331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNLZ,DNL-type zinc finger protein,20435,1186,0.96 [0.90-1.02],0.2312319933281502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM1,Dynamin-1,21010,1209,1.00 [0.95-1.05],0.939152917797442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM3,Dynamin-3,21095,1216,1.11 [1.01-1.22],0.035685177894151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNMBP,Dynamin-binding protein,24033,1375,1.12 [1.04-1.20],0.0040836560255598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPEP,Aspartyl aminopeptidase,21076,1210,0.95 [0.86-1.05],0.297036544676176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,24278,1410,1.05 [0.96-1.15],0.2454146233126188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,20531,1187,0.88 [0.75-1.04],0.1421435710397356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,20435,1186,0.99 [0.95-1.04],0.8052021692458098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK1,Docking protein 1,21076,1210,1.01 [0.97-1.06],0.4819872283991314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK2,Docking protein 2,24200,1394,1.04 [1.00-1.09],0.0329764188002642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP1,Dipeptidase 1,23984,1373,0.87 [0.79-0.96],0.00343027500749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP2,Dipeptidase 2,24101,1383,0.88 [0.74-1.05],0.1512003552507202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,24143,1396,1.49 [1.33-1.68],1.8299310208447983e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP4,Dipeptidyl peptidase 4,23707,1367,0.81 [0.69-0.95],0.0081533485768341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,24101,1383,0.58 [0.51-0.67],3.1398629265891025e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,23997,1381,1.19 [1.10-1.29],2.5771744793068468e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPT,Dermatopontin,24485,1416,0.93 [0.78-1.11],0.44292532281243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,24318,1397,1.18 [1.10-1.27],5.398107714674243e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRAXIN,Draxin,24033,1375,0.96 [0.86-1.08],0.4947582212008315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,24101,1383,1.07 [0.99-1.17],0.1054797766919661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,23938,1386,1.17 [1.03-1.33],0.0183604027272943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,21095,1216,0.76 [0.64-0.89],0.0007063272211262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG2,Desmoglein-2,24192,1398,0.79 [0.66-0.94],0.0076382297403296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG3,Desmoglein-3,24319,1398,0.89 [0.77-1.02],0.0955674299020923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG4,Desmoglein-4,24027,1378,0.94 [0.86-1.03],0.2179601497171579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,20675,1203,1.01 [0.95-1.08],0.7357626828388923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,20971,1211,1.30 [1.15-1.46],2.180566152871358e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,20531,1187,0.94 [0.86-1.03],0.1694511992621848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,24101,1383,1.28 [1.05-1.57],0.0150482668806158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTYMK,Thymidylate kinase,21125,1219,1.04 [0.97-1.13],0.2731985123581398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUOX2,Dual oxidase 2,23739,1376,1.04 [0.98-1.11],0.1777162054554274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,21007,1211,0.91 [0.79-1.04],0.1752123672216941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP29,Dual specificity phosphatase 29,20531,1187,1.07 [0.99-1.16],0.074883547995934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,23615,1355,0.97 [0.91-1.02],0.2476178409654081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",21010,1209,1.05 [0.99-1.10],0.0835407626128878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DXO,Decapping and exoribonuclease protein,21076,1210,1.07 [0.95-1.20],0.2894338079442628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,21007,1211,1.01 [0.90-1.14],0.8454549578293471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,20531,1187,0.96 [0.90-1.03],0.3036958323260461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,21007,1211,1.14 [1.00-1.30],0.042717436501925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,24033,1375,1.03 [0.98-1.08],0.2978377385730367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBI3_IL27,Interleukin-27,24361,1398,1.00 [0.86-1.16],0.9837215768445152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECE1,Endothelin-converting enzyme 1,23615,1355,0.85 [0.75-0.98],0.0208536293743516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",21125,1219,1.15 [1.08-1.24],6.13190385680819e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",20595,1191,1.11 [1.05-1.17],0.0004017480978801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,20461,1174,1.04 [0.96-1.14],0.3383447185614494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECM1,Extracellular matrix protein 1,20571,1196,1.07 [0.91-1.24],0.425077977138193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,20435,1186,0.98 [0.87-1.09],0.6707329376014235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,24400,1401,1.51 [1.33-1.71],1.2604106401587856e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,24143,1396,0.94 [0.90-0.99],0.0234880332035726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,21007,1211,0.98 [0.86-1.12],0.7836365777522247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,20461,1174,1.03 [0.89-1.21],0.6670564047706027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDF1,Endothelial differentiation-related factor 1,21095,1216,1.00 [0.92-1.08],0.9476544142495624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,23739,1376,1.44 [1.27-1.64],1.672966167384856e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,20595,1191,1.88 [1.56-2.26],2.5434408395566585e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDNRB,Endothelin receptor type B,20528,1188,1.00 [0.89-1.13],0.936128734294696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EEF1D,Elongation factor 1-delta,21125,1219,1.07 [1.01-1.13],0.0213699475282357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,21010,1209,1.60 [1.34-1.90],1.7446117591772077e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,20717,1204,1.08 [0.93-1.25],0.3233617822651288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,24225,1405,1.24 [1.06-1.44],0.0058598539259423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFHD1,EF-hand domain-containing protein D1,21095,1216,1.08 [0.93-1.25],0.3206406953941672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,24154,1398,1.75 [1.49-2.06],1.3992699180475231e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,23992,1371,1.67 [1.44-1.94],2.3564306150338598e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNB2,Ephrin-B2,20531,1187,0.95 [0.86-1.05],0.3051497160703082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGF,Pro-epidermal growth factor,24157,1401,1.03 [0.98-1.08],0.2219072589505204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,23618,1368,1.29 [1.16-1.44],5.547490457154625e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,21010,1209,1.35 [1.14-1.59],0.0003522091634969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,24485,1416,0.44 [0.33-0.58],9.908188246678358e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,24143,1396,1.20 [1.12-1.29],2.2673408729732285e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHBP1,EH domain-binding protein 1,21125,1219,1.05 [0.98-1.13],0.1855623530649319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHD3,EH domain-containing protein 3,20595,1191,1.02 [0.97-1.07],0.4860210128113394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",21076,1210,0.99 [0.90-1.09],0.8378763611800596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",20938,1206,1.06 [1.01-1.11],0.0252028151670881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,20461,1174,1.04 [0.96-1.13],0.3182036394343703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,20595,1191,1.04 [0.90-1.20],0.6354385085496759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,24033,1375,1.05 [0.97-1.14],0.2638158584696383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,20528,1188,1.02 [0.96-1.09],0.4365509887801697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,24200,1394,1.11 [1.03-1.19],0.0040592032911132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,24435,1413,1.06 [1.01-1.11],0.0197752933511977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,21095,1216,1.01 [0.94-1.09],0.7751385132886462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,20461,1174,0.99 [0.88-1.13],0.921172284942584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,23703,1359,1.01 [0.86-1.19],0.8719409035770944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,21095,1216,1.01 [0.94-1.07],0.862020433034048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAVL4,ELAV-like protein 4,20435,1186,1.03 [0.97-1.10],0.3228368070703277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,21125,1219,1.56 [1.35-1.81],3.272765352643488e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOA,Elongin-A,24101,1383,1.11 [1.02-1.20],0.010730620964857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOB,Elongin-B,20461,1174,1.09 [0.95-1.26],0.2157799401327343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,23703,1359,1.11 [1.00-1.23],0.0455927747080777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,19487,1115,0.82 [0.73-0.93],0.0012908542885385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENG,Endoglin,24485,1416,1.13 [0.85-1.50],0.3945110075953327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO1,Alpha-enolase,24156,1392,1.02 [0.97-1.09],0.4176284884804351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO2,Gamma-enolase,24408,1403,0.99 [0.93-1.07],0.8749639736963474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO3,Beta-enolase,20595,1191,1.06 [0.96-1.17],0.2284478686076627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOPH1,Enolase-phosphatase E1,21007,1211,0.93 [0.83-1.03],0.1673974262306386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,20461,1174,1.17 [0.96-1.43],0.1230569889636585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPEP,Glutamyl aminopeptidase,20461,1174,1.00 [0.88-1.12],0.9535748182806753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,24485,1416,1.05 [0.89-1.24],0.5353394245630819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,24314,1410,0.84 [0.75-0.93],0.0011465353161316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,20595,1191,0.92 [0.79-1.08],0.3127152862245184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,23439,1354,1.13 [1.07-1.19],6.937236656660331e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENSA,Alpha-endosulfine,21007,1211,1.03 [0.93-1.15],0.5220425103202144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,23618,1368,1.01 [0.90-1.13],0.8277731135018422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,23739,1376,1.11 [0.89-1.40],0.3515601365518366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,23739,1376,1.17 [0.98-1.39],0.0847086810370962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,20595,1191,1.10 [1.00-1.21],0.0485649338496159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EP300,Histone acetyltransferase p300,20528,1188,1.02 [0.86-1.21],0.8475290559974442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPB41L5,Band 4.1-like protein 5,20531,1187,0.94 [0.85-1.03],0.1555932198607268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPCAM,Epithelial cell adhesion molecule,24203,1403,1.01 [0.96-1.06],0.6365591743916312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPGN,Epigen,21007,1211,0.99 [0.89-1.11],0.8924825786855984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA1,Ephrin type-A receptor 1,24278,1410,1.19 [1.03-1.36],0.014800617744342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA10,Ephrin type-A receptor 10,23615,1355,0.96 [0.89-1.03],0.2666385279363196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,23364,1338,1.49 [1.29-1.72],7.558930531349107e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA4,Ephrin type-A receptor 4,20675,1203,0.77 [0.63-0.93],0.0079967346402192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,24485,1416,1.48 [1.25-1.76],8.051807809115835e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB6,Ephrin type-B receptor 6,23984,1373,1.15 [0.98-1.34],0.0825294273409445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,23739,1376,1.00 [0.93-1.07],0.9480736002721386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPN1,Epsin-1,20717,1204,1.04 [0.93-1.17],0.5020684303531069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,24143,1396,1.11 [1.04-1.17],0.0005980161689735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,20595,1191,1.16 [1.08-1.24],1.5601565880946162e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,24357,1400,1.35 [1.16-1.58],0.0001365381636015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,24272,1406,1.25 [1.03-1.51],0.0246375350869307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,24130,1400,1.12 [0.88-1.43],0.3530476215864888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,24272,1406,0.82 [0.68-0.99],0.0433415288595999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBIN,Erbin,24101,1383,1.03 [0.98-1.08],0.1993340278038466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERC2,ERC protein 2,20531,1187,1.01 [0.94-1.08],0.8343982357085735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,20372,1173,1.08 [0.92-1.27],0.3411273347585936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EREG,Proepiregulin,23984,1373,1.10 [1.04-1.16],0.0013476276181366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERI1,3'-5' exoribonuclease 1,20717,1204,1.26 [1.09-1.45],0.0016878679461498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERMAP,Erythroid membrane-associated protein,20528,1188,0.95 [0.83-1.07],0.3722455173504031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,21007,1211,0.94 [0.81-1.08],0.3675202109184642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,20675,1203,1.02 [0.98-1.07],0.3258479455494503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,24056,1380,1.15 [0.96-1.39],0.1346817300833611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,20461,1174,0.97 [0.86-1.09],0.5930971612112492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,24485,1416,1.31 [1.14-1.51],0.0001970629026215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESM1,Endothelial cell-specific molecule 1,24201,1404,0.82 [0.71-0.94],0.0034271543249976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESPL1,Separin,20372,1173,1.04 [0.94-1.14],0.4623677255414887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESR1,Estrogen receptor,20528,1188,0.94 [0.85-1.05],0.265771369747332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESYT2,Extended synaptotagmin-2,21076,1210,1.02 [0.96-1.09],0.5512746766462444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI2B,Protein EVI2B,20372,1173,0.99 [0.86-1.14],0.9095733586102224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,20528,1188,1.02 [0.96-1.09],0.5052070901164696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVPL,Envoplakin,20717,1204,0.88 [0.74-1.04],0.1349979475488876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXOSC10,Exosome component 10,20461,1174,0.97 [0.88-1.06],0.5013904593787122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXTL1,Exostosin-like 1,20461,1174,0.91 [0.80-1.02],0.1132930102582653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,24408,1403,1.50 [1.24-1.81],2.5789051120134283e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F10,Coagulation factor X,21143,1218,1.37 [1.09-1.73],0.0076898255700072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11,Coagulation factor XI,20862,1212,1.05 [0.89-1.25],0.5350863480651651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11R,Junctional adhesion molecule A,24192,1398,1.14 [1.05-1.24],0.0015871735180531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F12,Coagulation factor XII,21172,1227,1.00 [0.88-1.15],0.9426104254697988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F13B,Coagulation factor XIII B chain,21041,1221,1.31 [1.06-1.63],0.01291676810579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2,Prothrombin,21172,1227,0.79 [0.55-1.15],0.2181106967774246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2R,Proteinase-activated receptor 1,24271,1407,1.09 [1.01-1.19],0.0286084087057155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F3,Tissue factor,24257,1395,1.04 [0.88-1.24],0.6190310852148797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F7,Coagulation factor VII,24232,1402,1.24 [1.06-1.45],0.007237376739888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,24226,1403,2.31 [1.78-3.01],3.978119516585627e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",24201,1404,1.21 [1.16-1.27],2.2329383253289533e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",24200,1394,1.13 [1.07-1.19],8.225700357166399e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",21125,1219,1.45 [1.31-1.61],3.923327158117741e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",24485,1416,1.34 [1.22-1.48],4.617665418394763e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,24331,1400,1.12 [1.05-1.20],0.0008915280820322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP6,Gastrotropin,23698,1374,1.04 [0.96-1.13],0.3280611686600365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP9,Fatty acid-binding protein 9,24143,1396,0.97 [0.89-1.06],0.4777042992182495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FADD,FAS-associated death domain protein,24200,1394,1.04 [0.98-1.11],0.1801205042044618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM13A,Protein FAM13A,21010,1209,1.07 [0.99-1.16],0.102448872322726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171A2,Protein FAM171A2,21095,1216,1.01 [0.98-1.05],0.5417042377901533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171B,Protein FAM171B,21007,1211,1.02 [0.83-1.26],0.8401610825320888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,20595,1191,1.02 [0.93-1.11],0.7313815032930084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,21125,1219,1.94 [1.66-2.27],1.4035388371404312e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,24101,1383,1.36 [1.18-1.56],1.4793648115156094e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,24160,1391,1.51 [1.29-1.77],3.0562819479071577e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3D,Protein FAM3D,21010,1209,1.07 [1.00-1.14],0.0549853781556144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAP,Prolyl endopeptidase FAP,24485,1416,0.73 [0.61-0.87],0.0004204242104963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,20531,1187,1.00 [0.92-1.08],0.9952944343238568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,24408,1411,1.17 [1.01-1.36],0.0412382051060956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,24435,1413,0.80 [0.70-0.90],0.0002755961968883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBLN2,Fibulin-2,21122,1217,0.88 [0.74-1.04],0.1410450226362547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBN2,Fibrillin-2,20531,1187,1.05 [0.96-1.15],0.3151667017761997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",24200,1394,1.10 [1.04-1.18],0.0025762773204801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,21125,1219,1.04 [0.97-1.12],0.3070493534343686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,24143,1396,1.16 [1.05-1.29],0.0029603479353747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,21095,1216,1.18 [0.94-1.48],0.1561795628790357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,24192,1398,0.95 [0.86-1.05],0.2988402868085058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,24069,1391,1.03 [0.95-1.11],0.5361573865665692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,23618,1368,0.98 [0.90-1.06],0.5671853795598953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,24195,1398,1.01 [0.92-1.10],0.8701908299375336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,21101,1217,1.24 [1.11-1.37],6.750719541573562e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN2,Ficolin-2,24065,1393,0.99 [0.88-1.11],0.8997696043482676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL1,Fc receptor-like protein 1,24200,1394,0.90 [0.80-1.00],0.0486727234944181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL2,Fc receptor-like protein 2,24319,1405,0.99 [0.90-1.09],0.8981553393964252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL3,Fc receptor-like protein 3,23703,1359,1.00 [0.92-1.10],0.9554102360108224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL5,Fc receptor-like protein 5,24192,1398,0.97 [0.89-1.06],0.5135427140247157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL6,Fc receptor-like protein 6,24143,1396,0.95 [0.89-1.02],0.1590504374779601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,23618,1368,1.12 [1.03-1.21],0.0058067940891014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",20461,1174,1.12 [1.04-1.22],0.0048631453187268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",20461,1174,1.04 [0.94-1.15],0.4244109265063984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FEN1,Flap endonuclease 1,23618,1368,1.04 [0.97-1.12],0.2555341158969987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,23618,1368,1.01 [0.91-1.11],0.9010836051971534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FETUB,Fetuin-B,24226,1403,1.07 [0.92-1.24],0.3626941264657555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,20658,1192,1.08 [0.90-1.30],0.3827373195220445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",21095,1216,1.05 [0.98-1.12],0.1534408013746172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF12,Fibroblast growth factor 12,20528,1188,1.01 [0.89-1.14],0.9254314336539946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF16,Fibroblast growth factor 16,20528,1188,0.94 [0.83-1.06],0.2874368460314779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,24314,1410,1.11 [1.04-1.18],0.0010224451248801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF2,Fibroblast growth factor 2,24143,1396,1.10 [1.03-1.18],0.0068977099768656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF20,Fibroblast growth factor 20,20528,1188,0.94 [0.82-1.07],0.3326973481610781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,24361,1398,1.21 [1.16-1.25],6.829848211908798e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,24367,1400,1.28 [1.20-1.36],1.2172505446902631e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF3,Fibroblast growth factor 3,20528,1188,1.06 [0.88-1.26],0.550807234440789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF5,Fibroblast growth factor 5,23703,1359,1.19 [1.02-1.39],0.0245664785168037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF6,Fibroblast growth factor 6,20528,1188,0.91 [0.79-1.05],0.1879842586422467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF7,Fibroblast growth factor 7,20372,1173,0.99 [0.92-1.06],0.7806600757649071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF9,Fibroblast growth factor 9,20331,1170,1.06 [0.93-1.22],0.3666431395806306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,24272,1406,0.74 [0.64-0.85],4.8781025952729385e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,21122,1217,0.98 [0.88-1.09],0.716031529100748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,21076,1210,0.95 [0.81-1.10],0.4661314313001221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,24272,1406,1.63 [1.33-2.01],3.955162355514938e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,20675,1203,0.91 [0.82-1.01],0.0797585169061777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,21143,1218,1.28 [1.18-1.39],8.797740753354672e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGR,Tyrosine-protein kinase Fgr,23615,1355,1.07 [0.99-1.15],0.0768427979391592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FH,"Fumarate hydratase, mitochondrial",20435,1186,1.00 [0.94-1.07],0.9887902363408604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,20461,1174,0.98 [0.88-1.10],0.7833776029192594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,23615,1355,0.99 [0.93-1.06],0.7728189097722067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,24201,1405,1.08 [1.02-1.15],0.0077130652315356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,21095,1216,1.03 [0.98-1.09],0.2368402522946936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,24237,1400,1.01 [0.97-1.05],0.6026065897913326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,24033,1375,1.18 [1.06-1.32],0.0018663704796704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,24033,1375,1.06 [1.01-1.11],0.0291321964589934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,23566,1353,1.12 [1.01-1.23],0.033263935723024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBPL,FK506-binding protein-like,21010,1209,1.07 [0.97-1.17],0.1794170174254869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,23618,1368,1.04 [1.00-1.09],0.0523543245544435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,24033,1375,0.94 [0.80-1.11],0.4571091641617177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,24060,1381,1.01 [0.81-1.25],0.9233299470461138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,23618,1368,0.79 [0.68-0.93],0.0033298183275758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,24435,1413,1.27 [1.10-1.46],0.0010519021524541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,24272,1406,1.01 [0.88-1.16],0.89066737190751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMNL1,Formin-like protein 1,23615,1355,1.06 [0.98-1.13],0.1318418930166795
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMR1,Synaptic functional regulator FMR1,23618,1368,1.12 [0.98-1.29],0.0980082891703027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FN1,Fibronectin,21172,1227,1.07 [0.87-1.31],0.5204341502374412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,21076,1210,1.03 [0.91-1.16],0.6858749709158325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,21007,1211,1.04 [0.90-1.22],0.5700733871390296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,20528,1188,1.00 [0.94-1.05],0.8871892408983438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,24155,1396,1.26 [1.08-1.48],0.0042368602939571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,24408,1403,1.13 [0.97-1.33],0.1253368844985294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR3,Folate receptor gamma,24196,1401,1.01 [0.98-1.03],0.6033410162310603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOS,Proto-oncogene c-Fos,20331,1170,1.07 [0.91-1.25],0.4087063292705482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOSB,Protein fosB,23615,1355,1.08 [0.96-1.21],0.1970385880425856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXJ3,Forkhead box protein J3,20528,1188,1.13 [1.00-1.27],0.0422669303702091
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO1,Forkhead box protein O1,24143,1396,1.11 [1.05-1.17],0.0002959961811299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO3,Forkhead box protein O3,23618,1368,1.06 [1.01-1.12],0.0233216218959751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD4B,FERM domain-containing protein 4B,20461,1174,1.02 [0.95-1.11],0.5544474869190357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD7,FERM domain-containing protein 7,20531,1187,0.88 [0.75-1.05],0.1544934374203696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRZB,Secreted frizzled-related protein 3,23948,1366,0.88 [0.74-1.03],0.1149198784051308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSHB,Follitropin subunit beta,20595,1191,0.94 [0.87-1.02],0.1322013146301209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,24271,1407,1.14 [1.05-1.25],0.0033958334829984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,20595,1191,1.97 [1.54-2.51],5.5617088905468224e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,24162,1396,1.92 [1.67-2.20],5.501274084291865e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,21040,1210,1.12 [1.05-1.19],0.0005586983314309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,24342,1410,0.99 [0.93-1.05],0.7126870050828147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,20675,1203,1.26 [1.16-1.38],1.5379299513004924e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,24272,1406,1.43 [1.25-1.64],2.6995550634213336e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUS,RNA-binding protein FUS,23586,1367,1.14 [1.01-1.28],0.03515130235873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",20672,1202,0.95 [0.87-1.04],0.2793221786976287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,24408,1403,1.30 [1.18-1.43],2.600878830395031e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",24033,1375,1.05 [0.97-1.14],0.2136845534598277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXN,"Frataxin, mitochondrial",24400,1401,1.02 [0.96-1.09],0.486388055551052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,23703,1359,1.04 [0.97-1.12],0.2623577783705286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FYB1,FYN-binding protein 1,24158,1397,1.07 [1.02-1.13],0.0119159166321652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD10,Frizzled-10,20531,1187,1.10 [1.01-1.19],0.0209193851764125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD8,Frizzled-8,20435,1186,1.05 [0.93-1.19],0.4514431035495605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,21007,1211,1.10 [0.99-1.21],0.0728657888896132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,20717,1204,1.01 [0.93-1.11],0.7400241093806857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,20435,1186,1.00 [0.92-1.09],0.974938454088433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD1,Glutamate decarboxylase 1,20372,1173,1.13 [0.91-1.41],0.2638789288110745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD2,Glutamate decarboxylase 2,20528,1188,0.91 [0.80-1.04],0.1688866779769705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,20717,1204,0.94 [0.84-1.05],0.2640081507051624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,20595,1191,1.10 [0.99-1.22],0.0647300031532775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAGE2A,G antigen 2A,20372,1173,1.10 [1.02-1.19],0.0148773399376468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,24314,1410,0.82 [0.76-0.89],2.922750429883288e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,24101,1383,1.64 [1.41-1.92],5.478552195304797e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,24400,1401,0.79 [0.66-0.95],0.0121900431892104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,23703,1359,1.00 [0.89-1.12],0.9742554106633246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,21125,1219,1.25 [1.03-1.51],0.0259952775167311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,24101,1383,0.93 [0.74-1.17],0.5490377290608494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,20461,1174,1.08 [0.94-1.24],0.2772149335569357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,20232,1171,1.14 [0.96-1.36],0.1258533074005564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,21095,1216,1.12 [0.90-1.39],0.2959563037556725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS2,Growth arrest-specific protein 2,20717,1204,1.04 [0.94-1.15],0.4360140380559738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,24322,1406,1.18 [0.99-1.42],0.0677181508572185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GASK1A,Golgi-associated kinase 1A,20461,1174,0.99 [0.87-1.12],0.8587606654659639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,21076,1210,1.20 [1.16-1.25],3.3428338535406333e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,20372,1173,1.05 [0.85-1.30],0.6621218352694187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",20595,1191,1.00 [0.93-1.08],0.9033125395028986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBA,Lysosomal acid glucosylceramidase,20531,1187,1.11 [1.00-1.23],0.0491939845879407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,21043,1210,1.14 [1.04-1.24],0.0039389540264852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP2,Guanylate-binding protein 2,23703,1359,1.04 [0.95-1.12],0.400982031089423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP4,Guanylate-binding protein 4,23615,1355,1.05 [0.95-1.16],0.3481451314093513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP6,Guanylate-binding protein 6,20461,1174,1.08 [0.97-1.21],0.1738232608644784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GC,Vitamin D-binding protein,21172,1227,0.99 [0.80-1.22],0.9299264678914968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,21076,1210,1.02 [0.97-1.07],0.5089253649873722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCG,Pro-glucagon,23618,1368,1.11 [1.07-1.16],2.206398019497249e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,20197,1172,1.49 [1.39-1.60],1.478401235489561e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,20461,1174,1.02 [0.91-1.14],0.7451897595712823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",24101,1383,1.10 [0.96-1.27],0.1615748095456591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,24485,1416,2.07 [2.00-2.14],0.0
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF2,Growth/differentiation factor 2,24200,1394,0.81 [0.71-0.92],0.0016100835147648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,23615,1355,1.10 [0.97-1.24],0.1343291740337426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GET3,ATPase GET3,21125,1219,0.97 [0.88-1.06],0.4900677554069093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFAP,Glial fibrillary acidic protein,23581,1365,0.96 [0.87-1.07],0.5055748962671454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,23618,1368,1.19 [1.11-1.28],2.586487569219962e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,23618,1368,0.98 [0.95-1.02],0.3682796173368997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,24361,1398,1.77 [1.51-2.09],4.323594379589488e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA2,GDNF family receptor alpha-2,24101,1383,1.07 [0.86-1.34],0.5482344322088077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA3,GDNF family receptor alpha-3,23955,1368,0.85 [0.72-1.01],0.0665398557927378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,20431,1180,0.83 [0.76-0.92],0.0001235505013157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,23615,1355,1.00 [0.93-1.07],0.9681974390240412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,21125,1219,1.04 [0.96-1.13],0.2990400785861827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,21082,1219,1.01 [0.91-1.14],0.805566356117566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGH,Gamma-glutamyl hydrolase,23760,1371,1.25 [1.10-1.42],0.0007572102295506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,24154,1398,1.37 [1.26-1.50],8.652806746426381e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,24033,1375,1.25 [1.01-1.54],0.0398903190869266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH1,Somatotropin,24160,1391,0.96 [0.94-0.99],0.0145420615514154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH2,Growth hormone variant,23618,1368,0.97 [0.94-1.00],0.0271045596835196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,20675,1203,0.99 [0.82-1.20],0.9209731725820218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,23615,1355,1.01 [0.92-1.10],0.8709016116175842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRL,Appetite-regulating hormone,24200,1394,1.06 [1.00-1.12],0.0460509076690723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,21095,1216,0.96 [0.81-1.15],0.6729700300711576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,21095,1216,1.06 [0.99-1.13],0.1186663629093181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP7,GTPase IMAP family member 7,20675,1203,1.14 [0.97-1.34],0.1063477412824837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP8,GTPase IMAP family member 8,20372,1173,1.00 [0.89-1.11],0.9347865286599392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIP,Gastric inhibitory polypeptide,20595,1191,1.22 [1.10-1.35],0.0001408307818387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,21076,1210,1.45 [1.21-1.73],5.655928379020236e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,21010,1209,1.02 [0.96-1.07],0.6062678633034972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,20528,1188,1.02 [0.91-1.14],0.7412272762901881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,20528,1188,1.03 [0.97-1.09],0.2824640111600659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GJA8,Gap junction alpha-8 protein,20372,1173,0.99 [0.90-1.08],0.7783124785560088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,23158,1335,1.28 [1.08-1.52],0.0044061858155594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,20634,1200,1.57 [1.35-1.81],2.063814340810039e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,24033,1375,1.27 [1.14-1.43],2.615414700634717e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLI2,Zinc finger protein GLI2,20528,1188,1.00 [0.84-1.20],0.9629116799267112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,23739,1376,1.18 [1.09-1.28],3.7036965034736586e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,24158,1402,1.08 [0.95-1.23],0.2616214214789865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,20435,1186,0.91 [0.79-1.06],0.2363708459262815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX,Glutaredoxin-1,24053,1382,1.07 [0.98-1.16],0.1236691120334972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",20675,1203,1.07 [1.01-1.14],0.0333694101496683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,23615,1355,0.95 [0.85-1.05],0.3136070756222485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,21007,1211,1.02 [0.92-1.12],0.7522189722480401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,20600,1184,1.33 [1.21-1.47],1.7160602079111924e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMFG,Glia maturation factor gamma,21125,1219,1.03 [0.95-1.11],0.5090436595107009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR,GMP reductase 1,24435,1413,1.04 [0.95-1.14],0.4159850204565147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR2,GMP reductase 2,20675,1203,1.05 [0.96-1.13],0.287281890622411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNAS,Neuroendocrine secretory protein 55,21095,1216,1.00 [0.95-1.06],0.8738187285637911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,23618,1368,1.08 [1.00-1.16],0.0479533725177894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,20531,1187,1.00 [0.90-1.11],0.9759647978801556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNLY,Granulysin,24192,1398,1.02 [0.92-1.12],0.7451876266414128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,20595,1191,1.00 [0.86-1.15],0.9599238092444884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,20675,1203,0.93 [0.80-1.09],0.3797230561858689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLGA3,Golgin subfamily A member 3,21095,1216,1.05 [0.98-1.13],0.1706103788634025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,24408,1403,1.30 [1.07-1.58],0.0092506503583211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,24143,1396,1.03 [0.98-1.08],0.1845130781087396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,21010,1209,1.01 [0.90-1.14],0.821519043183693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",21122,1217,1.07 [0.94-1.22],0.2948014411511458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,24063,1391,1.13 [0.98-1.31],0.0996686286261397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,20461,1174,1.08 [0.99-1.17],0.0761986785145981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,23434,1349,0.92 [0.86-0.98],0.0123146415437693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP5,Platelet glycoprotein V,20675,1203,1.01 [0.87-1.18],0.8946565611628066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP6,Platelet glycoprotein VI,24158,1397,1.04 [0.98-1.10],0.174181238427426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPA33,Cell surface A33 antigen,24101,1383,1.01 [0.97-1.04],0.7371535420348416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC1,Glypican-1,24400,1401,0.96 [0.81-1.12],0.5767407748225295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,24033,1375,0.94 [0.87-1.03],0.1811208251561069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,21007,1211,1.28 [1.16-1.42],1.376508559836843e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,21010,1209,1.07 [0.97-1.19],0.1873153178933005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPI,Glucose-6-phosphate isomerase,21143,1218,1.05 [0.94-1.17],0.4029278955200406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,21010,1209,0.91 [0.85-0.98],0.0141708406832033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,23615,1355,1.28 [1.11-1.47],0.0004606836114806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,23554,1358,1.02 [0.86-1.22],0.7903640304389227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR101,Probable G-protein coupled receptor 101,20435,1186,0.99 [0.91-1.09],0.9072888509386828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR158,Probable G-protein coupled receptor 158,21095,1216,1.01 [0.87-1.18],0.8772707976829132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,21010,1209,1.12 [1.02-1.22],0.0169481536996499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,23739,1376,1.24 [1.15-1.33],5.358389853228213e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,21007,1211,1.26 [1.16-1.37],2.2596915089042244e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRAP2,GRB2-related adapter protein 2,24200,1394,1.02 [0.98-1.06],0.2803166754705056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,21125,1219,1.09 [1.00-1.18],0.0502808602695199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",21095,1216,0.91 [0.79-1.05],0.1988534782005678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",20435,1186,0.99 [0.90-1.10],0.9142043565804304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRK5,G protein-coupled receptor kinase 5,23739,1376,1.04 [0.95-1.15],0.3991663755396547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,24078,1395,1.30 [1.07-1.58],0.0093694941105239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRP,Gastrin-releasing peptide,20595,1191,1.12 [1.01-1.23],0.03212981157546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",24101,1383,1.27 [1.18-1.36],1.6294446124336348e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRSF1,G-rich sequence factor 1,20255,1164,1.01 [0.94-1.09],0.7296789849084531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSAP,Gamma-secretase-activating protein,23618,1368,1.01 [0.96-1.07],0.6141919894742613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,21074,1209,0.46 [0.37-0.59],1.6972120884162942e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSR,"Glutathione reductase, mitochondrial",21016,1216,0.92 [0.71-1.19],0.51930241404216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA1,Glutathione S-transferase A1,24166,1390,1.10 [1.04-1.16],0.0018421378504555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA3,Glutathione S-transferase A3,23618,1368,1.08 [1.01-1.14],0.0197251328879504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,20461,1174,0.99 [0.92-1.07],0.7497912113883012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTP1,Glutathione S-transferase P,23463,1342,1.02 [0.95-1.09],0.6199702360044363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,21076,1210,1.02 [1.00-1.04],0.09549785034947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,20717,1204,1.03 [0.96-1.11],0.428640878365503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTPBP2,GTP-binding protein 2,20531,1187,1.06 [0.99-1.14],0.0934397683532916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,24076,1393,1.23 [1.07-1.42],0.002858360173965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,20717,1204,1.02 [0.96-1.08],0.5574882566231079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUK1,Guanylate kinase,20461,1174,0.94 [0.81-1.09],0.4255733621352563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,24299,1407,1.19 [1.11-1.28],4.395106819722929e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",23739,1376,1.06 [1.01-1.12],0.0263782390443172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMA,Granzyme A,24435,1413,1.03 [0.90-1.17],0.6912420567557029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMB,Granzyme B,24143,1396,0.94 [0.87-1.02],0.1283976755324567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMH,Granzyme H,23739,1376,1.05 [0.98-1.11],0.1541722029213099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",H2AP,Huntingtin-interacting protein M,20372,1173,1.04 [0.94-1.16],0.4148965283651907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",20461,1174,1.01 [0.93-1.10],0.7465210643384372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",24326,1396,0.98 [0.92-1.05],0.5749304356862258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,24400,1401,1.09 [1.05-1.12],2.2672159002194973e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",24192,1398,1.03 [0.97-1.10],0.3206800491177949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,24365,1399,1.41 [1.32-1.52],1.683013252619715e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,24192,1398,1.68 [1.47-1.92],3.081195960825839e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,24326,1396,1.01 [0.94-1.07],0.8230638483114185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBQ1,Hemoglobin subunit theta-1,24400,1401,0.92 [0.85-1.00],0.0426358076921354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBZ,Hemoglobin subunit zeta,21125,1219,1.03 [0.98-1.09],0.256206260849958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCG22,Protein PBMUCL2,20461,1174,0.97 [0.87-1.07],0.5096292564535657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,24435,1413,1.10 [1.01-1.20],0.024186819365033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC8,Histone deacetylase 8,20528,1188,0.99 [0.90-1.09],0.8122746667305147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC9,Histone deacetylase 9,20435,1186,0.94 [0.85-1.03],0.1865281486981097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,21010,1209,0.91 [0.80-1.04],0.1529806057938805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGF,Hepatoma-derived growth factor,24371,1401,1.02 [0.97-1.07],0.5177953724333676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,21076,1210,1.09 [1.00-1.18],0.0565207448247066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEBP1,Heme-binding protein 1,23739,1376,1.09 [1.01-1.19],0.0336384651424424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,20675,1203,1.36 [1.12-1.64],0.0015512832822721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPACAM2,HEPACAM family member 2,21076,1210,0.93 [0.81-1.06],0.2852437055837299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPH,Hephaestin,21125,1219,1.39 [1.13-1.71],0.0021519602853488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEXIM1,Protein HEXIM1,24143,1396,1.09 [1.03-1.16],0.0027788792338074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,24435,1413,1.75 [1.54-1.99],1.1003925851973864e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGFAC,Hepatocyte growth factor activator,20938,1208,1.12 [0.91-1.36],0.2818584735051633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,23618,1368,1.05 [0.98-1.11],0.1489892242385004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,21076,1210,1.11 [1.03-1.19],0.0037151444489498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,20528,1188,0.96 [0.88-1.04],0.3007187807474598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1,Huntingtin-interacting protein 1,20461,1174,0.96 [0.81-1.13],0.6013571786974554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,21038,1209,1.26 [1.14-1.38],2.575539675467102e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,21095,1216,1.24 [1.09-1.40],0.0006516676898701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HK2,Hexokinase-2,23739,1376,1.13 [0.96-1.34],0.1454564720771065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",21095,1216,1.07 [0.90-1.27],0.4333850200266227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",24082,1392,1.07 [0.94-1.23],0.2929175386577811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24143,1396,1.38 [1.17-1.62],9.621372917937072e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMBS,Porphobilinogen deaminase,24400,1401,0.98 [0.88-1.08],0.6798711056657911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMCN2,Hemicentin-2,20640,1201,1.01 [0.91-1.11],0.91558369401328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",20595,1191,1.15 [1.04-1.28],0.0083801448787804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",20461,1174,1.14 [1.01-1.29],0.0312922038934046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMMR,Hyaluronan mediated motility receptor,20337,1173,1.09 [0.97-1.22],0.1384387352178356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX1,Heme oxygenase 1,23923,1379,0.97 [0.88-1.07],0.5411382026628268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,23615,1355,1.10 [1.00-1.22],0.0578391039246603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,20531,1187,0.96 [0.88-1.04],0.3025483750758645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,23909,1366,1.21 [1.10-1.34],0.0002149555265782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,23665,1370,1.06 [1.00-1.13],0.0571497507365351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,21095,1216,1.10 [0.98-1.23],0.1092180802812533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPCAL1,Hippocalcin-like protein 1,24435,1413,1.04 [0.98-1.11],0.2320281165002992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,23618,1368,0.68 [0.60-0.78],9.970677021457494e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,20835,1207,1.08 [1.02-1.15],0.0078848516158665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRAS,GTPase Hras,20675,1203,1.00 [0.94-1.06],0.9449742517289532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,20595,1191,1.00 [0.88-1.13],0.980292284843722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRG,Histidine-rich glycoprotein,21041,1221,1.14 [0.95-1.37],0.1502650682436859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS1BP3,HCLS1-binding protein 3,20595,1191,1.08 [1.01-1.15],0.0239604171418319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,24101,1383,1.24 [1.10-1.41],0.0006377020555446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,24400,1401,1.09 [0.95-1.25],0.2062889190660703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,20528,1188,1.06 [0.88-1.27],0.5499695769511891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSBP1,Heat shock factor-binding protein 1,20595,1191,1.04 [0.98-1.10],0.2433325567107258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,24143,1396,1.09 [0.97-1.23],0.134198306753412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,21076,1210,1.13 [1.04-1.24],0.0050115931285211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,20461,1174,1.01 [0.90-1.12],0.921513298645212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,20595,1191,1.04 [0.93-1.17],0.4807950402283364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSP90B1,Endoplasmin,23500,1349,1.00 [0.93-1.07],0.9175579416727722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,24278,1410,1.04 [0.98-1.11],0.1888902339800706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,21007,1211,1.10 [0.92-1.32],0.2838853775077344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB1,Heat shock protein beta-1,23813,1368,1.00 [0.93-1.07],0.9847916314779568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB6,Heat shock protein beta-6,24400,1401,1.24 [1.10-1.41],0.0007097021631557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,23981,1386,1.57 [1.32-1.87],3.976584918660482e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,20435,1186,0.98 [0.91-1.05],0.5144120257410134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,20435,1186,1.10 [0.97-1.25],0.1393699741022387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",24272,1406,1.09 [1.01-1.17],0.0326322661970507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,24029,1396,1.40 [1.16-1.69],0.0004051764727004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,24485,1416,1.50 [1.21-1.86],0.0002370771366457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICA1,Islet cell autoantigen 1,23703,1359,1.06 [1.00-1.13],0.0508006499623408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,24070,1391,1.69 [1.47-1.94],1.1120606410002621e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM2,Intercellular adhesion molecule 2,24485,1416,1.10 [0.95-1.28],0.1857215186378147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,24485,1416,0.97 [0.80-1.17],0.7493029961008376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM4,Intercellular adhesion molecule 4,24143,1396,0.95 [0.87-1.04],0.240119466274842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,24200,1394,1.42 [1.28-1.58],2.599079966541108e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICOSLG,ICOS ligand,24101,1383,0.82 [0.64-1.06],0.1288280030259141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,20717,1204,1.09 [0.98-1.23],0.1270542122173318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,23615,1355,1.10 [1.00-1.22],0.0564197559028203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",20595,1191,0.97 [0.89-1.06],0.4465456600622395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDS,Iduronate 2-sulfatase,24435,1413,0.58 [0.35-0.95],0.032406059474226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,24400,1401,1.27 [1.14-1.41],7.645916718508862e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20486,1177,1.84 [1.63-2.08],4.250742977656921e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,20717,1204,0.98 [0.88-1.09],0.6543445667331892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,20717,1204,1.05 [0.92-1.21],0.4739985057255532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,21010,1209,0.96 [0.78-1.19],0.7074458292686563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNG,Interferon gamma,23703,1359,1.05 [1.00-1.09],0.0405414189159677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR1,Interferon gamma receptor 1,24314,1410,1.06 [0.84-1.33],0.6406206820779554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,24033,1375,1.08 [0.98-1.18],0.1071431006287442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL1,Interferon lambda-1,23615,1355,1.12 [1.01-1.24],0.0361647666547945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL2,Interferon lambda-2,20435,1186,1.05 [0.96-1.13],0.2794981565631446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNLR1,Interferon lambda receptor 1,24143,1396,1.16 [1.03-1.32],0.0187917267139599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNW1,Interferon omega-1,20461,1174,0.97 [0.82-1.13],0.6728199111587206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,20531,1187,1.00 [0.88-1.13],0.9637677543905384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,21095,1216,1.01 [0.93-1.11],0.783700759161525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,20435,1186,0.97 [0.87-1.07],0.5365424878983598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,21122,1217,0.68 [0.56-0.84],0.0002543486620176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,24101,1383,0.91 [0.74-1.12],0.3902031066589355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,20461,1174,0.96 [0.85-1.09],0.5251155937714516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,24192,1398,1.27 [1.03-1.56],0.0244084355582106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,24442,1414,1.02 [0.98-1.06],0.3228157849155547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,24441,1415,1.09 [1.01-1.18],0.0225400792609135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,24267,1406,0.86 [0.72-1.02],0.0779864236737723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,23867,1376,1.89 [1.73-2.06],3.025488742510724e-45
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,24070,1392,1.08 [0.92-1.27],0.3308447502078243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,24485,1416,1.48 [1.26-1.73],1.2510202693227294e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,24200,1394,1.62 [1.42-1.85],1.4156560929085154e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFL4,Insulin growth factor-like family member 4,20528,1188,1.05 [0.98-1.12],0.1439668433601622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,20461,1174,1.01 [0.91-1.12],0.8467898051111831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,21130,1226,1.29 [1.03-1.60],0.0249215055982221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLON5,IgLON family member 5,20372,1173,1.05 [0.99-1.11],0.1295395903236555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,20595,1191,0.87 [0.75-1.02],0.0795213426191069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,24101,1383,1.23 [1.07-1.41],0.0033714352904746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,24200,1394,1.55 [1.33-1.81],2.2841750021826563e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,21125,1219,1.21 [1.13-1.29],6.066339602203266e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKBKG,NF-kappa-B essential modulator,24143,1396,1.08 [1.02-1.13],0.0056986771530622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKZF2,Zinc finger protein Helios,23618,1368,0.98 [0.93-1.04],0.5769853150667168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10,Interleukin-10,23703,1359,1.00 [0.95-1.06],0.925009504259544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,23703,1359,1.10 [1.02-1.18],0.0156290567351354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,24314,1410,1.63 [1.39-1.91],2.2788329269311476e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL11,Interleukin-11,23703,1359,0.98 [0.91-1.05],0.5304832890967752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12A_IL12B,Interleukin-12,24101,1383,0.94 [0.89-1.00],0.054795584476957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12B,Interleukin-12 subunit beta,24435,1413,0.91 [0.84-0.99],0.0309592033743086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,23703,1359,1.16 [1.02-1.33],0.0209291171458352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,20528,1188,0.90 [0.78-1.04],0.144779886992233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13,Interleukin-13,23703,1359,1.02 [0.94-1.11],0.6621610136659278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,23890,1381,1.38 [1.10-1.73],0.0047306625395475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,20435,1186,0.92 [0.76-1.12],0.4270645301632246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,24143,1396,1.68 [1.47-1.91],7.483715837086533e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,23703,1359,1.12 [0.97-1.28],0.1155535608121694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL16,Pro-interleukin-16,24435,1413,1.21 [1.08-1.34],0.0005542617061859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17A,Interleukin-17A,23674,1357,1.10 [0.98-1.23],0.1040451021052618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,23703,1359,1.10 [1.02-1.18],0.0133351338991718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17D,Interleukin-17D,23703,1359,0.99 [0.85-1.15],0.9092492526149236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17F,Interleukin-17F,23703,1359,1.00 [0.94-1.06],0.9290606479851784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RA,Interleukin-17 receptor A,24192,1398,0.98 [0.88-1.09],0.7015223373898554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RB,Interleukin-17 receptor B,23832,1368,0.89 [0.82-0.98],0.0133333412658068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,24122,1403,1.25 [1.14-1.38],3.7701870724298167e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,24267,1406,1.48 [1.28-1.72],2.0446980356498376e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,24435,1413,1.29 [1.13-1.48],0.0002317835302819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,23870,1361,0.99 [0.96-1.02],0.4250410548452507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,23595,1358,1.16 [1.09-1.25],1.373889503340132e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1A,Interleukin-1 alpha,23703,1359,1.04 [0.96-1.13],0.342094350494081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,23592,1353,1.15 [1.07-1.25],0.0002226289537935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,24154,1398,1.14 [0.93-1.40],0.2152665315097547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R2,Interleukin-1 receptor type 2,24166,1400,1.10 [0.86-1.40],0.4570446639808281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,24192,1398,0.91 [0.81-1.02],0.0967082399792999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,24408,1411,1.22 [1.10-1.35],0.0002414081370478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,23703,1359,0.86 [0.76-0.96],0.0094601758555683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,24159,1403,1.25 [1.16-1.34],3.407390416862991e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2,Interleukin-2,23703,1359,0.97 [0.83-1.14],0.746759117524682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20,Interleukin-20,23703,1359,1.11 [1.01-1.21],0.0224493975624499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,23703,1359,1.01 [0.90-1.14],0.8516748535676897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,20528,1188,1.11 [0.98-1.26],0.1142550557046147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL21R,Interleukin-21 receptor,20528,1188,0.89 [0.80-0.99],0.038945985721727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,21007,1211,1.19 [1.11-1.28],2.571472962022028e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,23703,1359,1.06 [0.95-1.19],0.2741125685700899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL24,Interleukin-24,23703,1359,1.00 [0.90-1.11],0.9675781578084142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL25,Interleukin-25,20296,1165,0.92 [0.78-1.08],0.2860260460539346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,24006,1384,1.44 [1.27-1.62],2.4516639889304923e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,23703,1359,0.89 [0.79-1.01],0.0793131001874327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,21007,1211,0.99 [0.85-1.14],0.8423328224986903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3,Interleukin-3,20372,1173,1.10 [1.00-1.22],0.0491978825519355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31,Interleukin-31,20528,1188,1.06 [0.97-1.16],0.2000042206603822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,20442,1184,1.01 [0.88-1.15],0.9295061752522328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,24143,1396,1.01 [0.91-1.13],0.7965988392937757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL33,Interleukin-33,23703,1359,0.98 [0.87-1.11],0.7927233240596868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL34,Interleukin-34,23578,1353,0.84 [0.74-0.96],0.0087353045936263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36A,Interleukin-36 alpha,20528,1188,1.08 [0.99-1.19],0.0918750772588477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36G,Interleukin-36 gamma,20439,1185,1.06 [0.98-1.15],0.156189952988286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,23703,1359,1.00 [0.86-1.16],0.9499090819907277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4,Interleukin-4,23703,1359,0.99 [0.94-1.04],0.7956012008072291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,24143,1396,1.44 [1.28-1.63],2.700901637258e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5,Interleukin-5,23703,1359,1.00 [0.97-1.03],0.8938077922268793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,24143,1396,1.09 [1.00-1.19],0.0467668675168166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,24101,1383,1.29 [1.23-1.34],8.002509961779283e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,24025,1390,1.05 [0.91-1.21],0.5088768241106083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,24200,1394,1.15 [0.87-1.52],0.3265410304696772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7,Interleukin-7,24143,1396,0.99 [0.92-1.07],0.8755215948427376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,24192,1398,0.80 [0.74-0.87],1.550079620712614e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL9,Interleukin-9,20717,1204,0.93 [0.84-1.03],0.1662784745363777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,23579,1351,1.09 [1.00-1.18],0.0448067299124289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,21007,1211,1.43 [1.31-1.57],3.2773736738026707e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPA1,Inositol monophosphatase 1,24033,1375,1.04 [0.96-1.12],0.3688621655784552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPACT,Protein IMPACT,21076,1210,1.08 [0.98-1.19],0.1241769602769388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,20435,1186,1.04 [0.87-1.24],0.653374777184754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ING1,Inhibitor of growth protein 1,23566,1353,1.14 [1.03-1.25],0.010119916965738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,20675,1203,1.32 [1.19-1.46],2.678895711180017e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBC,Inhibin beta C chain,24192,1398,1.22 [1.09-1.37],0.0006398750240842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,24101,1383,1.04 [0.96-1.14],0.3471046939445673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",20595,1191,1.22 [1.11-1.34],2.7314433012669835e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",21095,1216,1.08 [0.93-1.24],0.3127278838260059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",24101,1383,1.06 [1.01-1.11],0.0212558877941449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,21076,1210,0.97 [0.89-1.06],0.5216418862950067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL4,Early placenta insulin-like peptide,21007,1211,1.03 [0.94-1.14],0.5150901450978211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,21010,1209,1.12 [1.06-1.18],0.0001052142007439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,20528,1188,0.83 [0.59-1.16],0.2720055510029163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,23992,1371,1.11 [1.05-1.17],0.0003131198779585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,24101,1383,1.11 [1.02-1.20],0.0150115255327172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",23739,1376,1.05 [0.99-1.10],0.0774302219245759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,23703,1359,1.10 [1.03-1.18],0.0053034193341371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,24143,1396,1.03 [0.99-1.08],0.1739309027109756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,23280,1336,1.04 [0.91-1.18],0.5718985518524138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,24143,1396,1.19 [1.05-1.34],0.0064305915372733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM2,Isthmin-2,21122,1217,1.01 [0.89-1.15],0.8803836342594273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IST1,IST1 homolog,20858,1198,1.00 [0.95-1.06],0.9422372545327798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,24143,1396,0.72 [0.63-0.82],1.7296320306979472e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,20675,1203,0.84 [0.71-0.99],0.041621820000744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,24192,1398,1.13 [0.93-1.36],0.2204766876014145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA6,Integrin alpha-6,24143,1396,0.99 [0.91-1.08],0.8326764958268008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAL,Integrin alpha-L,20528,1188,1.01 [0.89-1.15],0.8360587678112886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,24192,1398,0.69 [0.59-0.81],4.015196235705333e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,24400,1401,0.44 [0.33-0.58],1.0010478577364755e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAX,Integrin alpha-X,20717,1204,1.00 [0.90-1.11],0.9793655352160529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1,Integrin beta-1,24148,1396,0.75 [0.60-0.94],0.0127372807850143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,23618,1368,1.07 [0.95-1.20],0.2644987562286001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,23739,1376,1.04 [0.99-1.08],0.1216979371727249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB2,Integrin beta-2,24022,1391,0.77 [0.64-0.92],0.0032206760413589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB5,Integrin beta-5,24272,1406,0.90 [0.79-1.02],0.09774685601953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB6,Integrin beta-6,23703,1359,1.05 [0.88-1.24],0.6065653499929751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB7,Integrin beta-7,24400,1401,1.02 [0.92-1.13],0.7111882896078059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,21122,1217,1.15 [0.98-1.34],0.0937006991257987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,21172,1227,1.03 [0.76-1.38],0.855821421824561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,24267,1406,1.24 [1.09-1.42],0.0008895900471766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,21172,1227,1.20 [0.97-1.48],0.0904590143782152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,21007,1211,0.98 [0.87-1.10],0.7102579196297476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITM2A,Integral membrane protein 2A,24143,1396,1.02 [0.94-1.10],0.6337020259993864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,20461,1174,1.08 [0.99-1.17],0.0723868195977112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",20595,1191,1.09 [1.02-1.17],0.0179053585425711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",20435,1186,1.01 [0.90-1.14],0.8488413592133408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",23615,1355,1.09 [0.99-1.20],0.0853127716457194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,20372,1173,0.96 [0.85-1.08],0.5133316679078981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM2,Junctional adhesion molecule B,24408,1403,1.16 [0.97-1.38],0.1016408834329015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM3,Junctional adhesion molecule C,20675,1203,1.20 [1.08-1.33],0.0005204428475752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,23703,1359,1.09 [1.01-1.18],0.0270917836011015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,20372,1173,1.01 [0.91-1.11],0.8852082865467454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,21010,1209,1.03 [0.97-1.10],0.3160185284674619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JUN,Transcription factor AP-1,23703,1359,1.07 [0.98-1.17],0.1571511538182063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,24101,1383,0.90 [0.81-1.00],0.0517985064512451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZN,Kazrin,21010,1209,1.04 [0.98-1.09],0.2022525230186581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,20435,1186,1.05 [0.96-1.16],0.2905067501283978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,20531,1187,0.96 [0.89-1.03],0.2718218180793377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNIP4,Kv channel-interacting protein 4,23615,1355,1.07 [0.97-1.17],0.1741935856248922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,20680,1187,1.16 [1.03-1.31],0.0159444746677762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDM3A,Lysine-specific demethylase 3A,20528,1188,0.97 [0.90-1.03],0.326233828292076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,24272,1406,0.88 [0.73-1.06],0.1824404531253744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KEL,Kell blood group glycoprotein,23615,1355,0.95 [0.83-1.08],0.4270232219681861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHDC3L,KH domain-containing protein 3,20372,1173,1.00 [0.92-1.09],0.9446381585477014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,20595,1191,1.22 [1.12-1.34],6.693150468204153e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,21076,1210,0.95 [0.80-1.14],0.5820311401629752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,20717,1204,0.99 [0.91-1.07],0.7591438598627184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,20717,1204,0.98 [0.81-1.18],0.8287952340478555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,21007,1211,0.97 [0.87-1.08],0.6068764380586776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF1C,Kinesin-like protein KIF1C,20461,1174,1.11 [0.96-1.28],0.1679680025655648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF20B,Kinesin-like protein KIF20B,20435,1186,1.00 [0.93-1.08],0.9703706625773232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF22,Kinesin-like protein KIF22,20461,1174,1.03 [0.98-1.07],0.2600170653221817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIFBP,KIF-binding protein,24101,1383,1.02 [0.96-1.08],0.6060988470811366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,21007,1211,1.04 [0.97-1.10],0.2975684807743456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,23618,1368,1.09 [1.02-1.15],0.0096762855898039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,21010,1209,1.01 [0.98-1.04],0.6075497392307406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,23618,1368,0.99 [0.95-1.03],0.5047470874545834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,20372,1173,0.97 [0.90-1.04],0.3517386619495291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,20435,1186,0.98 [0.89-1.08],0.6355654391157602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,23615,1355,0.80 [0.71-0.90],0.0003601508273244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,24226,1403,0.85 [0.73-0.99],0.0416756830620187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,24200,1394,0.69 [0.61-0.77],3.5532261611377536e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLB,Beta-klotho,23615,1355,0.94 [0.88-1.01],0.0954203577666855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,20435,1186,1.34 [1.18-1.52],3.1661642940919333e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLHL41,Kelch-like protein 41,21095,1216,0.98 [0.86-1.10],0.689638694320152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK1,Kallikrein-1,23935,1390,0.99 [0.95-1.02],0.4495004902370267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,24192,1404,1.15 [1.03-1.30],0.0174627532634246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,24044,1389,1.19 [1.03-1.39],0.0205591262393786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK12,Kallikrein-12,23618,1368,1.02 [0.98-1.05],0.349414023131065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,23688,1351,1.27 [1.14-1.40],9.259885836221456e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,24400,1401,1.11 [1.00-1.22],0.0463226172768507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK15,Kallikrein-15,20974,1210,0.97 [0.87-1.08],0.5355712175983065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK3,Prostate-specific antigen,21122,1217,0.98 [0.89-1.09],0.7175614996384039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,24400,1401,1.09 [1.01-1.17],0.0330927880711432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK6,Kallikrein-6,24242,1405,0.88 [0.76-1.03],0.1146770053958228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK7,Kallikrein-7,20125,1172,1.03 [0.89-1.19],0.7177971612188419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,23385,1350,1.14 [1.00-1.31],0.0505719586363115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLKB1,Plasma kallikrein,20741,1204,0.94 [0.76-1.16],0.5406417927300267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,24435,1413,1.04 [0.92-1.18],0.5409582142245275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,20435,1186,1.04 [0.95-1.14],0.3626452500092549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRD1,Natural killer cells antigen CD94,24435,1413,1.11 [1.00-1.23],0.0469159215403435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,20528,1188,0.95 [0.83-1.09],0.4638602733408232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,21076,1210,1.06 [0.94-1.20],0.3069275312682047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",22836,1310,0.93 [0.77-1.11],0.411268205983318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",20461,1174,1.03 [0.89-1.20],0.6793559987250293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",24101,1383,1.18 [1.12-1.25],3.2453508631869282e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",24108,1395,1.18 [1.10-1.26],1.6013744906493075e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",23615,1355,1.09 [0.99-1.20],0.090878528212606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",20461,1174,0.88 [0.76-1.02],0.0813066426965413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",20435,1186,1.19 [1.11-1.26],1.1093806252066537e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,24158,1393,1.03 [0.95-1.12],0.424402078268616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,24435,1413,1.26 [1.14-1.39],5.890419905164308e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L1CAM,Neural cell adhesion molecule L1,24272,1406,0.95 [0.81-1.13],0.5863687312600798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,21125,1219,1.03 [0.97-1.09],0.3576559706374086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACRT,Extracellular glycoprotein lacritin,20976,1210,0.91 [0.81-1.02],0.1056838627594423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACTB2,Endoribonuclease LACTB2,24200,1394,1.06 [0.99-1.14],0.1065501048087219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,24101,1383,0.90 [0.80-1.02],0.0873891062775567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24201,1404,1.42 [1.27-1.59],7.205466006039095e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,24033,1375,1.02 [0.97-1.07],0.4240669064759111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA1,Laminin subunit alpha-1,20461,1174,0.93 [0.84-1.04],0.2205797562922317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,24314,1410,1.33 [1.16-1.52],4.18262477104659e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMB1,Laminin subunit beta-1,20595,1191,1.10 [0.92-1.33],0.2941908140164855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,20508,1184,1.06 [0.88-1.28],0.5216734219862389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,23457,1347,1.34 [1.03-1.74],0.0313575846541844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,24392,1408,1.77 [1.64-1.90],1.0151844595541322e-52
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,21007,1211,1.05 [0.93-1.19],0.4262310451842994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAP3,Cytosol aminopeptidase,23703,1359,1.01 [0.91-1.11],0.8911178188559981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LARP1,La-related protein 1,21007,1211,1.07 [0.99-1.17],0.0940085498897069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT,Linker for activation of T-cells family member 1,24435,1413,1.04 [0.97-1.10],0.2636930388266281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT2,Linker for activation of T-cells family member 2,24101,1383,1.05 [1.01-1.09],0.018346824261849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,20528,1188,1.06 [0.99-1.13],0.0935521032957308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,23984,1373,1.47 [1.29-1.69],1.956316127805149e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,24267,1406,1.08 [1.00-1.16],0.044019353869373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,24408,1403,1.13 [1.06-1.20],0.0002207471346542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,21143,1218,0.90 [0.70-1.15],0.3889744490391503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN15,Lipocalin-15,21095,1216,1.07 [0.98-1.15],0.1131873193766686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,23442,1356,1.27 [1.13-1.42],2.5622362712294976e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCP1,Plastin-2,21122,1217,1.03 [0.92-1.15],0.6105095156990836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,24257,1405,1.12 [1.02-1.23],0.0125396365060262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,21095,1216,1.05 [0.99-1.11],0.1034269763581333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,21125,1219,1.17 [1.08-1.27],0.0002522207343587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEFTY2,Left-right determination factor 2,24361,1398,0.92 [0.84-1.00],0.0568881533692653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,19964,1167,1.00 [0.93-1.09],0.925531554206984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,20435,1186,1.02 [0.95-1.10],0.5521711320787771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,21095,1216,1.02 [0.87-1.19],0.821633564930257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEP,Leptin,24200,1394,1.05 [0.97-1.13],0.2473481570025179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEPR,Leptin receptor,24200,1394,0.93 [0.80-1.08],0.3525624015390011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,21095,1216,1.23 [1.11-1.36],6.11382824969399e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,24200,1394,1.32 [1.16-1.51],3.1813156249112094e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,24249,1400,1.38 [1.17-1.62],9.504657940136456e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,21172,1227,1.11 [0.92-1.34],0.288277503976133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,24201,1404,1.51 [1.39-1.64],1.959523415071858e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,24113,1384,1.20 [1.06-1.35],0.0027885129565658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS8,Galectin-8,24408,1403,1.10 [1.02-1.19],0.0125812675084662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,24194,1402,1.60 [1.39-1.84],5.172333250550244e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,24314,1410,1.42 [1.25-1.60],3.0177159887582195e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHB,Lutropin subunit beta,23618,1368,1.00 [0.95-1.06],0.9009067729378284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,24236,1408,1.04 [0.96-1.12],0.371277177847601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIF,Leukemia inhibitory factor,23615,1355,1.11 [1.02-1.21],0.018116912416174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIFR,Leukemia inhibitory factor receptor,24143,1396,1.01 [0.83-1.22],0.9272225926265494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,24192,1398,0.87 [0.77-0.99],0.0416979375110779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,21122,1217,0.99 [0.95-1.03],0.525404241793251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,20461,1174,0.99 [0.89-1.10],0.8177713318410381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,24160,1391,1.21 [1.04-1.41],0.0143447449157939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,21125,1219,1.03 [0.96-1.11],0.3739143257568225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,24485,1416,0.98 [0.83-1.16],0.8252193717326346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,24364,1410,1.09 [0.96-1.25],0.1847951746230126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,23703,1359,1.43 [1.28-1.59],1.2456684173523648e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,24485,1416,0.99 [0.93-1.06],0.7230287180042314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIPF,Gastric triacylglycerol lipase,20595,1191,1.19 [1.09-1.31],7.63670207872447e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB1,Lamin-B1,20964,1206,1.06 [0.97-1.16],0.1798030332847158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,21076,1210,1.47 [1.22-1.77],3.676546686644336e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,21095,1216,1.19 [1.04-1.37],0.01379740411059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD2,Leiomodin-2,20435,1186,0.91 [0.83-1.00],0.0618106967805637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",20595,1191,1.08 [1.01-1.15],0.0190478368664013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPA,Apolipoprotein(a),20644,1195,1.00 [0.97-1.03],0.9655922295058784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,24101,1383,1.16 [1.06-1.26],0.0011588968523579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPL,Lipoprotein lipase,24200,1394,0.94 [0.85-1.04],0.2148577270768037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPO,Lactoperoxidase,23446,1339,0.97 [0.90-1.05],0.4868946598528831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPP,Lipoma-preferred partner,20461,1174,1.03 [0.94-1.12],0.5357949406622136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,20461,1174,1.09 [1.01-1.18],0.0335239853682103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,20531,1187,0.97 [0.86-1.09],0.5561231587998083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,21172,1227,1.69 [1.37-2.07],6.055459557413049e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,24326,1396,1.17 [1.02-1.34],0.022911443693907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,20447,1186,1.13 [0.95-1.36],0.1769189550777052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,24101,1383,1.10 [0.92-1.31],0.318301196977268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,24200,1394,1.28 [1.12-1.46],0.0002689509639906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,20531,1187,1.01 [0.86-1.17],0.9389375296854224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2BP,LRP2-binding protein,20531,1187,1.00 [0.94-1.07],0.9753921515158708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,24408,1403,1.11 [1.02-1.19],0.0109675934224057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,24101,1383,1.30 [1.16-1.46],8.94404339292848e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,21010,1209,0.92 [0.81-1.04],0.1999101666213273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,20531,1187,1.03 [0.92-1.14],0.6298658065971633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,21125,1219,1.08 [0.96-1.21],0.1773061084307843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,21007,1211,1.09 [0.98-1.21],0.1148221056221053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,23703,1359,0.68 [0.60-0.77],7.925812406016449e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,20531,1187,1.00 [0.87-1.14],0.99509019110859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,21095,1216,0.73 [0.59-0.90],0.003112120529833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,23618,1368,1.04 [0.96-1.12],0.3372620809139326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,20717,1204,0.98 [0.91-1.05],0.5183889136598865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSP1,Lymphocyte-specific protein 1,24143,1396,1.15 [1.02-1.29],0.0213837792349223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA,Lymphotoxin-alpha,24143,1396,1.01 [0.90-1.13],0.8948711134846814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,24400,1401,1.19 [1.10-1.27],3.019415886034743e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTB,Lymphotoxin-beta,21007,1211,1.05 [0.91-1.21],0.4833419318246643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,24485,1416,1.27 [1.09-1.49],0.002385455262776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,23618,1368,1.09 [1.00-1.18],0.0532335772714076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,24088,1399,1.59 [1.35-1.86],2.221971864616392e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTO1,Protein LTO1 homolog,23703,1359,0.96 [0.85-1.09],0.5708644903319792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LUZP2,Leucine zipper protein 2,21007,1211,0.94 [0.82-1.07],0.3414302413948002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LXN,Latexin,23920,1370,0.95 [0.89-1.02],0.1844731427154396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,24078,1397,1.14 [1.00-1.28],0.0427405491802739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY75,Lymphocyte antigen 75,24143,1396,0.98 [0.87-1.11],0.7945612280699237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,23924,1379,1.03 [0.87-1.22],0.7586196944928562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,24033,1375,1.12 [0.97-1.29],0.1155547044706123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,23618,1368,1.00 [0.91-1.10],0.9862019734096386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYN,Tyrosine-protein kinase Lyn,24101,1383,1.02 [0.96-1.08],0.4702127173230308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,23615,1355,0.97 [0.90-1.05],0.4397575872410196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,24077,1389,1.10 [0.95-1.26],0.2025618811565661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,23618,1368,1.11 [1.01-1.23],0.0259799086029123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,20435,1186,1.01 [0.96-1.06],0.7868868564898637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,20531,1187,1.04 [0.99-1.09],0.1374978547184797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,21172,1227,0.76 [0.57-1.02],0.06500251364826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYZL2,Lysozyme-like protein 2,20372,1173,1.07 [0.92-1.25],0.3857019760255612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,20675,1203,1.03 [0.95-1.11],0.4358245621859541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,20595,1191,1.05 [0.92-1.20],0.4506258178164148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,23943,1370,1.22 [1.12-1.32],1.7201908862092887e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,23618,1368,1.11 [0.98-1.24],0.0887102280049418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAG,Myelin-associated glycoprotein,20531,1187,0.90 [0.80-1.01],0.0850717129047565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGEA3,Melanoma-associated antigen 3,20717,1204,1.00 [0.94-1.07],0.980877991381518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGED1,Melanoma-associated antigen D1,23618,1368,1.09 [0.99-1.21],0.0950565841021231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC2,MAM domain-containing protein 2,21125,1219,0.99 [0.84-1.15],0.8631288192191076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,21007,1211,1.24 [1.13-1.36],4.510252788095186e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",20595,1191,1.30 [1.05-1.61],0.0174928644645353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,21125,1219,1.20 [1.09-1.31],0.000113888440033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",20372,1173,1.08 [0.97-1.20],0.1835185669803326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,24314,1410,1.01 [0.97-1.05],0.6019523522126532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC1,MANSC domain-containing protein 1,24272,1406,1.14 [0.97-1.35],0.1201765447675199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC4,MANSC domain-containing protein 4,20461,1174,1.12 [1.03-1.22],0.0090599787315945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,20435,1186,0.99 [0.83-1.18],0.8910300561019358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,20461,1174,1.00 [0.92-1.09],0.9901539464610042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2,Microtubule-associated protein 2,21076,1210,1.07 [0.96-1.20],0.2222990760006329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,21010,1209,1.00 [0.92-1.09],0.9076279421183252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,24143,1396,1.02 [0.97-1.07],0.4551656896792934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,23618,1368,1.03 [0.98-1.08],0.2195197052727946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,23984,1373,1.04 [0.99-1.08],0.0935513322285567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,20372,1173,1.12 [1.00-1.26],0.0541139664709119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,24143,1396,1.17 [1.05-1.30],0.0055161686050543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,20717,1204,1.03 [0.96-1.12],0.3704249935472298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,20372,1173,0.99 [0.96-1.03],0.7778864021280333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPT,Microtubule-associated protein tau,23615,1355,0.94 [0.86-1.03],0.1721878327197958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,24200,1394,1.19 [0.99-1.42],0.0653054712151848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",20634,1200,1.06 [0.99-1.13],0.0816144340802498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,23984,1373,0.98 [0.80-1.20],0.8362795805511684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,24243,1405,1.18 [1.01-1.38],0.041059064078913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN3,Matrilin-3,23992,1371,1.24 [1.07-1.45],0.0043025479734838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,23618,1368,1.07 [1.02-1.13],0.0104153778995301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAX,Protein max,23615,1355,1.02 [0.98-1.07],0.3626973724645143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MB,Myoglobin,24485,1416,1.08 [0.98-1.19],0.1053668835373156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MBL2,Mannose-binding protein C,20863,1211,1.00 [0.95-1.05],0.9531863058269526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,24267,1406,0.70 [0.62-0.81],3.975049858751081e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",21095,1216,0.99 [0.88-1.11],0.8221789880474992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,20528,1188,1.08 [1.02-1.15],0.0069231409720239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,24101,1387,1.19 [1.07-1.33],0.0013124699074435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,21010,1209,1.12 [0.94-1.34],0.1962017362500726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,24033,1375,0.90 [0.84-0.96],0.0024864169690135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",21021,1213,1.04 [0.91-1.20],0.5348478030801812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,24205,1401,1.29 [1.19-1.40],1.1710869138932782e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDM1,Nuclear protein MDM1,20531,1187,0.93 [0.78-1.11],0.414690572575347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",20595,1191,1.06 [1.00-1.13],0.069276191507703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,23618,1368,1.04 [0.97-1.11],0.2567058070189679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,20461,1174,1.00 [0.89-1.11],0.941964810051604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,24201,1404,0.95 [0.84-1.07],0.3902098684639294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,20461,1174,1.00 [0.85-1.18],0.9952670240625404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,24408,1411,1.20 [0.95-1.50],0.1189454221510548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MELTF,Melanotransferrin,21125,1219,0.86 [0.72-1.04],0.1110790204240308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MENT,Protein MENT,20675,1203,0.80 [0.62-1.03],0.0823602403028396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1A,Meprin A subunit alpha,21010,1209,1.25 [1.16-1.35],8.878138832255775e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,24200,1394,0.95 [0.91-0.99],0.0142025110882683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,24201,1404,0.70 [0.59-0.82],1.4332070460187316e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,24435,1413,1.08 [0.90-1.30],0.3867335199530152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MESD,LRP chaperone MESD,24192,1398,1.02 [0.98-1.06],0.2538563011225947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,24260,1405,0.54 [0.42-0.68],3.100043443298855e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1,Methionine aminopeptidase 1,23615,1355,1.08 [0.92-1.27],0.371743434468617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",24143,1396,1.04 [0.98-1.10],0.1613735926000617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP2,Methionine aminopeptidase 2,24361,1398,1.08 [0.99-1.17],0.0733484474541044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,23739,1376,1.07 [0.97-1.17],0.1596740130617379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,20531,1187,0.94 [0.86-1.03],0.1813224499290752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,20675,1203,0.88 [0.74-1.05],0.1625620424601647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP5,Microfibrillar-associated protein 5,24485,1416,1.08 [0.96-1.21],0.2028176416070164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,24192,1398,1.37 [1.23-1.52],5.828065963132224e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGLL,Monoglyceride lipase,24271,1407,1.01 [0.96-1.07],0.6724094685704423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,24143,1396,1.03 [0.99-1.07],0.1663084982378069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIA,Melanoma-derived growth regulatory protein,24272,1406,0.91 [0.80-1.03],0.1466900782017116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICALL2,MICAL-like protein 2,20531,1187,1.05 [0.97-1.13],0.2414629337055813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,24143,1396,1.03 [1.00-1.07],0.0432982027114221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIF,Macrophage migration inhibitory factor,24161,1395,1.02 [0.95-1.09],0.6038564929124389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,23703,1359,0.97 [0.88-1.06],0.5292111593140556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,21007,1211,1.01 [0.96-1.06],0.7118092693975961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINK1,Misshapen-like kinase 1,21076,1210,1.01 [0.95-1.07],0.7954993020630029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MITD1,MIT domain-containing protein 1,24033,1375,1.03 [0.98-1.08],0.234973633178159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MKI67,Proliferation marker protein Ki-67,20528,1188,0.95 [0.82-1.09],0.4575285392819322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLLT1,Protein ENL,20372,1173,1.03 [0.95-1.11],0.4701281775406553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLN,Promotilin,24143,1396,1.08 [1.03-1.14],0.0040898467885479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,24101,1383,1.20 [1.14-1.27],6.531503614532425e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,23256,1345,1.12 [1.06-1.18],2.4505731466640743e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,24166,1400,1.09 [1.01-1.18],0.0215435428399101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,24204,1392,1.79 [1.65-1.93],2.79461125369865e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP13,Collagenase 3,23615,1355,1.07 [0.92-1.23],0.3982164943245263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP15,Matrix metalloproteinase-15,21125,1219,1.01 [0.91-1.12],0.7856241145751399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,24192,1398,1.25 [1.14-1.37],2.610795653531685e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,23699,1374,1.37 [1.24-1.52],1.091373928098487e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,24369,1401,1.12 [1.06-1.19],0.0001602760880984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,24150,1397,1.17 [1.09-1.27],5.567671849561581e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",20461,1174,1.01 [0.90-1.13],0.8506139314699293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MN1,Transcriptional activator MN1,20531,1187,0.95 [0.86-1.04],0.2691509984828581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,20717,1204,1.04 [0.92-1.17],0.5150138481587211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,24166,1390,1.04 [0.99-1.09],0.089770510013986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,20675,1203,1.17 [1.08-1.27],0.000116656705138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,24400,1401,0.97 [0.84-1.12],0.6500872216856952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,21076,1210,0.90 [0.74-1.11],0.3265982469378961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,20717,1204,0.96 [0.83-1.10],0.5542826780781349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,20372,1173,0.97 [0.83-1.13],0.6902509481970667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORN4,MORN repeat-containing protein 4,20372,1173,1.04 [0.97-1.11],0.250236108124118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,23739,1376,1.07 [1.01-1.14],0.0300794936611032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPI,Mannose-6-phosphate isomerase,24101,1383,1.04 [0.98-1.10],0.1787535369452392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,24271,1407,1.03 [0.97-1.10],0.2820414206666498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,24192,1398,1.06 [0.97-1.16],0.2163080810158621
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,20962,1209,0.96 [0.85-1.09],0.5722347973724611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,21143,1218,1.19 [0.98-1.43],0.0734867837679279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,20531,1187,0.95 [0.88-1.03],0.2429836569463576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",20461,1174,1.13 [0.99-1.28],0.0603860754445065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",21095,1216,0.95 [0.80-1.13],0.5518373167840311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",23615,1355,1.03 [0.86-1.23],0.7429313307696079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",20337,1173,1.09 [0.86-1.37],0.4705266896566545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",21095,1216,1.06 [0.98-1.14],0.1355909284467973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",20528,1188,0.97 [0.80-1.17],0.7179037049153596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,24064,1379,1.66 [1.57-1.76],1.1344173749689015e-64
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLNL,Mesothelin-like protein,20531,1187,0.91 [0.78-1.06],0.2402014627755541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,24113,1398,1.24 [1.16-1.33],2.0630096169961616e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,24408,1403,1.34 [1.20-1.49],6.522447768140984e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,24272,1406,1.04 [0.97-1.11],0.2440892297638903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MST1,Hepatocyte growth factor-like protein,20821,1199,1.08 [0.98-1.19],0.1290189331859939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,23739,1376,0.77 [0.71-0.85],5.967997964345205e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTDH,Protein LYRIC,20528,1188,1.07 [1.00-1.13],0.0418295319368297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",21076,1210,1.00 [0.81-1.24],0.9882276929633768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,20717,1204,1.04 [0.99-1.10],0.0995015318694328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",21010,1209,1.01 [0.95-1.07],0.7972882404502436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTPN,Myotrophin,23739,1376,1.10 [0.96-1.26],0.1624844806981453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTR,Methionine synthase,20461,1174,1.07 [0.99-1.15],0.1006372379423251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS1,Protein MTSS 1,21010,1209,1.02 [0.97-1.08],0.3341084553045182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS2,Protein MTSS 2,21007,1211,1.07 [1.02-1.13],0.0123340558419243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,20717,1204,1.25 [1.15-1.36],1.2887988742940853e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,23615,1355,1.16 [1.05-1.27],0.0024602750229299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC16,Mucin-16,24101,1383,1.01 [0.98-1.03],0.5403648396974501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC2,Mucin-2,21122,1217,1.00 [0.94-1.06],0.942878374865316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUCL3,Mucin-like protein 3,20372,1173,0.90 [0.79-1.03],0.1367253237327524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,23703,1359,1.23 [1.16-1.31],2.6073013922904597e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,20675,1203,0.66 [0.55-0.79],9.900921117041736e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",21125,1219,1.11 [1.02-1.20],0.0120989211583865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",20595,1191,1.01 [0.95-1.08],0.6637216782832551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,21095,1216,1.03 [0.95-1.11],0.5188286998075786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYDGF,Myeloid-derived growth factor,21125,1219,1.04 [0.99-1.10],0.1313243419489922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH4,Myosin-4,20461,1174,1.15 [1.03-1.28],0.011823013742878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH7B,Myosin-7B,20372,1173,1.00 [0.88-1.13],0.9765529816490052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH9,Myosin-9,21122,1217,1.03 [0.98-1.09],0.1774728425521086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",20461,1174,1.04 [0.92-1.18],0.5280661401933084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL3,Myosin light chain 3,20595,1191,1.10 [1.01-1.19],0.022102258746569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL4,Myosin light chain 4,20595,1191,1.01 [0.91-1.12],0.8656889374306271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL6B,Myosin light chain 6B,20531,1187,0.97 [0.91-1.03],0.2737492118268671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",20531,1187,0.98 [0.86-1.12],0.7946875295762847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO6,Unconventional myosin-VI,21095,1216,0.99 [0.86-1.14],0.8467726432349949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO9B,Unconventional myosin-IXb,23703,1359,1.04 [0.97-1.11],0.3063621423117771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOC,Myocilin,24192,1398,0.95 [0.86-1.06],0.3545854234196766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM1,Myomesin-1,20435,1186,1.05 [0.94-1.17],0.3847091199331436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM2,Myomesin-2,20461,1174,1.07 [0.95-1.21],0.251760625399803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM3,Myomesin-3,20675,1203,1.01 [0.95-1.08],0.6633271487626548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,24286,1408,1.26 [1.16-1.37],1.1173879217831334e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,23618,1368,1.05 [0.96-1.15],0.2556281095477866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA10,N-alpha-acetyltransferase 10,20461,1174,1.03 [0.92-1.15],0.5820528886099532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA80,N-alpha-acetyltransferase 80,20531,1187,1.04 [0.99-1.09],0.1436392163804829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,23909,1371,1.03 [0.96-1.12],0.3961033025498347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,21007,1211,1.01 [0.92-1.12],0.7770614800707709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NADK,NAD kinase,24200,1394,1.00 [0.92-1.09],0.9341717397805112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,20484,1187,1.03 [0.94-1.14],0.5124540899572005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,20554,1188,1.03 [0.94-1.13],0.5267988018723019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,20675,1203,1.27 [0.98-1.65],0.067344588561093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,23618,1368,1.04 [0.96-1.14],0.3225109728147787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,20974,1209,1.01 [0.88-1.15],0.9394175462722256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,21076,1210,0.83 [0.70-0.98],0.0313789053637521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",21095,1216,0.98 [0.87-1.10],0.7614403448535739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,24272,1406,1.60 [1.34-1.91],1.4958676979195517e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBN,Nibrin,23703,1359,1.10 [1.01-1.19],0.0241559294995842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,24267,1406,0.62 [0.52-0.73],2.509005821787473e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM2,Neural cell adhesion molecule 2,24192,1398,0.74 [0.62-0.89],0.0010740435406443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,24408,1403,0.66 [0.58-0.74],5.9160297496666976e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,24115,1394,1.05 [1.00-1.11],0.0520668672431374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCK2,Cytoplasmic protein NCK2,24314,1410,1.04 [1.00-1.09],0.0815008613282296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCLN,Nicalin,23703,1359,0.98 [0.87-1.10],0.73672685749387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,24109,1395,0.94 [0.82-1.07],0.3244429136962222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,21010,1209,1.19 [1.01-1.40],0.0329983811547675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCS1,Neuronal calcium sensor 1,24400,1401,1.11 [0.94-1.31],0.2172434271048659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDRG1,Protein NDRG1,23615,1355,1.05 [0.98-1.12],0.1735634771608538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,21007,1211,1.07 [1.00-1.15],0.0577802423381967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,20490,1186,1.10 [0.93-1.28],0.2628468678047069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,21010,1209,1.00 [0.94-1.06],0.8840598256909487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",23618,1368,1.04 [0.98-1.11],0.1821456423561876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEB,Nebulin,20461,1174,1.12 [0.97-1.29],0.1194940363528746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,20461,1174,1.10 [1.01-1.19],0.0259887124800695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN1,Nectin-1,20528,1188,0.89 [0.74-1.06],0.2015616216678447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,24160,1391,1.72 [1.48-2.00],5.865311162755281e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,24272,1406,1.33 [1.15-1.54],0.0001228619294597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,20528,1188,0.97 [0.87-1.09],0.6265087275866146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD9,Enhancer of filamentation 1,20528,1188,1.00 [0.85-1.18],0.982795137222926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,23539,1354,1.32 [1.18-1.48],7.252875444745978e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,20717,1204,1.00 [0.93-1.08],0.9076750128536536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,24272,1406,0.74 [0.66-0.83],1.164436357038691e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,24314,1410,0.78 [0.65-0.92],0.0033471204711052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NENF,Neudesin,21007,1211,0.97 [0.91-1.03],0.2963650643338388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEO1,Neogenin,21095,1216,1.01 [0.77-1.32],0.9575225998444076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEXN,Nexilin,21143,1218,1.02 [0.94-1.10],0.7195400932163041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,24435,1413,1.21 [1.02-1.43],0.0255182371607134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,20528,1188,1.01 [0.94-1.07],0.8403204826374815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",24143,1396,1.07 [1.02-1.13],0.004242809626783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",23703,1359,1.13 [1.04-1.22],0.0035141563597145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,20595,1191,1.06 [0.99-1.15],0.1106688637678913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFIC,Nuclear factor 1 C-type,21095,1216,1.00 [0.89-1.11],0.9396910358138983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,20461,1174,1.10 [1.02-1.19],0.0153957756756829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,20717,1204,1.00 [0.91-1.09],0.9701679161929438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,23618,1368,1.18 [1.07-1.30],0.0007321240001401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",21010,1209,1.01 [0.96-1.06],0.7507857504252166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFX1,Transcriptional repressor NF-X1,20461,1174,1.03 [0.95-1.12],0.4756661098100398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,20461,1174,1.10 [0.96-1.25],0.1780315306447224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGF,Beta-nerve growth factor,24033,1375,1.05 [0.71-1.56],0.8044612862295196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,21125,1219,1.03 [0.86-1.22],0.7651017151997848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGRN,Neugrin,21076,1210,1.23 [0.98-1.55],0.080814676764949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,20182,1172,1.64 [1.37-1.97],5.8647005400832283e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,24182,1397,1.28 [1.15-1.43],1.3366318546536903e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID2,Nidogen-2,24192,1398,1.09 [1.02-1.16],0.0058496593156394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NINJ1,Ninjurin-1,23618,1368,1.08 [0.99-1.18],0.0825380485706447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT1,Deaminated glutathione amidase,20595,1191,1.07 [0.95-1.21],0.2444252086466772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT2,Omega-amidase NIT2,21051,1215,1.05 [0.98-1.13],0.1974157924501159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN1,Neuroligin-1,20531,1187,0.97 [0.89-1.05],0.4182446288782774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN2,Neuroligin-2,20435,1186,1.02 [0.91-1.14],0.7977457160457329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME1,Nucleoside diphosphate kinase A,20528,1188,1.04 [0.81-1.35],0.7392634505072236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,24243,1405,1.02 [0.83-1.24],0.8577327158726094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMI,N-myc-interactor,20933,1206,1.06 [0.98-1.14],0.1218104681137689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,24033,1375,1.05 [0.98-1.11],0.1448247158543212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,20372,1173,1.01 [0.89-1.16],0.8525496163373887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,21095,1216,1.04 [0.95-1.13],0.4153181337109595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOMO1,Nodal modulator 1,24192,1398,1.17 [0.96-1.43],0.1287595137684339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOP56,Nucleolar protein 56,20461,1174,0.97 [0.92-1.03],0.3465527319086171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS1,"Nitric oxide synthase, brain",23615,1355,1.11 [1.01-1.23],0.0282833232103551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS2,"Nitric oxide synthase, inducible",20461,1174,1.08 [0.94-1.24],0.2523058283927258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",23615,1355,1.10 [1.01-1.20],0.0349147514087014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,24485,1416,0.58 [0.43-0.78],0.0003834945847423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,21122,1217,0.81 [0.63-1.05],0.1170826742175773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,24485,1416,0.77 [0.68-0.88],0.0001539298863187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,20767,1196,1.91 [1.73-2.11],1.7945258174129252e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,24200,1394,1.57 [1.37-1.80],1.3832348401372103e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS1,Nephrin,20528,1188,0.89 [0.75-1.06],0.1853382885433265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS2,Podocin,20528,1188,1.06 [1.01-1.11],0.021848120595001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,21125,1219,1.27 [1.12-1.43],0.0001207579642682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,23739,1376,1.12 [1.08-1.17],6.551638256492665e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPC,C-type natriuretic peptide,24143,1396,1.08 [0.97-1.20],0.1620349624805064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,20461,1174,0.90 [0.77-1.06],0.2039847941427739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTN,Neuroplastin,23618,1368,0.97 [0.92-1.03],0.3436967920260573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,24192,1398,1.29 [1.15-1.45],1.8099499365407983e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,21122,1217,0.96 [0.81-1.13],0.5842299302769165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,24200,1394,0.83 [0.72-0.95],0.0069719681897626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPY,Pro-neuropeptide Y,24400,1401,1.15 [1.07-1.23],0.0001999253601138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRCAM,Neuronal cell adhesion molecule,24200,1394,0.82 [0.69-0.97],0.0220292813093523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRGN,Neurogranin,21143,1218,1.04 [0.98-1.10],0.2234348616960136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRN1,Neuritin,21095,1216,0.89 [0.75-1.07],0.2123540502909426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP1,Neuropilin-1,24308,1407,1.06 [0.90-1.25],0.5005268174995046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP2,Neuropilin-2,24192,1398,0.89 [0.76-1.05],0.1743676814994145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRTN,Neurturin,23703,1359,0.96 [0.87-1.07],0.4825706097262116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRXN3,Neurexin-3,20531,1187,0.92 [0.78-1.08],0.2924849487975758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NSFL1C,NSFL1 cofactor p47,24408,1403,1.02 [0.95-1.09],0.6286963694238741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",21125,1219,1.02 [0.95-1.10],0.6146101547133194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,21076,1210,1.58 [1.36-1.84],3.583833027004866e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,24113,1394,0.97 [0.92-1.03],0.3355853751847995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,24272,1406,1.09 [1.00-1.18],0.0396546073051834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF3,Neurotrophin-3,24143,1396,1.14 [1.00-1.30],0.0463053321418239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF4,Neurotrophin-4,23618,1368,1.02 [0.91-1.15],0.7016917593551121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,24200,1394,0.70 [0.58-0.84],0.0001325565205416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,24408,1403,0.48 [0.39-0.59],7.713641722893944e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,24200,1394,1.17 [1.12-1.23],2.7505380238210212e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUB1,NEDD8 ultimate buster 1,24143,1396,1.05 [1.00-1.12],0.0613795501630784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,21007,1211,0.99 [0.93-1.06],0.8220695452265112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,24362,1398,1.29 [1.14-1.46],5.284394677391669e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDC,Nuclear migration protein nudC,24435,1413,1.07 [1.00-1.16],0.0586290664305643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,20595,1191,1.13 [0.95-1.35],0.1701638513633267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,20461,1174,1.13 [1.03-1.24],0.0082541177736222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,20971,1208,1.04 [0.98-1.11],0.1644008032255277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],24101,1383,1.00 [0.92-1.08],0.9849364497377804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,24192,1398,1.11 [1.01-1.21],0.0272241441926066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUMB,Protein numb homolog,20528,1188,1.05 [0.98-1.12],0.1689274346722959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUP50,Nuclear pore complex protein Nup50,20461,1174,1.20 [1.03-1.40],0.0183520924240138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPE4,NXPE family member 4,20461,1174,1.09 [0.94-1.27],0.264594881799301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH1,Neurexophilin-1,23615,1355,1.04 [0.91-1.18],0.5655666131190651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH3,Neurexophilin-3,20528,1188,0.76 [0.64-0.91],0.0023032925085979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OBP2B,Odorant-binding protein 2b,23952,1370,0.96 [0.89-1.03],0.285701532631999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,21095,1216,1.83 [1.63-2.04],3.978275197263694e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,23578,1353,0.88 [0.80-0.97],0.0069425949121906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,20717,1204,1.03 [0.96-1.11],0.4339134691322629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGA,Protein O-GlcNAcase,21010,1209,1.05 [0.97-1.13],0.2349719353070205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGFR,Opioid growth factor receptor,24101,1383,1.12 [0.97-1.29],0.1309196084842468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,24192,1398,1.20 [1.07-1.35],0.0015887457801373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,20717,1204,0.99 [0.90-1.09],0.8668998625507494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLFM4,Olfactomedin-4,19893,1151,1.04 [0.99-1.09],0.134990988463311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,23972,1383,1.15 [1.07-1.24],0.0001025185891422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,24314,1410,0.69 [0.63-0.76],8.753259625006583e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,24101,1383,0.78 [0.73-0.84],1.0993913137991367e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMP,Olfactory marker protein,20435,1186,1.01 [0.90-1.14],0.8175143427679976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPHN1,Oligophrenin-1,21076,1210,1.03 [0.98-1.09],0.1985077844848857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPLAH,5-oxoprolinase,20595,1191,1.08 [0.99-1.17],0.0769368280878689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPTC,Opticin,24101,1383,0.92 [0.82-1.04],0.1720833891052309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,21094,1222,2.14 [1.64-2.79],1.8563441646028247e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,21076,1210,0.96 [0.84-1.11],0.5891304152388184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,24243,1405,1.47 [1.28-1.69],8.137700971388529e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,24032,1391,1.18 [1.11-1.26],4.026714761524426e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,24308,1407,1.49 [1.20-1.85],0.0002482400341062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSTN,Osteocrin,20531,1187,1.00 [0.87-1.14],0.9646645679086914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTOA,Otoancorin,20435,1186,1.02 [0.92-1.13],0.6679556846674767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,21010,1209,1.02 [0.93-1.12],0.6816444529070907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD7B,OTU domain-containing protein 7B,21095,1216,1.06 [0.98-1.16],0.1532513556148526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",20595,1191,1.10 [1.01-1.19],0.0247078039773093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,24408,1403,1.12 [1.09-1.16],3.3853526418910174e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,24080,1399,1.24 [1.10-1.40],0.0006486295205905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,20461,1174,1.05 [0.96-1.15],0.2625694121965387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI2,Protein-arginine deiminase type-2,23703,1359,1.00 [0.92-1.09],0.991725388986126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI4,Protein-arginine deiminase type-4,23578,1353,1.01 [0.95-1.08],0.795186219668046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAEP,Glycodelin,24033,1375,0.99 [0.96-1.03],0.6783747091366533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,21095,1216,0.97 [0.91-1.04],0.3855901034812699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",20717,1204,1.11 [1.00-1.24],0.0593235082203819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,23739,1376,1.27 [1.17-1.38],3.4842126814750118e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,20595,1191,1.16 [1.05-1.29],0.0044875559924739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,20331,1170,0.96 [0.86-1.07],0.4702354260274806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,23615,1355,1.07 [0.99-1.16],0.1103425761925969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALLD,Palladin,20528,1188,0.95 [0.82-1.09],0.4662072119677244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM,Paralemmin-1,20893,1201,1.09 [0.91-1.32],0.3484535858160751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,21076,1210,1.63 [1.44-1.85],2.089163963368321e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM3,Paralemmin-3,20461,1174,0.98 [0.90-1.06],0.6233815412582956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,24351,1411,1.25 [1.05-1.47],0.0098982240115373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAMR1,Inactive serine protease PAMR1,24192,1398,1.00 [0.84-1.18],0.995486830459996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAPPA,Pappalysin-1,23703,1359,0.99 [0.89-1.11],0.9249360772298808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARD3,Partitioning defective 3 homolog,20717,1204,1.07 [1.00-1.15],0.055663935907961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARK7,Parkinson disease protein 7,24192,1398,1.04 [0.95-1.14],0.3818167472686453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,24143,1396,1.16 [1.08-1.24],6.012149443925189e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAXX,Protein PAXX,20675,1203,1.22 [1.09-1.37],0.0008258440214606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,20372,1173,0.93 [0.77-1.12],0.453801562239204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,23615,1355,1.12 [1.02-1.23],0.0210203904840141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,21010,1209,1.14 [0.96-1.35],0.1442966328844893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCARE,Photoreceptor cilium actin regulator,20435,1186,1.00 [0.94-1.07],0.9413777410159884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,20636,1203,1.27 [1.14-1.43],2.194050117424436e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBP2,Poly(rC)-binding protein 2,21095,1216,1.04 [0.96-1.12],0.3477421164734704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH1,Protocadherin-1,24359,1406,1.11 [0.90-1.37],0.3183244997854176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH12,Protocadherin-12,21095,1216,0.84 [0.67-1.04],0.1158678918477313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH17,Protocadherin-17,24200,1394,0.81 [0.70-0.93],0.0029213793040713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH7,Protocadherin-7,21010,1209,0.95 [0.82-1.11],0.5308969171239076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH9,Protocadherin-9,21010,1209,0.82 [0.71-0.95],0.0094718693819697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,21007,1211,1.00 [0.88-1.15],0.964501257529259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCNA,Proliferating cell nuclear antigen,20372,1173,1.02 [0.93-1.11],0.723638813925314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,21007,1211,1.00 [0.88-1.13],0.9628073710318208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,24485,1416,1.27 [1.13-1.42],8.201669258358604e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,21010,1209,1.05 [0.98-1.13],0.1528196954009342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,21125,1219,1.04 [0.98-1.10],0.2172730142390589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1,Programmed cell death protein 1,24364,1400,1.04 [0.93-1.17],0.449169658969922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,24101,1383,0.99 [0.85-1.16],0.9231899210668156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD5,Programmed cell death protein 5,24408,1403,1.10 [1.01-1.19],0.0257480317787242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD6,Programmed cell death protein 6,24200,1394,1.06 [0.99-1.13],0.1038198968276965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCL2,Phosducin-like protein 2,20372,1173,1.08 [0.99-1.19],0.0958245598261574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",20372,1173,0.93 [0.83-1.04],0.1814773732145541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",20461,1174,0.93 [0.84-1.02],0.133694642282302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",20675,1203,1.02 [0.97-1.08],0.4673445007693386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,24485,1416,1.10 [1.03-1.17],0.0054046035837525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,24314,1410,1.08 [1.02-1.14],0.0080599194334901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFC,Platelet-derived growth factor C,23618,1368,1.16 [0.99-1.35],0.0707407629803415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,24200,1394,1.15 [0.98-1.37],0.0941776896905233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,24485,1416,0.93 [0.81-1.06],0.285131064065693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA2,Protein disulfide-isomerase A2,20372,1173,0.98 [0.85-1.12],0.7285105074586846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA3,Protein disulfide-isomerase A3,20675,1203,1.13 [0.91-1.41],0.274251662560008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA4,Protein disulfide-isomerase A4,21122,1217,1.06 [0.97-1.16],0.2125276333659043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA5,Protein disulfide-isomerase A5,20372,1173,1.07 [0.98-1.17],0.1135893578905781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,21095,1216,1.01 [0.97-1.06],0.5587389113285827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,24314,1410,1.03 [0.99-1.07],0.1710443275214004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",23618,1368,1.06 [0.96-1.16],0.2348848797772255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,20531,1187,0.94 [0.84-1.05],0.2619041870029315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,20372,1173,0.98 [0.90-1.07],0.676234530188419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,20461,1174,1.11 [1.01-1.21],0.0242662014922337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,20528,1188,1.28 [1.15-1.44],1.2996337548280846e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,24485,1416,0.88 [0.72-1.09],0.2461143752345275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,24192,1398,1.04 [0.96-1.12],0.3589011857357979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,24192,1398,1.00 [0.86-1.17],0.9904142332655468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,20595,1191,1.18 [0.98-1.43],0.0832402387312965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PENK,Proenkephalin-A,20675,1203,1.37 [1.15-1.63],0.0003760359259756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEPD,Xaa-Pro dipeptidase,21143,1218,0.88 [0.71-1.09],0.2466405123889512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PER3,Period circadian protein homolog 3,20528,1188,1.04 [1.00-1.09],0.0673548943298943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PF4,Platelet factor 4,21016,1220,1.07 [1.01-1.13],0.017642373942854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN2,Prefoldin subunit 2,23615,1355,1.03 [0.95-1.13],0.4696514476261813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN4,Prefoldin subunit 4,20372,1173,1.03 [0.93-1.13],0.6298748655943368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN6,Prefoldin subunit 6,20531,1187,1.00 [0.93-1.09],0.9298929825369492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",24056,1380,1.06 [1.00-1.13],0.0561382149299039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,21143,1218,1.23 [1.13-1.34],5.616411627365505e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",21125,1219,1.05 [0.96-1.16],0.3001964237003114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,24435,1413,1.54 [1.34-1.76],7.391173876311331e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,24364,1410,1.24 [1.12-1.37],4.5041173740697256e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,20895,1218,1.16 [0.97-1.39],0.1012613451410531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,20461,1174,1.01 [0.92-1.10],0.8147174529209973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGM2,Phosphoglucomutase-2,20531,1187,0.97 [0.88-1.06],0.4748475054125507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGR,Progesterone receptor,20528,1188,0.98 [0.92-1.04],0.522956845428406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,21095,1216,1.02 [0.97-1.07],0.4729916002030218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,21010,1209,1.13 [1.02-1.25],0.016466041726037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,20372,1173,1.02 [0.96-1.08],0.5681885013578479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,24033,1375,1.25 [1.08-1.45],0.0027482560718523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,20675,1203,1.08 [0.94-1.23],0.2787326361912503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI16,Peptidase inhibitor 16,21143,1218,0.85 [0.69-1.06],0.1496160666921582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,23861,1376,1.28 [1.17-1.39],3.100281195415456e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",21095,1216,1.03 [0.96-1.10],0.4552142319144515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,23886,1382,2.75 [2.47-3.06],5.965083055459413e-77
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,24143,1396,1.08 [1.00-1.17],0.0475115736500312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24192,1398,1.56 [1.32-1.85],2.106480824205713e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,20528,1188,1.08 [0.98-1.19],0.1242464032777361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,24192,1398,1.40 [1.24-1.57],2.5820786022763334e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,24200,1394,1.22 [1.11-1.33],1.2048384744168566e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,20675,1203,1.01 [0.93-1.09],0.8901985649177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PITHD1,PITH domain-containing protein 1,20331,1170,1.00 [0.94-1.07],0.9370414167667428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD1,Polycystin-1,21125,1219,0.93 [0.76-1.14],0.4930326732890385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD2,Polycystin-2,20461,1174,1.11 [1.01-1.21],0.0297194445269888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKLR,Pyruvate kinase PKLR,24235,1407,0.99 [0.92-1.06],0.678089875178147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKN3,Serine/threonine-protein kinase N3,20717,1204,1.05 [0.98-1.12],0.15789429645175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,24033,1375,1.04 [0.96-1.13],0.3168528650530799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,24272,1406,1.68 [1.41-1.99],3.0738526412747807e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,24436,1409,0.79 [0.71-0.89],5.7059030382000976e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",24111,1392,1.13 [1.05-1.21],0.0013439965568968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,24314,1410,1.03 [0.98-1.09],0.2373366566293988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,24192,1398,0.85 [0.73-0.98],0.0262582710801718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,24408,1411,1.31 [1.20-1.44],1.3772722880688742e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,24192,1398,0.95 [0.81-1.11],0.5247485345437907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,24049,1398,3.16 [2.66-3.76],3.5982224719565176e-39
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",21076,1210,0.91 [0.83-1.00],0.0403854261666285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",20528,1188,0.97 [0.85-1.09],0.5805207717652088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",21076,1210,1.03 [0.98-1.09],0.2391639102656295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,21076,1210,1.12 [1.03-1.21],0.0052507501999815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,20619,1198,1.34 [1.03-1.73],0.0297723930404875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN1,Perilipin-1,23615,1355,1.08 [0.95-1.23],0.265194643769794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN3,Perilipin-3,24200,1394,1.20 [1.08-1.33],0.0004701051822281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,24200,1394,1.05 [0.98-1.12],0.178355014746866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLSCR3,Phospholipid scramblase 3,21048,1208,1.06 [0.96-1.17],0.2229774971565857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLTP,Phospholipid transfer protein,24392,1413,0.75 [0.67-0.85],5.518945385089545e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC1,Plexin domain-containing protein 1,23618,1368,0.80 [0.68-0.94],0.0083351859926929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC2,Plexin domain-containing protein 2,21076,1210,0.81 [0.66-1.00],0.0458616440093563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNA4,Plexin-A4,24143,1396,1.04 [0.98-1.10],0.1622522420313234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,24366,1406,1.17 [0.95-1.43],0.1436788740958657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB3,Plexin-B3,24119,1389,1.06 [0.96-1.17],0.2523111039299888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,24077,1383,0.97 [0.94-0.99],0.006038282546917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMCH,Pro-MCH,20461,1174,1.01 [0.95-1.08],0.701511036322757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMM2,Phosphomannomutase 2,20461,1174,1.07 [0.98-1.18],0.1273848210295395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMS1,PMS1 protein homolog 1,20531,1187,1.05 [0.94-1.16],0.4130982420834084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMVK,Phosphomevalonate kinase,23574,1355,1.00 [0.96-1.04],0.9218035316150998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,21143,1218,0.89 [0.81-0.97],0.0066328712010772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,21076,1210,1.01 [0.94-1.09],0.7508360471975516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,24201,1404,1.01 [0.99-1.02],0.4524145628117566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,20595,1191,1.07 [0.97-1.19],0.1506895738463714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,20435,1186,1.19 [1.05-1.34],0.0067578095571005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",23703,1359,0.99 [0.95-1.03],0.6023142971604472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL,Podocalyxin,24101,1383,0.73 [0.54-0.99],0.0445693305545065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL2,Podocalyxin-like protein 2,24272,1406,0.81 [0.69-0.96],0.017395904442855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POF1B,Protein POF1B,20528,1188,1.09 [0.97-1.23],0.1484815398257032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,20528,1188,1.05 [0.87-1.27],0.598736062801416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",24101,1383,1.38 [1.24-1.54],3.3551199290598507e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POMC,Pro-opiomelanocortin,20595,1191,0.87 [0.80-0.95],0.001685152718588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,21143,1218,0.66 [0.55-0.79],5.788387035265542e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,23739,1376,1.38 [1.21-1.58],2.747051036772509e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,24314,1410,0.78 [0.66-0.91],0.0015589436208535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POSTN,Periostin,21122,1217,0.91 [0.79-1.06],0.2344135763339214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPBP,Platelet basic protein,21012,1220,1.08 [1.01-1.15],0.019988832173529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,24408,1403,1.05 [0.96-1.16],0.28224510617698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,24197,1400,1.04 [0.99-1.10],0.1114674713722587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,20717,1204,1.05 [0.97-1.14],0.1889762114526008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",21122,1217,1.04 [0.95-1.13],0.3873293795167082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPL,Periplakin,20528,1188,1.14 [0.98-1.33],0.0952296714333414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1A,Protein phosphatase 1A,23618,1368,0.97 [0.83-1.13],0.6998167673101697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1B,Protein phosphatase 1B,20528,1188,0.99 [0.90-1.08],0.7586245560742739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1F,Protein phosphatase 1F,21125,1219,1.03 [0.93-1.15],0.52313774530582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPME1,Protein phosphatase methylesterase 1,24101,1383,1.04 [0.96-1.12],0.3568466430111423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,21007,1211,1.03 [0.96-1.10],0.4242266673870327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,24272,1406,1.05 [1.00-1.10],0.066462299470851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,20717,1204,0.99 [0.92-1.07],0.8819796729014993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,21095,1216,1.02 [0.95-1.09],0.598234144891185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,21095,1216,1.28 [1.12-1.45],0.0002001599481246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,24200,1394,1.06 [0.99-1.12],0.0737889776471815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R9B,Neurabin-2,24435,1413,1.04 [0.99-1.09],0.1094134805945889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,21010,1209,1.00 [0.96-1.05],0.8609604823904622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP3R1,Calcineurin subunit B type 1,24033,1375,0.99 [0.89-1.11],0.8886476387807094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,20531,1187,0.98 [0.91-1.05],0.5713641540885531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPY,Pancreatic prohormone,24180,1396,1.06 [1.01-1.11],0.0170047064603847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PQBP1,Polyglutamine-binding protein 1,23618,1368,1.03 [0.95-1.12],0.4706864913136632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,20372,1173,0.93 [0.74-1.16],0.5066905796470815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,21122,1217,1.65 [1.45-1.89],1.486832385942688e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRC1,Protein regulator of cytokinesis 1,21007,1211,1.01 [0.90-1.13],0.9318113433693324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,24327,1405,1.23 [1.05-1.44],0.0085090527354665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX1,Peroxiredoxin-1,23539,1344,1.02 [0.96-1.07],0.5807098218615547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX2,Peroxiredoxin-2,20788,1197,0.98 [0.90-1.07],0.6305311676966782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",23703,1359,1.05 [0.99-1.13],0.1263899681066977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",24435,1413,1.01 [0.94-1.08],0.806720691660718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX6,Peroxiredoxin-6,24400,1401,0.94 [0.87-1.02],0.1461638896908672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PREB,Prolactin regulatory element-binding protein,23703,1359,1.03 [0.87-1.21],0.7392895008672893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRELP,Prolargin,24201,1404,0.93 [0.76-1.15],0.5055348911892252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,21122,1217,1.14 [1.02-1.27],0.0181196981090368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG3,Proteoglycan 3,21122,1217,0.96 [0.86-1.08],0.5243510956764785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,23703,1359,1.15 [1.05-1.25],0.0017032820459541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,20531,1187,0.82 [0.68-0.99],0.0340894961171657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,24200,1394,1.00 [0.95-1.06],0.9452105187430696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,21042,1209,1.04 [0.97-1.11],0.2301409600725197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKCQ,Protein kinase C theta type,23703,1359,1.03 [0.92-1.15],0.5784709658977563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,20461,1174,0.97 [0.86-1.09],0.565556647236493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,20675,1203,1.01 [0.97-1.06],0.532550097156098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,23618,1368,1.13 [1.05-1.21],0.0010704617275138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRL,Prolactin,24408,1403,1.08 [1.02-1.14],0.0108687874998458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRND,Prion-like protein doppel,21076,1210,1.06 [0.95-1.17],0.280927831215798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROC,Vitamin K-dependent protein C,24226,1403,0.94 [0.78-1.13],0.5153706633790566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROCR,Endothelial protein C receptor,20461,1174,1.00 [0.86-1.17],0.9950041812248462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROK1,Prokineticin-1,24143,1396,1.05 [0.98-1.12],0.1898262763084394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROS1,Vitamin K-dependent protein S,21172,1227,1.13 [0.89-1.44],0.3209090160535757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR4,Proline-rich protein 4,20528,1192,0.98 [0.91-1.07],0.7132834316075938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR5,Proline-rich protein 5,20528,1188,0.98 [0.87-1.11],0.7643509364178517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,20595,1191,1.08 [0.93-1.25],0.3033819607831892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,24267,1406,1.21 [1.11-1.31],1.2823102442724451e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,20528,1188,1.01 [0.87-1.18],0.8843760172622677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS27,Serine protease 27,24124,1390,1.13 [1.01-1.27],0.0353845476172579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS53,Serine protease 53,21076,1210,1.01 [0.88-1.17],0.8662492415160272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,24117,1402,1.98 [1.79-2.19],5.386195027754739e-41
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,23615,1355,1.01 [0.96-1.05],0.7731987857663029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTG,Protogenin,24400,1401,0.95 [0.78-1.15],0.5839790678585959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTN3,Myeloblastin,23549,1368,1.12 [1.02-1.23],0.0198584251741958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRUNE2,Protein prune homolog 2,20717,1204,1.30 [1.10-1.53],0.0017526462515038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,20922,1209,1.72 [1.51-1.97],2.714344631370929e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,21010,1209,0.95 [0.86-1.06],0.3598477232627645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSCA,Prostate stem cell antigen,21010,1209,0.99 [0.97-1.01],0.2846133168802491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,24033,1375,1.05 [1.01-1.10],0.0185595255028005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,24143,1396,1.12 [1.04-1.20],0.0016434268850349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMA1,Proteasome subunit alpha type-1,23618,1368,0.92 [0.83-1.03],0.1422800689338189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,20372,1173,1.00 [0.83-1.20],0.988430060598586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,21095,1216,1.00 [0.90-1.11],0.9650912933701956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,20531,1187,0.98 [0.88-1.08],0.6274301033310195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,24101,1383,1.02 [0.93-1.10],0.7062908338288514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME1,Proteasome activator complex subunit 1,23999,1374,1.11 [0.98-1.26],0.0983464203281178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME2,Proteasome activator complex subunit 2,23915,1366,1.17 [1.03-1.32],0.0181496461532308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG3,Proteasome assembly chaperone 3,24143,1396,1.05 [0.96-1.15],0.2887758999745695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG4,Proteasome assembly chaperone 4,20528,1188,1.00 [0.91-1.10],0.9564317178465612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSPN,Persephin,24143,1396,1.00 [0.95-1.04],0.8727262912880854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,23618,1368,1.08 [1.00-1.17],0.0491508904518139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,19908,1169,1.02 [0.97-1.08],0.4271092055154766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",23615,1355,1.08 [0.92-1.27],0.3474995825036886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,23982,1382,1.33 [1.13-1.56],0.000459147140428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGES2,Prostaglandin E synthase 2,20355,1181,1.17 [1.06-1.30],0.0019662654268673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,21125,1219,1.08 [1.01-1.16],0.0197151995659814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH,Parathyroid hormone,20531,1187,1.07 [1.00-1.15],0.0580990093211692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,24143,1396,1.03 [0.91-1.17],0.6281632105078343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,23615,1355,1.04 [0.92-1.18],0.5545921817522015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,23739,1376,1.25 [1.14-1.37],1.6228781884301564e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,20528,1188,1.03 [0.93-1.13],0.6208679427511208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,24033,1375,1.06 [0.99-1.12],0.0758342293665059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,24271,1407,1.01 [0.96-1.06],0.7300100994219318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,20487,1184,1.05 [0.91-1.21],0.5140806367570141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,21125,1219,1.30 [1.09-1.55],0.0034902753471648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,21122,1217,0.94 [0.74-1.20],0.616346505525153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,24485,1416,0.85 [0.72-1.00],0.0495354790023421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,21010,1209,0.81 [0.72-0.92],0.0007215835436094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,21010,1209,1.03 [0.81-1.30],0.8309294928192942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,24106,1395,0.78 [0.64-0.95],0.0119848483500407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,23947,1373,1.21 [1.04-1.40],0.0118592152233666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,21076,1210,0.88 [0.75-1.03],0.1031026078997167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,24485,1416,0.78 [0.65-0.94],0.0107574692768485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,21125,1219,0.89 [0.76-1.05],0.166829965986155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,20675,1203,0.99 [0.90-1.09],0.8465618430552996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,23512,1343,1.10 [1.01-1.20],0.0274569150863891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTTG1,Securin,20717,1204,1.07 [0.95-1.19],0.2739162438101118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,24143,1396,1.13 [1.03-1.25],0.0128754893800814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVALB,Parvalbumin alpha,24284,1394,0.99 [0.95-1.03],0.7097782817596017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,24408,1403,1.33 [1.19-1.49],5.13603796520038e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXDNL,Peroxidasin-like protein,21007,1211,1.00 [0.90-1.10],0.9264443725196998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXN,Paxillin,23615,1355,1.08 [0.98-1.18],0.1033376745959102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYDC1,Pyrin domain-containing protein 1,20595,1191,0.99 [0.87-1.13],0.8878128623562341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,20461,1174,1.21 [1.14-1.27],1.690374338988134e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PZP,Pregnancy zone protein,21172,1227,1.05 [0.96-1.14],0.2778232979281706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QDPR,Dihydropteridine reductase,24092,1385,1.11 [0.99-1.23],0.0641995156358205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,24219,1399,1.27 [1.06-1.52],0.0089330497423901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,20736,1206,1.02 [0.89-1.17],0.7479499028404033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB10,Ras-related protein Rab-10,21125,1219,1.02 [0.92-1.13],0.6704292705769748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,21125,1219,1.02 [0.97-1.07],0.5372549818348116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB27B,Ras-related protein Rab-27B,21125,1219,1.01 [0.94-1.08],0.8232018541154831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB2B,Ras-related protein Rab-2B,21007,1211,1.00 [0.91-1.09],0.9891278016841252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB33A,Ras-related protein Rab-33A,20461,1174,1.07 [0.98-1.16],0.1190054330412743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB37,Ras-related protein Rab-37,23703,1359,1.00 [0.94-1.06],0.9346496497242478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB39B,Ras-related protein Rab-39B,20461,1174,0.94 [0.87-1.00],0.0672357729289104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,20435,1186,0.98 [0.88-1.08],0.664237194466896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB44,Ras-related protein Rab-44,21007,1211,0.98 [0.87-1.10],0.6854160022128495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,24143,1396,0.88 [0.80-0.97],0.0097963965213547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6B,Ras-related protein Rab-6B,23615,1355,1.09 [0.99-1.21],0.0951004810002031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,20675,1203,1.06 [0.98-1.13],0.126657407587141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,23618,1368,1.01 [0.93-1.10],0.7792340195838089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,23703,1359,1.10 [1.01-1.19],0.0237376419080454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,20531,1187,0.98 [0.91-1.07],0.6917187254503596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,23618,1368,1.05 [0.95-1.17],0.3440023054977346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,20717,1204,1.03 [0.94-1.14],0.5107465832210034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALB,Ras-related protein Ral-B,20528,1188,1.06 [0.88-1.28],0.5602470883918752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALY,RNA-binding protein Raly,21007,1211,1.10 [0.99-1.21],0.0758235972860939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,20595,1191,1.07 [0.96-1.19],0.2004953365650176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,20435,1186,0.92 [0.78-1.10],0.3684923838175463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,23618,1368,1.07 [0.97-1.18],0.1649232847928723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAP1A,Ras-related protein Rap-1A,20528,1188,0.96 [0.88-1.04],0.331454148312455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,20717,1204,1.05 [0.95-1.17],0.3270338439873154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,23618,1368,1.09 [0.95-1.25],0.23464154835762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,24308,1407,1.49 [1.36-1.62],4.439048031072699e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASA1,Ras GTPase-activating protein 1,23615,1355,0.92 [0.79-1.07],0.3015419182296019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,20372,1173,1.15 [1.02-1.31],0.0247505990965496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,23618,1368,1.12 [1.04-1.21],0.0018368751035574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,21095,1216,1.61 [1.44-1.80],6.24098578970182e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBKS,Ribokinase,23620,1355,1.03 [0.94-1.13],0.5004921718756493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM17,Splicing factor 45,21095,1216,1.02 [0.95-1.10],0.500681249116461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM19,Probable RNA-binding protein 19,20461,1174,0.97 [0.86-1.10],0.6570384886559428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM25,RNA-binding protein 25,20372,1173,1.07 [0.96-1.21],0.2291768238316184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP1,Retinol-binding protein 1,20531,1187,0.98 [0.91-1.06],0.6960093658922029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,24101,1383,1.16 [1.10-1.23],2.55713384325301e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,24101,1383,1.29 [1.20-1.40],1.0811355420543435e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,21010,1209,1.07 [0.99-1.16],0.1098532080279478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,20528,1188,1.00 [0.92-1.08],0.98719990532362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,20595,1191,1.03 [0.98-1.09],0.2462339654640155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCC1,Regulator of chromosome condensation,21007,1211,1.04 [0.93-1.15],0.5187842142301446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCOR1,REST corepressor 1,23739,1376,1.04 [0.94-1.16],0.4681984370539511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,20595,1191,0.85 [0.64-1.12],0.2471674972675764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REEP4,Receptor expression-enhancing protein 4,21095,1216,1.04 [0.96-1.14],0.3347324016135594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,24032,1391,1.29 [1.18-1.42],3.796757750638201e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,24485,1416,1.22 [1.13-1.33],1.0325700571737804e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,24485,1416,1.15 [1.07-1.24],0.0002850080988269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,21007,1211,1.02 [0.89-1.17],0.7460423490848822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,24243,1405,1.33 [1.21-1.46],1.9990088976803947e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELB,Transcription factor RelB,20528,1188,0.95 [0.86-1.07],0.4072876779814431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,24192,1398,1.70 [1.44-1.99],1.5416450642084203e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,24200,1394,1.26 [1.18-1.34],6.542906821086104e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,20528,1188,1.06 [0.92-1.22],0.4057349738919628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REST,RE1-silencing transcription factor,20372,1173,1.07 [0.92-1.25],0.3704928045179416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,24101,1383,0.92 [0.82-1.04],0.17040250765427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RETN,Resistin,24126,1397,1.17 [1.05-1.30],0.0040119323745736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",20461,1174,0.96 [0.86-1.08],0.4995433811349689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RFC4,Replication factor C subunit 4,21007,1211,1.36 [1.11-1.67],0.0034063269902869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGCC,Regulator of cell cycle RGCC,21095,1216,1.03 [0.95-1.10],0.498325073744752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,20717,1204,0.96 [0.88-1.05],0.383573518062398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,24408,1403,0.72 [0.62-0.84],2.0364473046402875e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMB,RGM domain family member B,24408,1403,0.91 [0.75-1.09],0.2956578048689537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS10,Regulator of G-protein signaling 10,21095,1216,1.09 [1.00-1.20],0.0509858412465163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS8,Regulator of G-protein signaling 8,23703,1359,1.02 [0.95-1.09],0.5827314622754707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,23874,1366,1.01 [0.97-1.05],0.5776881566558287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,20528,1188,0.98 [0.87-1.10],0.7267535683760605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,20675,1203,1.24 [1.11-1.38],0.0001105844887808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILP,Rab-interacting lysosomal protein,24326,1396,1.01 [0.94-1.10],0.723230388262352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILPL2,RILP-like protein 2,21125,1219,1.03 [0.97-1.09],0.2892246896471311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,20461,1174,1.02 [0.95-1.10],0.5701385394236055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN1,Prorelaxin H1,21095,1216,0.99 [0.93-1.06],0.7941486474164899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN2,Prorelaxin H2,20638,1200,1.00 [0.96-1.04],0.9723870272392056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,21143,1218,1.53 [1.24-1.88],6.607730613334441e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,20595,1191,1.18 [1.05-1.32],0.0038969908389559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE3,Eosinophil cationic protein,24090,1386,1.02 [0.98-1.06],0.3450229610561469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,20450,1176,1.40 [1.16-1.69],0.0004654103646158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,20988,1209,1.86 [1.61-2.15],2.939897016328918e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,21095,1216,1.04 [0.93-1.17],0.4643882039857318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,24364,1408,1.51 [1.28-1.78],7.279522602659611e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,20595,1191,1.86 [1.57-2.19],2.4767846952929066e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,20528,1188,1.01 [0.88-1.16],0.8333064930251743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,20528,1188,0.92 [0.78-1.08],0.314249793967889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,20717,1204,1.06 [0.98-1.15],0.1477767170583986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,23618,1368,1.06 [0.98-1.13],0.1346709524566484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,20717,1204,1.02 [0.93-1.11],0.7259178841060944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,20595,1191,1.05 [0.98-1.14],0.1757989614755584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO1,Roundabout homolog 1,24243,1405,0.94 [0.77-1.14],0.5062922072779745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO2,Roundabout homolog 2,24408,1403,0.91 [0.75-1.11],0.3384496931660474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO4,Roundabout homolog 4,20595,1191,1.20 [0.88-1.63],0.2404270424539118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,24200,1394,0.92 [0.79-1.07],0.2939253272796687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RP2,Protein XRP2,24101,1383,0.99 [0.88-1.10],0.8047664633712617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPA2,Replication protein A 32 kDa subunit,20528,1188,1.05 [0.87-1.26],0.6212832260524703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,20717,1204,1.03 [0.95-1.11],0.5338630607141732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,20531,1187,1.00 [0.88-1.14],0.9751494389734676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPL14,60S ribosomal protein L14,20595,1191,1.11 [0.98-1.26],0.0971629329165307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPS10,40S ribosomal protein S10,20461,1174,1.00 [0.87-1.14],0.9802635972718948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRAS,Ras-related protein R-Ras,20531,1187,1.04 [1.00-1.09],0.0610653323511099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,23618,1368,1.22 [1.14-1.31],2.98142845520788e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,23618,1368,0.97 [0.91-1.04],0.4476314874775408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRP15,RRP15-like protein,20435,1186,0.96 [0.91-1.02],0.232148568064779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,24033,1375,1.37 [1.20-1.56],4.567989817206624e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,24400,1401,1.44 [1.23-1.70],9.43041578013932e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTBDN,Retbindin,24101,1383,1.05 [0.90-1.24],0.5116261255013982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTKN2,Rhotekin-2,20461,1174,1.00 [0.90-1.10],0.9647792994537516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",21095,1216,1.01 [0.95-1.07],0.7805883873758956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4R,Reticulon-4 receptor,24400,1401,1.06 [0.93-1.21],0.3758562530200593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RUVBL1,RuvB-like 1,23618,1368,1.00 [0.96-1.05],0.9918539198194484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RWDD1,RWD domain-containing protein 1,24408,1403,1.04 [0.97-1.12],0.266153470589118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RYR1,Ryanodine receptor 1,20461,1174,1.02 [0.87-1.19],0.8374844688937388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,24007,1383,1.10 [1.01-1.21],0.0325180109336026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A12,Protein S100-A12,23883,1377,1.07 [1.00-1.13],0.0394483401860786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A13,Protein S100-A13,20528,1188,1.01 [0.87-1.18],0.8562356973543115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A14,Protein S100-A14,21095,1216,0.99 [0.89-1.10],0.8547463448302957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A16,Protein S100-A16,23578,1353,1.04 [0.97-1.12],0.2790565391095555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A3,Protein S100-A3,21007,1211,0.95 [0.82-1.09],0.4512693169127991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A4,Protein S100-A4,24272,1406,1.00 [0.92-1.09],0.9367501073572008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100G,Protein S100-G,21095,1216,1.09 [0.97-1.22],0.1311991079778708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100P,Protein S100-P,23739,1376,1.05 [0.97-1.14],0.2608786327556651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAA4,Serum amyloid A-4 protein,21172,1227,0.96 [0.79-1.17],0.6657852318738395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAFB2,Scaffold attachment factor B2,21095,1216,0.95 [0.76-1.17],0.6027186971744112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAG,S-arrestin,20435,1186,1.00 [0.89-1.11],0.9538317904142826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,24143,1396,1.08 [1.01-1.15],0.0183313013992889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,20717,1204,0.98 [0.91-1.05],0.5516191292539541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SARG,Specifically androgen-regulated gene protein,21040,1217,1.04 [0.99-1.10],0.1146405024686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,20461,1174,1.04 [0.90-1.21],0.5737965599742312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT1,Diamine acetyltransferase 1,20461,1174,0.91 [0.81-1.03],0.1345712548139469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,20717,1204,0.98 [0.91-1.07],0.7052474640717781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SATB1,DNA-binding protein SATB1,21095,1216,0.98 [0.81-1.19],0.8489765802793663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SBSN,Suprabasin,21081,1214,1.06 [0.90-1.25],0.4612295853801134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,24101,1383,1.06 [1.00-1.12],0.0534184151856174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARA5,Scavenger receptor class A member 5,24408,1403,1.12 [0.95-1.32],0.1721969276383592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB1,Scavenger receptor class B member 1,23615,1355,1.01 [0.93-1.10],0.8149017993035647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,23585,1349,1.66 [1.44-1.92],9.608883551059692e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,24485,1416,1.23 [1.10-1.37],0.0002073107639149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,24408,1403,1.03 [0.87-1.21],0.7555319025000331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,24288,1393,1.37 [1.19-1.59],1.980941947791886e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG3,Secretogranin-3,24243,1405,0.91 [0.79-1.04],0.1671803327462667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,24237,1405,0.64 [0.61-0.68],2.3730449585159266e-50
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB2A2,Mammaglobin-A,20461,1174,1.02 [0.86-1.21],0.8422551250966974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,20675,1203,1.27 [1.01-1.58],0.0392632567082383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,24271,1407,1.20 [1.15-1.25],4.899241599934832e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGN,Secretagogin,23703,1359,1.08 [0.97-1.20],0.1414044354655646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCIN,Adseverin,20435,1186,0.96 [0.88-1.04],0.2853033672927883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,24326,1396,1.30 [1.19-1.42],1.8437304746859925e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,20435,1186,0.95 [0.84-1.07],0.4003836932130796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2B,Sodium channel subunit beta-2,20531,1187,0.91 [0.75-1.11],0.3702902306650837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,20531,1187,0.96 [0.83-1.12],0.6228179581376804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3B,Sodium channel subunit beta-3,20435,1186,1.00 [0.90-1.12],0.9563712638432386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN4B,Sodium channel subunit beta-4,20595,1191,1.20 [1.06-1.37],0.0054344970043301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCP2,Non-specific lipid-transfer protein,23618,1368,1.02 [0.96-1.09],0.5284616085148852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,20507,1183,1.35 [1.21-1.50],5.7084510150610016e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRG1,Scrapie-responsive protein 1,21125,1219,1.17 [0.96-1.42],0.1161393010345209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRIB,Protein scribble homolog,20595,1191,1.05 [0.99-1.11],0.0769761171206798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRN1,Secernin-1,24143,1396,1.02 [0.94-1.11],0.6569944270593526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCT,Secretin,20531,1187,0.87 [0.77-0.99],0.0306462130245827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,24200,1394,1.08 [0.95-1.22],0.2352841006020623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC4,Syndecan-4,24200,1394,0.96 [0.87-1.07],0.4550602899086099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,21007,1211,1.03 [0.98-1.08],0.2318308886649243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,21010,1209,1.07 [0.99-1.15],0.0912675425149522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDK2,Protein sidekick-2,20675,1203,0.97 [0.84-1.12],0.6644469416893358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEC31A,Protein transport protein Sec31A,20595,1191,1.05 [0.98-1.13],0.191180346474394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,20595,1191,1.32 [1.15-1.52],0.0001192260218319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,24485,1416,1.17 [1.06-1.28],0.0011713002580242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,21172,1227,0.63 [0.49-0.81],0.0002747449749269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELL,L-selectin,21172,1227,0.59 [0.47-0.74],5.3963534403073664e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELP,P-selectin,24267,1406,1.14 [1.06-1.24],0.0010454600965595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,24143,1396,1.38 [1.16-1.64],0.0002966898791573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3F,Semaphorin-3F,24200,1394,1.27 [1.06-1.53],0.0105737431607314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3G,Semaphorin-3G,20675,1203,0.97 [0.85-1.10],0.6076068678560389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4C,Semaphorin-4C,24101,1383,0.93 [0.78-1.11],0.4358933272228694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4D,Semaphorin-4D,24408,1403,1.07 [0.92-1.25],0.3910388289979103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA6C,Semaphorin-6C,20528,1188,1.00 [0.80-1.24],0.9681166488148228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA7A,Semaphorin-7A,24408,1411,0.85 [0.71-1.03],0.0920151665913591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,21095,1216,0.99 [0.92-1.07],0.793850224238742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN7,Septin-7,20717,1204,1.01 [0.91-1.12],0.8781414513964466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,21037,1208,1.45 [1.24-1.69],2.7317899467432617e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN9,Septin-9,24101,1383,1.07 [0.90-1.27],0.427297645074316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,20763,1204,3.19 [1.53-6.63],0.001909206990658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,24485,1416,1.06 [0.94-1.19],0.3253832226908019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA12,Serpin A12,23500,1360,0.98 [0.93-1.02],0.3049529931287257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,21088,1225,1.97 [1.41-2.73],5.843894301162038e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA4,Kallistatin,20775,1199,0.93 [0.73-1.18],0.5484108548245985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA5,Plasma serine protease inhibitor,20858,1207,1.07 [0.90-1.28],0.4573722496506003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,21172,1227,1.10 [0.82-1.48],0.5185601288902466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA7,Thyroxine-binding globulin,21172,1227,0.95 [0.71-1.27],0.7339579071056825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA9,Serpin A9,23978,1372,1.06 [0.99-1.13],0.0852648912184597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,24119,1394,1.04 [0.99-1.10],0.1305739533047644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB5,Serpin B5,23739,1376,0.95 [0.86-1.05],0.3142784749581913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB6,Serpin B6,24334,1399,1.06 [0.98-1.14],0.1711684811592679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,24435,1413,1.20 [1.12-1.29],3.4608390797411174e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB9,Serpin B9,24033,1375,1.02 [0.88-1.18],0.8164900889843296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINC1,Antithrombin-III,21123,1225,0.78 [0.53-1.14],0.1926082722437749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,21123,1225,1.65 [1.35-2.01],1.0061790990291903e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,24485,1416,1.15 [1.07-1.24],0.0001243243287695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE2,Glia-derived nexin,21125,1219,1.09 [1.01-1.18],0.0248114797235118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF1,Pigment epithelium-derived factor,20848,1207,1.52 [1.23-1.87],0.0001085377519684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,20769,1207,0.67 [0.45-0.99],0.0425850710591627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,21123,1225,1.61 [1.20-2.16],0.0013675358166251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINH1,Serpin H1,20717,1204,1.05 [1.01-1.10],0.01841564283996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI1,Neuroserpin,20634,1200,1.06 [0.89-1.26],0.4912201883742064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI2,Serpin I2,21010,1209,0.94 [0.85-1.04],0.2058971426785145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,23615,1355,1.09 [1.01-1.17],0.0239571162852319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,23954,1366,0.99 [0.84-1.17],0.8855073717326953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6,Seizure protein 6 homolog,20531,1187,0.89 [0.74-1.06],0.194658978135576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L,Seizure 6-like protein,24272,1406,0.73 [0.61-0.86],0.0002597893412935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L2,Seizure 6-like protein 2,24101,1383,0.89 [0.72-1.09],0.2448270267120461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SF3B4,Splicing factor 3B subunit 4,24101,1383,0.97 [0.91-1.04],0.3945738215941129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,23955,1371,1.17 [1.05-1.30],0.0059975011646326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,20675,1203,0.85 [0.74-0.97],0.0154493362161363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,23618,1368,1.11 [1.03-1.20],0.0052990911523953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,23618,1368,1.43 [1.34-1.53],1.709370051326919e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,24200,1394,1.18 [1.10-1.26],3.449435073195568e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,20758,1193,1.17 [1.06-1.28],0.0010825080650342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2B3,SH2B adapter protein 3,23618,1368,1.06 [1.01-1.11],0.0269391980934675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,24143,1396,1.14 [1.06-1.23],0.0005710483689011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,20435,1186,1.05 [0.96-1.14],0.2951123447841018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BP1,SH3 domain-binding protein 1,21010,1209,1.08 [0.96-1.20],0.1928866439052109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GL3,Endophilin-A3,20603,1198,1.00 [0.94-1.07],0.918452703292555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GLB2,Endophilin-B2,21076,1210,1.05 [0.97-1.14],0.2384427610243735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHBG,Sex hormone-binding globulin,21143,1218,0.99 [0.89-1.10],0.8788014164073848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHC1,SHC-transforming protein 1,20372,1173,0.99 [0.95-1.04],0.8250533944903888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHD,SH2 domain-containing adapter protein D,20417,1173,1.01 [0.94-1.07],0.8422880844827222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHH,Sonic hedgehog protein,20528,1188,1.04 [0.92-1.18],0.5671414819879924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,21122,1217,1.91 [1.61-2.26],1.0050061030624633e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",24271,1407,1.03 [0.98-1.09],0.2507784971780068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHPK,Sedoheptulokinase,20717,1204,0.91 [0.78-1.05],0.1803667275371619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,24232,1402,1.19 [1.08-1.31],0.0005255364487075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,24314,1410,1.25 [1.12-1.39],6.44693936798996e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,24143,1396,1.25 [1.09-1.44],0.0016020418802164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,23615,1355,0.94 [0.88-1.00],0.0428842169094713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,24192,1398,1.02 [0.97-1.06],0.4761520431734227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,24400,1401,1.07 [0.94-1.23],0.3092486557678179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,24200,1394,1.65 [1.41-1.93],7.548613374164057e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,20595,1191,1.25 [1.11-1.41],0.000179650839905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,24365,1399,1.23 [1.04-1.44],0.0133966826439133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIL1,Nucleotide exchange factor SIL1,20595,1191,1.18 [1.02-1.36],0.0234139302157365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,24239,1402,1.04 [0.96-1.13],0.3164607114038719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,24165,1404,1.18 [1.06-1.31],0.0019280030565068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,20528,1188,0.98 [0.91-1.05],0.5578627328350486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,24101,1383,1.03 [0.97-1.08],0.3345692419967146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23615,1355,1.03 [0.95-1.12],0.5018468863435177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,23703,1359,1.30 [1.20-1.41],9.897142102752431e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,23984,1373,1.15 [1.08-1.22],1.5032275603993357e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,24314,1410,1.03 [0.98-1.07],0.2438368940412759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKIV2L,Helicase SKI2W,20461,1174,0.99 [0.86-1.13],0.8378553158566757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLA2,Src-like-adapter 2,21095,1216,1.01 [0.95-1.06],0.8231525847912138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,23703,1359,1.08 [0.99-1.17],0.0678715055797895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,23618,1368,1.20 [1.05-1.36],0.0063185183273143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,24143,1396,1.06 [0.98-1.15],0.1407790045760513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,23618,1368,1.16 [1.06-1.28],0.0014858257515861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC12A2,Solute carrier family 12 member 2,20461,1174,0.97 [0.78-1.20],0.7540327588241234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC13A1,Solute carrier family 13 member 1,21007,1211,1.01 [0.92-1.12],0.7573649615705911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,23615,1355,1.05 [0.97-1.13],0.2181152079616942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC1A4,Neutral amino acid transporter A,20531,1187,0.97 [0.87-1.08],0.5952306769851738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,23615,1355,1.05 [0.98-1.13],0.1597682597694147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,20372,1173,1.03 [0.94-1.12],0.5749148659466632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,20372,1173,0.99 [0.88-1.11],0.8465823612960438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A14,Zinc transporter ZIP14,23615,1355,1.05 [0.91-1.21],0.4777701667879308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A5,Zinc transporter ZIP5,24143,1396,1.10 [1.02-1.19],0.0191969296621885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC44A4,Choline transporter-like protein 4,20531,1187,0.98 [0.90-1.06],0.5900668262553782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC4A1,Band 3 anion transport protein,21122,1217,0.89 [0.79-0.99],0.0356210032975697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC51B,Organic solute transporter subunit beta,20461,1174,1.04 [0.97-1.11],0.2904655685188612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,20675,1203,1.08 [1.01-1.15],0.0239591413123486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,21010,1209,1.01 [0.91-1.13],0.803856336410878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",20372,1173,0.96 [0.87-1.07],0.4736272795855787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIT2,Slit homolog 2 protein,23615,1355,1.05 [0.96-1.15],0.2805566219758197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,20528,1188,0.63 [0.53-0.75],1.400592853638932e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,24400,1401,0.67 [0.60-0.76],1.635953348239994e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,23739,1376,0.84 [0.73-0.97],0.0180088999337575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,20717,1204,1.02 [0.95-1.10],0.563040742781155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,21010,1209,1.03 [0.97-1.10],0.3168222324275623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,20959,1207,1.03 [0.89-1.19],0.6893518775985341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,23618,1368,1.08 [1.02-1.15],0.0070239390566164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,21007,1211,1.09 [1.01-1.18],0.0289173895885514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,21007,1211,0.99 [0.88-1.11],0.8435185099170239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,24101,1383,1.39 [1.08-1.78],0.0111831998559105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,23615,1355,1.06 [1.00-1.14],0.0603835031242733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,20372,1173,0.88 [0.79-0.98],0.0239022898994956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,21010,1209,1.10 [1.03-1.19],0.0085538667271833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,24400,1401,1.37 [1.19-1.58],1.027182111200648e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,24314,1410,1.34 [1.19-1.51],1.6236945593220365e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,24291,1398,1.35 [1.24-1.48],3.5214244462084327e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,20528,1188,0.97 [0.87-1.08],0.5373941593385015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,24278,1410,1.13 [1.05-1.22],0.0009397974620116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,21007,1211,1.10 [1.02-1.18],0.0146125907805504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMS,Spermine synthase,20435,1186,1.03 [0.94-1.13],0.4830009681077863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,21035,1209,1.06 [1.00-1.12],0.0461384255948999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP23,Synaptosomal-associated protein 23,24200,1394,1.04 [0.98-1.09],0.2247473919058543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP25,Synaptosomal-associated protein 25,20435,1186,1.09 [0.97-1.23],0.1374091439853595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP29,Synaptosomal-associated protein 29,24272,1406,1.05 [1.00-1.11],0.0574504879972456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAPIN,SNARE-associated protein Snapin,21095,1216,1.08 [0.98-1.18],0.1344939254789389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCA,Alpha-synuclein,20675,1203,1.01 [0.96-1.06],0.6870667493462748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCG,Gamma-synuclein,24033,1375,1.03 [0.96-1.11],0.4242963683523814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",20595,1191,1.13 [0.96-1.33],0.145321734891193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',21076,1210,1.16 [1.05-1.29],0.0037740101614126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNU13,NHP2-like protein 1,20461,1174,0.94 [0.86-1.04],0.2315003090455472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX15,Sorting nexin-15,20675,1203,1.05 [0.95-1.16],0.3138664378603473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX18,Sorting nexin-18,21010,1209,1.00 [0.89-1.13],0.9528302569625356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX2,Sorting nexin-2,21007,1211,1.03 [0.95-1.11],0.5089474472453039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX5,Sorting nexin-5,20595,1191,1.11 [0.92-1.35],0.2699291577844501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX9,Sorting nexin-9,24200,1394,1.07 [1.00-1.14],0.0607342711519093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],23682,1370,1.05 [0.96-1.16],0.2998512215591136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",24192,1398,1.34 [1.19-1.50],1.1583948728484134e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD3,Extracellular superoxide dismutase,21143,1218,0.94 [0.85-1.04],0.2083157791952327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,21095,1216,1.08 [0.96-1.21],0.2235813924156215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,23618,1368,1.42 [1.24-1.62],1.7398778022162178e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORD,Sorbitol dehydrogenase,24289,1395,1.06 [0.99-1.14],0.0819493700828793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORT1,Sortilin,24160,1391,1.19 [1.05-1.34],0.0063917002318263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOST,Sclerostin,24160,1391,1.13 [0.99-1.27],0.0616090276491951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,20531,1187,0.94 [0.84-1.06],0.3250194079252325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX2,Transcription factor SOX-2,21059,1216,0.89 [0.69-1.14],0.3504620072936818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX9,Transcription factor SOX-9,20531,1187,0.95 [0.77-1.17],0.6230209670015183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,21095,1216,0.82 [0.67-1.00],0.0462333823173165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPAG1,Sperm-associated antigen 1,21095,1216,1.00 [0.91-1.10],0.976806529249499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARC,SPARC,24272,1406,1.13 [1.06-1.21],0.0004093288967482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARCL1,SPARC-like protein 1,24192,1404,0.88 [0.74-1.05],0.1690513797865229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPART,Spartin,20675,1203,1.08 [1.00-1.16],0.0377387470406214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPESP1,Sperm equatorial segment protein 1,21125,1219,1.15 [0.94-1.41],0.168712325816406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,24192,1398,1.53 [1.40-1.67],1.884321946025669e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,20675,1203,1.19 [1.04-1.37],0.0132030103648036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,24143,1396,1.19 [1.11-1.28],5.048453928356954e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,24192,1398,0.96 [0.83-1.11],0.5463681977166152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,24400,1401,1.15 [1.06-1.26],0.0016109011567029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,20461,1174,0.94 [0.81-1.11],0.4800018486001104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,24123,1395,1.73 [1.47-2.03],2.9526553745646545e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,24314,1410,1.26 [1.12-1.41],5.630298577094493e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,21010,1209,0.98 [0.94-1.03],0.4477045638601501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPOCK1,Testican-1,24033,1375,0.79 [0.66-0.96],0.0157306417585103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,24243,1405,1.45 [1.26-1.68],2.65094517931384e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,24081,1385,1.48 [1.30-1.69],2.607643627097987e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,24441,1415,1.06 [0.96-1.17],0.2571924150148278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",20528,1188,1.02 [0.90-1.16],0.7466427947869239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRING1,SREBP regulating gene protein,20372,1173,0.99 [0.90-1.09],0.8065136282837997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR1B,Cornifin-B,20717,1204,0.98 [0.91-1.05],0.5790050863631583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR3,Small proline-rich protein 3,21076,1210,1.04 [0.97-1.12],0.2685648207804325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRY2,Protein sprouty homolog 2,23703,1359,1.07 [1.01-1.13],0.0127563921686902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",20435,1186,0.97 [0.82-1.16],0.7630321062635756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,21076,1210,1.08 [0.94-1.24],0.279875809601431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,24231,1405,1.01 [0.97-1.05],0.5628186230941028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,24101,1383,1.12 [1.04-1.21],0.0033549620167596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPK2,SRSF protein kinase 2,24143,1396,1.09 [1.03-1.15],0.0035827628658195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,21125,1219,1.23 [1.04-1.45],0.0156792724557291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSB,Lupus La protein,23615,1355,1.02 [0.94-1.12],0.5973462085713837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",20528,1188,0.96 [0.82-1.14],0.663400061894559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,24160,1391,0.92 [0.88-0.96],0.0005505624872907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,24267,1406,1.15 [1.03-1.28],0.0121188880779915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,20372,1173,1.11 [0.93-1.34],0.2529528199849953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,21010,1209,1.05 [0.95-1.17],0.3295046133181231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST13,Hsc70-interacting protein,20675,1203,1.01 [0.92-1.11],0.8586666170606779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",24101,1383,1.00 [0.89-1.11],0.9411471549756968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",24485,1416,1.61 [1.37-1.88],2.934048241607988e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",20528,1188,0.93 [0.82-1.06],0.2810035896441267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,21122,1217,1.16 [0.96-1.40],0.1289423666322924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAM,Signal transducing adapter molecule 1,21007,1211,1.02 [0.89-1.17],0.7478823776359314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAMBP,STAM-binding protein,23984,1373,1.05 [0.98-1.13],0.181100875881733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT2,Signal transducer and activator of transcription 2,20528,1188,1.06 [0.98-1.14],0.1421240517774051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,24101,1383,1.01 [0.97-1.04],0.6395381891282762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,20372,1173,1.00 [0.92-1.09],0.9834733884261796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,24408,1403,1.21 [1.08-1.35],0.0006708997658368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC2,Stanniocalcin-2,24162,1396,1.19 [0.99-1.43],0.0591761680663159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STEAP4,Metalloreductase STEAP4,20435,1186,0.97 [0.90-1.05],0.4575668675380319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,24161,1395,1.03 [0.96-1.11],0.4111763044842024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK11,Serine/threonine-protein kinase STK11,23739,1376,1.06 [1.00-1.13],0.0671322322090061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK24,Serine/threonine-protein kinase 24,23615,1355,1.06 [0.98-1.14],0.173767018068918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK4,Serine/threonine-protein kinase 4,24200,1394,1.04 [0.98-1.10],0.1790444997106445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",20372,1173,0.98 [0.92-1.04],0.5190231687937558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX16,Syntaxin-16,23618,1368,1.01 [0.93-1.10],0.7319273885623536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX1B,Syntaxin-1B,20531,1187,0.90 [0.78-1.04],0.1551443289349948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX3,Syntaxin-3,21076,1210,1.00 [0.87-1.15],0.9744858188852448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX4,Syntaxin-4,24101,1383,1.05 [0.97-1.13],0.2106641567820186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX5,Syntaxin-5,20528,1188,0.85 [0.73-0.99],0.0372789058400036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX6,Syntaxin-6,23618,1368,1.03 [0.96-1.11],0.4147050340646689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX7,Syntaxin-7,20528,1188,0.94 [0.84-1.04],0.2371724813573664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX8,Syntaxin-8,24143,1396,1.12 [1.02-1.23],0.0207631135980814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP1,Syntaxin-binding protein 1,21095,1216,0.98 [0.91-1.05],0.5100572878589333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP3,Syntaxin-binding protein 3,23618,1368,1.06 [0.95-1.19],0.283095480103391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,21010,1209,1.11 [0.97-1.26],0.1212954010976759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGT1,Protein SGT1 homolog,23618,1368,1.02 [0.97-1.09],0.4281866299711503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT1A1,Sulfotransferase 1A1,24408,1403,1.00 [0.97-1.04],0.8491527042192589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,24143,1396,1.28 [1.20-1.38],2.1796472453247864e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF1,Formylglycine-generating enzyme,20528,1188,1.05 [0.97-1.13],0.2547007589906184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,24408,1403,1.13 [1.03-1.24],0.0096609692991042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",21095,1216,1.09 [1.00-1.19],0.0620918855206485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD1,Sushi domain-containing protein 1,23739,1376,1.03 [0.94-1.14],0.5052276211651585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,24192,1398,1.75 [1.57-1.96],7.794361232423927e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD4,Sushi domain-containing protein 4,21007,1211,0.90 [0.80-1.03],0.1222344239672413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,20559,1199,0.80 [0.68-0.95],0.0089719378743296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,20531,1187,1.00 [0.92-1.10],0.9319309864914136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SWAP70,Switch-associated protein 70,21010,1209,1.14 [0.98-1.32],0.0818213573971037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYAP1,Synapse-associated protein 1,20675,1203,1.10 [1.00-1.21],0.0566969618000581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,20435,1186,1.03 [0.94-1.13],0.5420222588289639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYT1,Synaptotagmin-1,21076,1210,1.11 [0.98-1.26],0.1056227305045872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYTL4,Synaptotagmin-like protein 4,21125,1219,1.06 [0.98-1.14],0.1259543040730543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,20717,1204,1.01 [0.96-1.06],0.7683781523755177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,24101,1383,1.00 [0.96-1.05],0.8118665898812016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,21440,1222,0.96 [0.80-1.14],0.6301700941139695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TADA3,Transcriptional adapter 3,21007,1211,1.13 [0.98-1.30],0.0903941679744657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,24101,1383,1.24 [1.09-1.41],0.0011114558743742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAGLN3,Transgelin-3,20372,1173,0.93 [0.85-1.02],0.1362028279249185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TALDO1,Transaldolase,21038,1216,1.11 [0.98-1.25],0.0885709425411531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,23703,1359,1.10 [1.03-1.17],0.0047276536973505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAP1,Antigen peptide transporter 1,20717,1204,0.98 [0.89-1.08],0.6656317962537737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,23615,1355,1.07 [1.01-1.14],0.0328340029365046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",20531,1187,0.95 [0.88-1.02],0.1556123343567614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",21007,1211,0.93 [0.80-1.07],0.3099652258209022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAX1BP1,Tax1-binding protein 1,21076,1210,1.10 [1.01-1.20],0.0210849881638028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D17,TBC1 domain family member 17,23615,1355,0.98 [0.88-1.09],0.6844491658647816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D23,TBC1 domain family member 23,24101,1383,1.02 [0.97-1.08],0.4223088384040708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D5,TBC1 domain family member 5,24143,1396,1.06 [1.00-1.12],0.0544856716852794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCA,Tubulin-specific chaperone A,20675,1203,1.04 [0.97-1.10],0.2777602783468615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCB,Tubulin-folding cofactor B,24033,1375,1.02 [0.97-1.07],0.4178549032702885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCC,Tubulin-specific chaperone C,24033,1375,1.04 [0.98-1.10],0.249997726155398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,23618,1368,1.03 [0.97-1.09],0.2803691384969363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBR1,T-box brain protein 1,20531,1187,1.01 [0.90-1.13],0.8971162641791354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,23993,1373,1.03 [0.98-1.08],0.3085271325368224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,23739,1376,0.98 [0.92-1.05],0.5416573871049307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,20712,1197,1.04 [0.87-1.23],0.685962784027942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,24441,1415,1.06 [0.91-1.25],0.4357990441102022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,21125,1219,1.39 [1.18-1.63],5.134472353676656e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCP11,T-complex protein 11 homolog,20717,1204,0.98 [0.88-1.08],0.6491821620219498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,21125,1219,1.49 [1.24-1.80],2.7723097021835124e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,23615,1355,1.01 [0.98-1.05],0.5629477862428043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",20531,1187,0.98 [0.85-1.14],0.8184092697761356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,21007,1211,1.01 [0.93-1.10],0.8115115855855917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDRKH,Tudor and KH domain-containing protein,23615,1355,1.02 [0.97-1.08],0.4178741652458526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEF,Thyrotroph embryonic factor,20461,1174,1.02 [0.90-1.16],0.7206781283824084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEK,Angiopoietin-1 receptor,24272,1406,0.88 [0.71-1.10],0.2729531542241596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TERF1,Telomeric repeat-binding factor 1,20528,1188,0.94 [0.78-1.14],0.5472498987586102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TET2,Methylcytosine dioxygenase TET2,20675,1203,1.02 [0.97-1.08],0.3832643535702461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX101,Testis-expressed protein 101,20531,1187,0.99 [0.86-1.14],0.9082730395321412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX33,Testis-expressed protein 33,20717,1204,0.90 [0.79-1.03],0.1416076146100869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TF,Serotransferrin,21172,1227,1.14 [0.89-1.47],0.3053334519383789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,20435,1186,1.00 [0.91-1.11],0.9361988357827132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,24070,1393,1.25 [1.18-1.31],6.067202076235228e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,24271,1407,1.52 [1.42-1.63],6.0488847435728e-32
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,24147,1398,1.31 [1.20-1.42],1.83274936438842e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI,Tissue factor pathway inhibitor,24105,1392,1.17 [1.01-1.35],0.0408475072198211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,24192,1404,1.39 [1.29-1.50],2.4564390060503697e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFRC,Transferrin receptor protein 1,24272,1406,0.98 [0.87-1.10],0.744202126501821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TG,Thyroglobulin,21007,1211,1.03 [0.99-1.09],0.1665404898669339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,24143,1396,1.42 [1.30-1.55],2.1084315260092138e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,24392,1408,1.35 [1.20-1.52],1.1848831142637756e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,21007,1211,0.99 [0.90-1.10],0.8992953098780777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,24025,1390,1.09 [0.91-1.29],0.3560316516538223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR1,TGF-beta receptor type-1,20528,1188,1.24 [0.99-1.56],0.0603144058886464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,24272,1406,1.45 [1.27-1.67],1.244178574047457e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,24485,1416,1.07 [0.93-1.24],0.338587105933763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,24161,1392,1.00 [0.94-1.06],0.97423357950624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,21143,1218,1.18 [0.96-1.45],0.115669198786689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,20331,1170,1.01 [0.95-1.07],0.773320227276822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBD,Thrombomodulin,24200,1394,1.06 [0.90-1.26],0.4843194376489039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,24192,1398,1.36 [1.21-1.54],7.441384895118267e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS4,Thrombospondin-4,24182,1397,1.01 [0.91-1.13],0.8189481556551546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,24090,1387,1.24 [1.06-1.45],0.0077139828492169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THPO,Thrombopoietin,23739,1376,1.17 [1.03-1.31],0.0128792990020419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,20461,1174,0.98 [0.94-1.03],0.5041418341382258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,20359,1183,0.87 [0.74-1.03],0.1121924234267199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THTPA,Thiamine-triphosphatase,20980,1209,1.04 [0.98-1.11],0.1839094402581946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THY1,Thy-1 membrane glycoprotein,24408,1403,1.10 [0.93-1.31],0.2494371748046731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,23469,1362,1.02 [0.98-1.06],0.3157302206747668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,24485,1416,1.13 [1.01-1.26],0.0324370432114352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",23566,1353,1.12 [1.01-1.24],0.0276851594657274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,20717,1204,1.16 [1.01-1.34],0.0411456715654896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,24267,1406,1.14 [1.02-1.26],0.0166474522030444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,21125,1219,1.08 [0.94-1.24],0.2593928526060473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,21076,1210,1.02 [0.96-1.09],0.5237418343903282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,23896,1380,1.72 [1.48-2.01],6.9396997557334266e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,21125,1219,1.21 [0.95-1.55],0.1159526292338456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,24314,1410,1.03 [1.00-1.07],0.0700623694054126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,24192,1398,1.24 [1.11-1.39],9.549745423750992e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,24115,1389,0.73 [0.58-0.91],0.0043881379500848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJAP1,Tight junction-associated protein 1,24272,1406,1.07 [1.01-1.13],0.0265997701213065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJP3,Tight junction protein ZO-3,20435,1186,1.00 [0.87-1.14],0.9497731725127092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TK1,"Thymidine kinase, cytosolic",20717,1204,0.99 [0.87-1.13],0.9077873301053496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR1,Toll-like receptor 1,20528,1188,0.98 [0.79-1.21],0.868604292330829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR2,Toll-like receptor 2,20717,1204,1.12 [0.89-1.43],0.3348011225992634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR3,Toll-like receptor 3,24435,1413,1.04 [0.97-1.12],0.2964037032945004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR4,Toll-like receptor 4,20528,1188,0.97 [0.79-1.18],0.7287361434073579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,20531,1187,1.07 [0.97-1.18],0.171562770597395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,20717,1204,1.00 [0.91-1.10],0.9487159987806324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,20461,1174,0.94 [0.83-1.06],0.295458006514352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,20461,1174,0.94 [0.85-1.05],0.2525746053605747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED8,Protein TMED8,21010,1209,1.02 [0.97-1.08],0.4332637473922202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM106A,Transmembrane protein 106A,21007,1211,1.04 [0.97-1.12],0.2799687511418381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM132A,Transmembrane protein 132A,20595,1191,1.02 [0.93-1.11],0.7293870526830832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM25,Transmembrane protein 25,21095,1216,0.98 [0.85-1.13],0.7649871924610935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMOD4,Tropomodulin-4,20372,1173,1.09 [0.96-1.25],0.1845894731526549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,20435,1186,0.95 [0.88-1.03],0.1992652827855446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,21037,1208,1.07 [0.92-1.24],0.4062472233431571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS15,Enteropeptidase,24101,1383,1.11 [1.06-1.17],5.104687052084289e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS5,Transmembrane protease serine 5,23914,1367,0.91 [0.80-1.03],0.1210728087581987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,24192,1398,1.12 [1.05-1.19],0.00037665216294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,24267,1406,1.03 [0.93-1.14],0.5218562721744393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,23703,1373,1.36 [1.25-1.47],7.125407247293008e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,21010,1209,1.18 [1.07-1.30],0.0013662777309987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,23703,1359,0.97 [0.85-1.11],0.6983189300115046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,20675,1203,1.05 [0.97-1.15],0.2313279529414561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,24033,1375,1.95 [1.73-2.20],3.914848764192059e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,24033,1375,1.83 [1.77-1.88],0.0
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,24233,1407,1.14 [1.04-1.25],0.0053208674413514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,24435,1413,1.38 [1.23-1.55],4.3325815464936144e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,24201,1404,1.37 [1.18-1.59],4.278595550109084e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,24272,1406,1.81 [1.60-2.05],1.6810380255587182e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,24243,1405,1.33 [1.15-1.53],0.0001140412315708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,23703,1359,0.92 [0.82-1.03],0.1393033096269088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,24243,1405,1.69 [1.46-1.96],3.715444752842153e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20675,1203,0.91 [0.80-1.05],0.1942484006802499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,24400,1401,1.25 [1.08-1.45],0.0025119912524391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24192,1398,1.82 [1.57-2.12],2.8888692083031626e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,24192,1398,1.58 [1.47-1.68],7.361229438004342e-41
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,24408,1403,1.16 [0.98-1.38],0.0913254077400804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24392,1408,1.33 [1.18-1.50],2.0762730776083352e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,24033,1375,1.47 [1.37-1.58],3.144932205658965e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,24408,1403,1.02 [0.92-1.14],0.6715621455421086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24033,1375,1.32 [1.17-1.48],3.0316148620671293e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,24435,1413,0.92 [0.77-1.10],0.3445734969206251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,24143,1396,0.85 [0.79-0.92],4.444457530745255e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,24435,1413,0.82 [0.70-0.96],0.0164621368944995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,24314,1410,1.62 [1.37-1.92],3.0477948776529386e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,24443,1415,1.57 [1.34-1.83],1.0985614285002742e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,24033,1375,1.11 [1.02-1.20],0.0135527283500422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,21122,1217,1.07 [0.93-1.24],0.3437802191161766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,21076,1210,1.06 [1.00-1.13],0.0529861184314157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNN,Tenascin-N,21122,1217,0.90 [0.79-1.02],0.1032861084439595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNNI3,"Troponin I, cardiac muscle",23739,1376,0.97 [0.92-1.02],0.1782908606909402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNPO1,Transportin-1,20717,1204,0.99 [0.84-1.16],0.855328468314273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,24033,1375,0.69 [0.62-0.77],1.001074124187436e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNXB,Tenascin-X,24192,1398,0.90 [0.75-1.08],0.2707065662503123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,21125,1219,1.05 [0.98-1.13],0.1669470201664135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1,DNA topoisomerase 1,21010,1209,0.94 [0.89-0.99],0.0296846519188986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",20372,1173,1.06 [0.96-1.18],0.2697640822163756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP2B,DNA topoisomerase 2-beta,20528,1188,1.10 [1.03-1.18],0.005654444527252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,20595,1191,1.10 [1.00-1.20],0.0597080288098566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53,Cellular tumor antigen p53,23618,1368,1.02 [0.91-1.15],0.7213098029347313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53BP1,TP53-binding protein 1,20528,1188,0.91 [0.86-0.98],0.008136213070846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,20228,1169,1.08 [0.98-1.20],0.1321089613095907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,23739,1376,0.99 [0.85-1.14],0.849121508040041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP73,Tumor protein p73,20531,1187,0.92 [0.79-1.09],0.3333952158402678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPBGL,Trophoblast glycoprotein-like,20531,1187,0.92 [0.80-1.06],0.2330159251787597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPD52L2,Tumor protein D54,20675,1203,1.02 [0.97-1.08],0.4046640676660046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,21125,1219,1.30 [1.09-1.55],0.003287834388652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPM3,Tropomyosin alpha-3 chain,20461,1174,1.07 [0.93-1.22],0.3434269955488006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPMT,Thiopurine S-methyltransferase,23618,1368,1.00 [0.94-1.07],0.9782514497344597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,24045,1394,1.49 [1.38-1.60],7.616813034549256e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,20717,1204,0.97 [0.91-1.04],0.4076975378925288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,23615,1355,1.02 [0.91-1.15],0.6924058100213787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPR,Nucleoprotein TPR,20461,1174,1.07 [0.96-1.19],0.2190342591300592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,20372,1173,0.92 [0.84-1.01],0.0816949751945992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSAB1,Tryptase alpha/beta-1,24395,1409,1.09 [1.00-1.20],0.0585531863264698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSD1,Tryptase delta,21095,1216,1.07 [0.93-1.23],0.3703780870822702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSG1,Tryptase gamma,20528,1188,1.10 [0.90-1.35],0.3431420428945673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPT1,Translationally-controlled tumor protein,23703,1359,0.93 [0.86-1.00],0.042583040085048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF2,TNF receptor-associated factor 2,24143,1396,1.04 [0.97-1.11],0.2548439861054444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",20528,1188,0.94 [0.80-1.10],0.4416525766433766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,20461,1174,0.98 [0.87-1.11],0.7573160011277036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,20717,1204,1.05 [0.98-1.11],0.1391727873924103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREH,Trehalase,21122,1217,1.07 [0.99-1.15],0.0845726622620301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,24201,1404,1.69 [1.55-1.83],1.0204887229723368e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML1,Trem-like transcript 1 protein,21143,1218,1.06 [0.96-1.17],0.2697844418424082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML2,Trem-like transcript 2 protein,24192,1398,0.90 [0.79-1.04],0.1517919839266479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,24400,1401,1.11 [1.03-1.20],0.0044074672866777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,24143,1396,1.00 [0.95-1.07],0.8852717534388123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,20671,1201,1.10 [1.01-1.20],0.0225871787252329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,21010,1209,1.04 [0.98-1.09],0.1832990039362533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM26,Tripartite motif-containing protein 26,20372,1173,0.99 [0.89-1.09],0.8357707520792762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,20531,1187,1.07 [1.00-1.16],0.062691110835437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM5,Tripartite motif-containing protein 5,24143,1396,1.05 [0.99-1.11],0.0810722245748161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,21007,1211,1.03 [0.96-1.09],0.4382826570038315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,20461,1174,0.93 [0.83-1.05],0.2548269863671697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC1,Hamartin,20528,1188,0.98 [0.91-1.06],0.6516086548996904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC22D1,TSC22 domain family protein 1,21095,1216,1.02 [0.94-1.11],0.6082892662447501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSHB,Thyrotropin subunit beta,24200,1394,0.95 [0.90-1.01],0.0913099553160238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSLP,Thymic stromal lymphopoietin,23739,1376,0.98 [0.90-1.06],0.582991427842694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSNAX,Translin-associated protein X,20461,1174,0.95 [0.82-1.09],0.4456528411254186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN1,Tetraspanin-1,23739,1376,0.88 [0.73-1.06],0.1867197565677092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN15,Tetraspanin-15,20461,1174,0.96 [0.85-1.07],0.439089668161581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN7,Tetraspanin-7,20435,1186,0.95 [0.89-1.02],0.1580952915002724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,21010,1209,1.08 [1.02-1.13],0.0076053985871667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,20528,1188,1.04 [0.90-1.19],0.6068162602623716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TST,Thiosulfate sulfurtransferase,23571,1354,1.03 [0.96-1.09],0.4433808748718633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTF2,Transcription termination factor 2,20531,1187,1.04 [0.93-1.17],0.4398335857346686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTN,Titin,20461,1174,0.98 [0.90-1.08],0.7370111597035064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,20929,1213,1.03 [0.83-1.28],0.7702985274423377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TUBB3,Tubulin beta-3 chain,20435,1186,1.03 [0.85-1.25],0.732724725908855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TWF2,Twinfilin-2,21122,1217,1.04 [0.97-1.11],0.275163020256252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXK,Tyrosine-protein kinase TXK,20717,1204,1.00 [0.93-1.07],0.9369324105531138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXLNA,Alpha-taxilin,24033,1375,1.09 [1.03-1.15],0.003210820815826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXN,Thioredoxin,20798,1198,1.06 [0.93-1.20],0.3799439598632952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,24272,1406,1.20 [1.02-1.42],0.0328830794950286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,24408,1403,1.09 [1.02-1.17],0.01167342214938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,21076,1210,1.06 [0.96-1.17],0.2522818242714393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNL1,Thioredoxin-like protein 1,20390,1181,0.97 [0.91-1.04],0.4014259942070742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",24192,1398,1.09 [0.98-1.20],0.1160662566617798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,24036,1383,1.09 [1.01-1.17],0.0204401787250724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,24200,1394,0.85 [0.72-1.00],0.0523787478011585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",20528,1188,1.10 [1.00-1.20],0.0433939587083089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,24101,1383,1.00 [0.87-1.14],0.9493459913663672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,21007,1211,0.96 [0.79-1.15],0.6339664462134255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,21125,1219,1.15 [1.05-1.26],0.0020120536516385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,20528,1188,1.00 [0.91-1.10],0.9647472558701136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBQLN3,Ubiquilin-3,20461,1174,0.99 [0.88-1.13],0.920814264033904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBXN1,UBX domain-containing protein 1,20675,1203,1.06 [0.98-1.15],0.1210341654038721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,21010,1209,1.02 [0.98-1.06],0.379066893066066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,20461,1174,1.00 [0.94-1.06],0.929703241861668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,20461,1174,0.99 [0.84-1.16],0.870942926932187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,24033,1375,1.43 [1.26-1.61],1.090663047957219e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,24411,1409,0.77 [0.71-0.84],8.620626725002611e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC5D,Netrin receptor UNC5D,20528,1188,1.07 [0.86-1.32],0.5498296136846483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC79,Protein unc-79 homolog,20372,1173,1.06 [0.97-1.17],0.2169805551509802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNG,Uracil-DNA glycosylase,21007,1211,1.07 [0.91-1.26],0.4135499339010937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPB1,Beta-ureidopropionase,21125,1219,1.11 [1.05-1.17],0.0004950068321914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3A,Uroplakin-3a,20435,1186,1.02 [0.91-1.14],0.7266308675067901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,20681,1204,0.97 [0.88-1.07],0.5852717434864172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROD,Uroporphyrinogen decarboxylase,20675,1203,1.05 [0.97-1.13],0.2603420988044449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROS,Uroporphyrinogen-III synthase,20531,1187,0.96 [0.88-1.04],0.2801155186992619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USO1,General vesicular transport factor p115,24101,1383,1.01 [0.96-1.06],0.7627661596554616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,21007,1211,1.08 [1.00-1.17],0.0423332379848999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,21076,1210,1.03 [0.90-1.18],0.691902749522699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,20461,1174,0.98 [0.92-1.05],0.5890878336366472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,23739,1376,1.05 [0.99-1.10],0.0779738131880456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,23618,1368,1.05 [0.96-1.15],0.2533935409452753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,23739,1376,1.07 [0.97-1.17],0.1744340231882765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,20528,1188,1.04 [0.98-1.11],0.1848224882715463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,24143,1396,1.04 [0.98-1.10],0.2326669974629581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASN,Vasorin,23777,1368,0.92 [0.78-1.10],0.3587837330965264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,21143,1218,1.03 [0.95-1.11],0.4537000729676005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,24101,1383,0.67 [0.53-0.86],0.0014556656835241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,20435,1186,1.03 [0.97-1.09],0.3450769574345036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,24226,1403,0.99 [0.83-1.18],0.869214328940716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,24408,1403,0.99 [0.85-1.15],0.8750187980297685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,20372,1173,0.97 [0.91-1.04],0.4452474625529981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,24354,1408,1.24 [1.15-1.33],1.8850490128521564e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,20528,1188,1.06 [0.87-1.29],0.550953165572797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFC,Vascular endothelial growth factor C,24272,1406,1.09 [1.00-1.19],0.0411702458229994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,24389,1412,1.17 [1.02-1.35],0.0224933074704469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VGF,Neurosecretory protein VGF,21095,1216,0.94 [0.79-1.13],0.5185900363919547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIM,Vimentin,23739,1376,1.01 [0.97-1.05],0.6926256333324341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,20595,1191,1.12 [0.92-1.37],0.2615706158076195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,21125,1219,1.22 [1.04-1.42],0.0123088224764064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,24101,1383,1.11 [1.03-1.19],0.0055355309471266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN1,Pantetheinase,21143,1218,1.08 [1.00-1.16],0.0560008855063656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,24101,1383,1.06 [0.96-1.17],0.2616592943776273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,20717,1204,1.04 [0.96-1.13],0.3711407898326671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,24101,1383,1.05 [0.99-1.11],0.1226571672361729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,21007,1211,1.03 [0.97-1.09],0.3812407284259631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,24101,1383,1.04 [0.98-1.11],0.1875811908812454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,21007,1211,1.07 [0.93-1.23],0.3557021322977022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,20461,1174,1.13 [0.96-1.34],0.1275456758542306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,21007,1211,1.47 [1.34-1.60],6.066064291309193e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,24162,1396,1.51 [1.34-1.69],4.827509925622754e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,24166,1390,1.10 [1.03-1.18],0.0081424787679661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,21076,1210,1.21 [1.04-1.40],0.0108472793995659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,23615,1355,1.08 [0.98-1.19],0.1322257930228664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,20717,1204,0.99 [0.86-1.13],0.8698538291425398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,23739,1376,1.06 [0.97-1.15],0.190421829884375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,24408,1403,1.00 [0.94-1.07],0.9229906251312432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,23618,1368,1.02 [0.87-1.19],0.805613585548059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,20675,1203,1.10 [1.01-1.20],0.0374989910808146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,24361,1398,1.54 [1.39-1.71],5.901429847828957e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,20372,1173,1.06 [0.99-1.13],0.0861793300329056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,23943,1369,1.33 [1.18-1.50],4.062139361577216e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,21095,1216,0.99 [0.88-1.11],0.8784716114896347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWF,von Willebrand factor,24485,1416,1.06 [0.99-1.13],0.0903319405705997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",24192,1398,1.20 [1.05-1.36],0.0062173298732287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,23703,1359,1.04 [0.97-1.11],0.2560576407580125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,23739,1376,1.06 [1.00-1.11],0.0323039250339761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,23615,1355,1.00 [0.95-1.06],0.9307302131723274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASHC3,WASH complex subunit 3,21076,1210,1.04 [0.97-1.11],0.2843356177466203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,20528,1188,0.94 [0.85-1.03],0.1851356494353471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WDR46,WD repeat-containing protein 46,21007,1211,1.08 [0.94-1.24],0.2769442807594539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,20580,1183,1.16 [1.07-1.26],0.0005565876783997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,24365,1400,1.15 [1.07-1.24],8.219718047976294e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,22947,1323,2.56 [2.34-2.81],1.8179306868103188e-91
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",23954,1366,0.70 [0.62-0.78],3.7098014371358646e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",24243,1405,0.82 [0.72-0.93],0.0030337074617189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,24400,1401,0.97 [0.85-1.12],0.7102331367080941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,23703,1359,1.12 [0.96-1.30],0.149748301197292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,24033,1375,1.04 [0.95-1.13],0.4438558817999515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,24400,1401,1.15 [1.06-1.25],0.0005421288320714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XG,Glycoprotein Xg,24363,1407,1.07 [0.91-1.25],0.4238093743266529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,20528,1188,1.06 [0.96-1.16],0.2523450351948167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,24272,1406,0.98 [0.93-1.03],0.3875610237374903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XRCC4,DNA repair protein XRCC4,23615,1355,1.11 [0.98-1.27],0.1000229281485736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,21076,1210,1.66 [1.36-2.01],3.542186547614791e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",21010,1209,1.02 [0.98-1.06],0.3394529236140674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YES1,Tyrosine-protein kinase Yes,24101,1383,1.04 [1.00-1.09],0.0536335438758758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YJU2,Splicing factor YJU2,21007,1211,1.02 [0.87-1.19],0.8344925242840359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,20461,1174,1.03 [0.94-1.13],0.4973966717158689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YTHDF3,YTH domain-containing family protein 3,23703,1359,1.05 [0.99-1.11],0.1229026387467727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YWHAQ,14-3-3 protein theta,20675,1203,1.04 [0.97-1.12],0.2880801789899252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YY1,Transcriptional repressor protein YY1,20528,1188,1.15 [0.94-1.39],0.1673388513558756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBP1,Z-DNA-binding protein 1,20528,1188,1.00 [0.87-1.15],0.9977036790270774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,23618,1368,1.04 [0.97-1.12],0.2485079444343731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,23739,1376,1.22 [1.11-1.34],5.565503691134362e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,20461,1174,1.04 [0.95-1.13],0.3711043885606223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,21010,1209,1.00 [0.94-1.06],0.8954575698345683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,21076,1210,1.05 [0.89-1.23],0.5675610009532456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF174,Zinc finger protein 174,20528,1188,1.01 [0.87-1.16],0.9451185503321932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF75D,Zinc finger protein 75D,20717,1204,0.97 [0.88-1.06],0.5235157679030247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF830,Zinc finger protein 830,21007,1211,0.97 [0.90-1.04],0.4121200657493961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRD2,Protein ZNRD2,21010,1209,1.08 [1.00-1.17],0.0435351245684936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,21007,1211,1.02 [0.92-1.13],0.6678515157427981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,20595,1191,1.00 [0.98-1.02],0.9031251856605248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,20372,1173,0.90 [0.76-1.07],0.2332899027555806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZPR1,Zinc finger protein ZPR1,20435,1186,1.01 [0.95-1.07],0.7944093058656132
